AromaDb: A Database of Plant's Aroma Molecules

Butyro-1,4-lactone Details

: IUPAC Name
4-Hydroxybutyricacidlactone
:Chemical Class
:CAS Registry Number
96-48-0
:Description

:Fragrance Type
caramel

Physical and Chemical properties

PUBCHEM ID7302
Molecular Weight (mg/mol)86.092
Molecular FormulaC4H6O2
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count0
Rotatable Bond Count0
IUPAC Name4-Hydroxybutyricacidlactone
Canonical SMILESO=C1CCCO1
PUBCHEM IUPAC INCHIKEYYEJRWHAVMIAJKC-UHFFFAOYSA-N
Solubility Level4
Vapour Pressure-0.103

Absorption and Metabolism information

XLOGP3 AANA
CACTVS TPSA0
BBB Level2
Absorption Level1
EXT PPB#Prediction0
AlogP980.276
EXT CYP2D6#Prediction0

Toxicological Information

Mouse Female FDAMulti-Carcinogen
Mouse Male FDAMulti-Carcinogen
Rat Female FDASingle-Carcinogen
Rat Male FDAMulti-Carcinogen
Ames PredictionNon-Mutagen
Developmental / Reproductive ToxicityToxic
Rat Oral LD503.42902
Ocular IrritancyModerate
Hepatotoxic#Prediction0
Effected Human GenesNA

Ecological Information

Aerobic Biodegradability PredictionDegradable

Hazard(s) Identification

Physical hazardsnot classified
Health hazards Mild
Environmental hazardsnot classified
About Table Headings

Compound Biological Activity

Serial No.Cas No Gene SymbolOrganismInteraction Interaction ActionsPubMed Id
1 96-48-0 AAAS Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AAAS mRNA affects^cotreatment|increases^expression 19167446
2 96-48-0 AAAS Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AAAS mRNA affects^cotreatment|increases^expression 19167446
3 96-48-0 ABCC5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ABCC5 mRNA affects^cotreatment|decreases^expression 19167446
4 96-48-0 ABCC5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ABCC5 mRNA affects^cotreatment|decreases^expression 19167446
5 96-48-0 ABCF1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ABCF1 mRNA affects^cotreatment|increases^expression 19167446
6 96-48-0 ABCF1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ABCF1 mRNA affects^cotreatment|increases^expression 19167446
7 96-48-0 ABCG1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ABCG1 mRNA affects^cotreatment|decreases^expression 19167446
8 96-48-0 ABCG1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ABCG1 mRNA affects^cotreatment|decreases^expression 19167446
9 96-48-0 ABHD11 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ABHD11 mRNA affects^cotreatment|decreases^expression 19167446
10 96-48-0 ABHD11 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ABHD11 mRNA affects^cotreatment|decreases^expression 19167446
11 96-48-0 ABHD12 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ABHD12 mRNA affects^cotreatment|increases^expression 19167446
12 96-48-0 ABHD12 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ABHD12 mRNA affects^cotreatment|increases^expression 19167446
13 96-48-0 ABHD2 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of ABHD2 mRNA decreases^expression 19167446
14 96-48-0 ABHD2 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of ABHD2 mRNA decreases^expression 19167446
15 96-48-0 ACAA2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ACAA2 mRNA affects^cotreatment|decreases^expression 19167446
16 96-48-0 ACAA2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ACAA2 mRNA affects^cotreatment|decreases^expression 19167446
17 96-48-0 ACAT2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ACAT2 mRNA affects^cotreatment|increases^expression 19167446
18 96-48-0 ACAT2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ACAT2 mRNA affects^cotreatment|increases^expression 19167446
19 96-48-0 ACBD3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ACBD3 mRNA affects^cotreatment|decreases^expression 19167446
20 96-48-0 ACBD3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ACBD3 mRNA affects^cotreatment|decreases^expression 19167446
21 96-48-0 ACKR3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ACKR3 mRNA affects^cotreatment|decreases^expression 19167446
22 96-48-0 ACKR3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ACKR3 mRNA affects^cotreatment|decreases^expression 19167446
23 96-48-0 ACLY Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ACLY mRNA affects^cotreatment|increases^expression 19167446
24 96-48-0 ACLY Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ACLY mRNA affects^cotreatment|increases^expression 19167446
25 96-48-0 ACOT4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ACOT4 mRNA affects^cotreatment|increases^expression 19167446
26 96-48-0 ACOT4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ACOT4 mRNA affects^cotreatment|increases^expression 19167446
27 96-48-0 ACOT7 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ACOT7 mRNA affects^cotreatment|increases^expression 19167446
28 96-48-0 ACOT7 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ACOT7 mRNA affects^cotreatment|increases^expression 19167446
29 96-48-0 ACYP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ACYP1 mRNA affects^cotreatment|increases^expression 19167446
30 96-48-0 ACYP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ACYP1 mRNA affects^cotreatment|increases^expression 19167446
31 96-48-0 ADAT1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ADAT1 mRNA affects^cotreatment|increases^expression 19167446
32 96-48-0 ADAT1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ADAT1 mRNA affects^cotreatment|increases^expression 19167446
33 96-48-0 ADD3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ADD3 mRNA affects^cotreatment|increases^expression 19167446
34 96-48-0 ADD3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ADD3 mRNA affects^cotreatment|increases^expression 19167446
35 96-48-0 AFAP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AFAP1 mRNA affects^cotreatment|decreases^expression 19167446
36 96-48-0 AFAP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AFAP1 mRNA affects^cotreatment|decreases^expression 19167446
37 96-48-0 AFF4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AFF4 mRNA affects^cotreatment|decreases^expression 19167446
38 96-48-0 AFF4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AFF4 mRNA affects^cotreatment|decreases^expression 19167446
39 96-48-0 AGR2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AGR2 mRNA affects^cotreatment|increases^expression 19167446
40 96-48-0 AGR2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AGR2 mRNA affects^cotreatment|increases^expression 19167446
41 96-48-0 AGR3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AGR3 mRNA affects^cotreatment|increases^expression 19167446
42 96-48-0 AGR3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AGR3 mRNA affects^cotreatment|increases^expression 19167446
43 96-48-0 AJUBA Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AJUBA mRNA affects^cotreatment|decreases^expression 19167446
44 96-48-0 AJUBA Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AJUBA mRNA affects^cotreatment|decreases^expression 19167446
45 96-48-0 AKAP13 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AKAP13 mRNA affects^cotreatment|decreases^expression 19167446
46 96-48-0 AKAP13 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AKAP13 mRNA affects^cotreatment|decreases^expression 19167446
47 96-48-0 ALG6 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ALG6 mRNA affects^cotreatment|increases^expression 19167446
48 96-48-0 ALG6 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ALG6 mRNA affects^cotreatment|increases^expression 19167446
49 96-48-0 ALG8 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ALG8 mRNA affects^cotreatment|increases^expression 19167446
50 96-48-0 ALG8 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ALG8 mRNA affects^cotreatment|increases^expression 19167446
51 96-48-0 AMD1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AMD1 mRNA affects^cotreatment|increases^expression 19167446
52 96-48-0 AMD1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AMD1 mRNA affects^cotreatment|increases^expression 19167446
53 96-48-0 AMMECR1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AMMECR1 mRNA affects^cotreatment|increases^expression 19167446
54 96-48-0 AMMECR1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AMMECR1 mRNA affects^cotreatment|increases^expression 19167446
55 96-48-0 AMOTL2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AMOTL2 mRNA affects^cotreatment|decreases^expression 19167446
56 96-48-0 AMOTL2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AMOTL2 mRNA affects^cotreatment|decreases^expression 19167446
57 96-48-0 ANLN Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of ANLN mRNA increases^expression 19167446
58 96-48-0 ANLN Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of ANLN mRNA increases^expression 19167446
59 96-48-0 ANLN Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ANLN mRNA affects^cotreatment|increases^expression 19167446
60 96-48-0 ANLN Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ANLN mRNA affects^cotreatment|increases^expression 19167446
61 96-48-0 ANO6 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of ANO6 mRNA decreases^expression 19167446
62 96-48-0 ANO6 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of ANO6 mRNA decreases^expression 19167446
63 96-48-0 ANO6 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ANO6 mRNA affects^cotreatment|decreases^expression 19167446
64 96-48-0 ANO6 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ANO6 mRNA affects^cotreatment|decreases^expression 19167446
65 96-48-0 ANP32E Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ANP32E mRNA affects^cotreatment|increases^expression 19167446
66 96-48-0 ANP32E Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ANP32E mRNA affects^cotreatment|increases^expression 19167446
67 96-48-0 ANXA2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ANXA2 mRNA affects^cotreatment|decreases^expression 19167446
68 96-48-0 ANXA2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ANXA2 mRNA affects^cotreatment|decreases^expression 19167446
69 96-48-0 ANXA2P2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ANXA2P2 mRNA affects^cotreatment|decreases^expression 19167446
70 96-48-0 ANXA2P2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ANXA2P2 mRNA affects^cotreatment|decreases^expression 19167446
71 96-48-0 ANXA3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ANXA3 mRNA affects^cotreatment|decreases^expression 19167446
72 96-48-0 ANXA3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ANXA3 mRNA affects^cotreatment|decreases^expression 19167446
73 96-48-0 ANXA9 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ANXA9 mRNA affects^cotreatment|increases^expression 19167446
74 96-48-0 ANXA9 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ANXA9 mRNA affects^cotreatment|increases^expression 19167446
75 96-48-0 AP1B1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AP1B1 mRNA affects^cotreatment|increases^expression 19167446
76 96-48-0 AP1B1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AP1B1 mRNA affects^cotreatment|increases^expression 19167446
77 96-48-0 AP1M1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AP1M1 mRNA affects^cotreatment|increases^expression 19167446
78 96-48-0 AP1M1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AP1M1 mRNA affects^cotreatment|increases^expression 19167446
79 96-48-0 APBB2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of APBB2 mRNA affects^cotreatment|decreases^expression 19167446
80 96-48-0 APBB2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of APBB2 mRNA affects^cotreatment|decreases^expression 19167446
81 96-48-0 APOBEC3B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of APOBEC3B mRNA affects^cotreatment|increases^expression 19167446
82 96-48-0 APOBEC3B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of APOBEC3B mRNA affects^cotreatment|increases^expression 19167446
83 96-48-0 AQP3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AQP3 mRNA affects^cotreatment|decreases^expression 19167446
84 96-48-0 AQP3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AQP3 mRNA affects^cotreatment|decreases^expression 19167446
85 96-48-0 ARFGEF3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ARFGEF3 mRNA affects^cotreatment|decreases^expression 19167446
86 96-48-0 ARFGEF3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ARFGEF3 mRNA affects^cotreatment|decreases^expression 19167446
87 96-48-0 ARHGDIA Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ARHGDIA mRNA affects^cotreatment|increases^expression 19167446
88 96-48-0 ARHGDIA Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ARHGDIA mRNA affects^cotreatment|increases^expression 19167446
89 96-48-0 ARHGEF26 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ARHGEF26 mRNA affects^cotreatment|increases^expression 19167446
90 96-48-0 ARHGEF26 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ARHGEF26 mRNA affects^cotreatment|increases^expression 19167446
91 96-48-0 ARHGEF37 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ARHGEF37 mRNA affects^cotreatment|decreases^expression 19167446
92 96-48-0 ARHGEF37 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ARHGEF37 mRNA affects^cotreatment|decreases^expression 19167446
93 96-48-0 ARL3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ARL3 mRNA affects^cotreatment|increases^expression 19167446
94 96-48-0 ARL3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ARL3 mRNA affects^cotreatment|increases^expression 19167446
95 96-48-0 ARS2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ARS2 mRNA affects^cotreatment|increases^expression 19167446
96 96-48-0 ARS2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ARS2 mRNA affects^cotreatment|increases^expression 19167446
97 96-48-0 ARX Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ARX mRNA affects^cotreatment|decreases^expression 19167446
98 96-48-0 ARX Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ARX mRNA affects^cotreatment|decreases^expression 19167446
99 96-48-0 ASF1B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ASF1B mRNA affects^cotreatment|increases^expression 19167446
100 96-48-0 ASF1B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ASF1B mRNA affects^cotreatment|increases^expression 19167446
101 96-48-0 ASPM Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ASPM mRNA affects^cotreatment|increases^expression 19167446
102 96-48-0 ASPM Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ASPM mRNA affects^cotreatment|increases^expression 19167446
103 96-48-0 ATAD2 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of ATAD2 mRNA increases^expression 19167446
104 96-48-0 ATAD2 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of ATAD2 mRNA increases^expression 19167446
105 96-48-0 ATAD2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ATAD2 mRNA affects^cotreatment|increases^expression 19167446
106 96-48-0 ATAD2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ATAD2 mRNA affects^cotreatment|increases^expression 19167446
107 96-48-0 ATF3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATF3 mRNA affects^cotreatment|decreases^expression 19167446
108 96-48-0 ATF3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATF3 mRNA affects^cotreatment|decreases^expression 19167446
109 96-48-0 ATF5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ATF5 mRNA affects^cotreatment|increases^expression 19167446
110 96-48-0 ATF5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ATF5 mRNA affects^cotreatment|increases^expression 19167446
111 96-48-0 ATP1B1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATP1B1 mRNA affects^cotreatment|decreases^expression 19167446
112 96-48-0 ATP1B1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATP1B1 mRNA affects^cotreatment|decreases^expression 19167446
113 96-48-0 ATP23 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ATP23 mRNA affects^cotreatment|increases^expression 19167446
114 96-48-0 ATP23 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ATP23 mRNA affects^cotreatment|increases^expression 19167446
115 96-48-0 ATP2B1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATP2B1 mRNA affects^cotreatment|decreases^expression 19167446
116 96-48-0 ATP2B1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATP2B1 mRNA affects^cotreatment|decreases^expression 19167446
117 96-48-0 ATP2C1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATP2C1 mRNA affects^cotreatment|decreases^expression 19167446
118 96-48-0 ATP2C1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATP2C1 mRNA affects^cotreatment|decreases^expression 19167446
119 96-48-0 ATP5G1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ATP5G1 mRNA affects^cotreatment|increases^expression 19167446
120 96-48-0 ATP5G1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ATP5G1 mRNA affects^cotreatment|increases^expression 19167446
121 96-48-0 ATP6V0E1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATP6V0E1 mRNA affects^cotreatment|decreases^expression 19167446
122 96-48-0 ATP6V0E1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATP6V0E1 mRNA affects^cotreatment|decreases^expression 19167446
123 96-48-0 ATP9A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATP9A mRNA affects^cotreatment|decreases^expression 19167446
124 96-48-0 ATP9A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATP9A mRNA affects^cotreatment|decreases^expression 19167446
125 96-48-0 ATRX Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of ATRX mRNA decreases^expression 19167446
126 96-48-0 ATRX Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of ATRX mRNA decreases^expression 19167446
127 96-48-0 ATXN1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATXN1 mRNA affects^cotreatment|decreases^expression 19167446
128 96-48-0 ATXN1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATXN1 mRNA affects^cotreatment|decreases^expression 19167446
129 96-48-0 AURKA Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AURKA mRNA affects^cotreatment|increases^expression 19167446
130 96-48-0 AURKA Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AURKA mRNA affects^cotreatment|increases^expression 19167446
131 96-48-0 AURKB Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AURKB mRNA affects^cotreatment|increases^expression 19167446
132 96-48-0 AURKB Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AURKB mRNA affects^cotreatment|increases^expression 19167446
133 96-48-0 AXUD1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AXUD1 mRNA affects^cotreatment|decreases^expression 19167446
134 96-48-0 AXUD1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AXUD1 mRNA affects^cotreatment|decreases^expression 19167446
135 96-48-0 B3GALNT1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of B3GALNT1 mRNA affects^cotreatment|increases^expression 19167446
136 96-48-0 B3GALNT1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of B3GALNT1 mRNA affects^cotreatment|increases^expression 19167446
137 96-48-0 B3GNT5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of B3GNT5 mRNA affects^cotreatment|decreases^expression 19167446
138 96-48-0 B3GNT5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of B3GNT5 mRNA affects^cotreatment|decreases^expression 19167446
139 96-48-0 BACE1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BACE1 mRNA affects^cotreatment|decreases^expression 19167446
140 96-48-0 BACE1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BACE1 mRNA affects^cotreatment|decreases^expression 19167446
141 96-48-0 BACE2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BACE2 mRNA affects^cotreatment|decreases^expression 19167446
142 96-48-0 BACE2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BACE2 mRNA affects^cotreatment|decreases^expression 19167446
143 96-48-0 BAG3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BAG3 mRNA affects^cotreatment|decreases^expression 19167446
144 96-48-0 BAG3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BAG3 mRNA affects^cotreatment|decreases^expression 19167446
145 96-48-0 BARD1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BARD1 mRNA affects^cotreatment|increases^expression 19167446
146 96-48-0 BARD1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BARD1 mRNA affects^cotreatment|increases^expression 19167446
147 96-48-0 BCAR3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BCAR3 mRNA affects^cotreatment|decreases^expression 19167446
148 96-48-0 BCAR3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BCAR3 mRNA affects^cotreatment|decreases^expression 19167446
149 96-48-0 BCL2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BCL2 mRNA affects^cotreatment|increases^expression 19167446
150 96-48-0 BCL2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BCL2 mRNA affects^cotreatment|increases^expression 19167446
151 96-48-0 BCL2L12 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BCL2L12 mRNA affects^cotreatment|increases^expression 19167446
152 96-48-0 BCL2L12 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BCL2L12 mRNA affects^cotreatment|increases^expression 19167446
153 96-48-0 BCL3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BCL3 mRNA affects^cotreatment|decreases^expression 19167446
154 96-48-0 BCL3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BCL3 mRNA affects^cotreatment|decreases^expression 19167446
155 96-48-0 BCL9 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BCL9 mRNA affects^cotreatment|decreases^expression 19167446
156 96-48-0 BCL9 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BCL9 mRNA affects^cotreatment|decreases^expression 19167446
157 96-48-0 BEX2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BEX2 mRNA affects^cotreatment|decreases^expression 19167446
158 96-48-0 BEX2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BEX2 mRNA affects^cotreatment|decreases^expression 19167446
159 96-48-0 BHLHE40 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BHLHE40 mRNA affects^cotreatment|decreases^expression 19167446
160 96-48-0 BHLHE40 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BHLHE40 mRNA affects^cotreatment|decreases^expression 19167446
161 96-48-0 BIRC5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BIRC5 mRNA affects^cotreatment|increases^expression 19167446
162 96-48-0 BIRC5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BIRC5 mRNA affects^cotreatment|increases^expression 19167446
163 96-48-0 BLM Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BLM mRNA affects^cotreatment|increases^expression 19167446
164 96-48-0 BLM Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BLM mRNA affects^cotreatment|increases^expression 19167446
165 96-48-0 BLNK Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BLNK mRNA affects^cotreatment|decreases^expression 19167446
166 96-48-0 BLNK Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BLNK mRNA affects^cotreatment|decreases^expression 19167446
167 96-48-0 BMF Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BMF mRNA affects^cotreatment|decreases^expression 19167446
168 96-48-0 BMF Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BMF mRNA affects^cotreatment|decreases^expression 19167446
169 96-48-0 BMP7 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BMP7 mRNA affects^cotreatment|decreases^expression 19167446
170 96-48-0 BMP7 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BMP7 mRNA affects^cotreatment|decreases^expression 19167446
171 96-48-0 BMPR2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BMPR2 mRNA affects^cotreatment|decreases^expression 19167446
172 96-48-0 BMPR2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BMPR2 mRNA affects^cotreatment|decreases^expression 19167446
173 96-48-0 BRAT1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BRAT1 mRNA affects^cotreatment|increases^expression 19167446
174 96-48-0 BRAT1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BRAT1 mRNA affects^cotreatment|increases^expression 19167446
175 96-48-0 BRCA1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BRCA1 mRNA affects^cotreatment|increases^expression 19167446
176 96-48-0 BRCA1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BRCA1 mRNA affects^cotreatment|increases^expression 19167446
177 96-48-0 BRCA2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BRCA2 mRNA affects^cotreatment|increases^expression 19167446
178 96-48-0 BRCA2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BRCA2 mRNA affects^cotreatment|increases^expression 19167446
179 96-48-0 BRI3BP Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BRI3BP mRNA affects^cotreatment|increases^expression 19167446
180 96-48-0 BRI3BP Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BRI3BP mRNA affects^cotreatment|increases^expression 19167446
181 96-48-0 BRWD1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BRWD1 mRNA affects^cotreatment|decreases^expression 19167446
182 96-48-0 BRWD1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BRWD1 mRNA affects^cotreatment|decreases^expression 19167446
183 96-48-0 BSDC1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BSDC1 mRNA affects^cotreatment|decreases^expression 19167446
184 96-48-0 BSDC1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BSDC1 mRNA affects^cotreatment|decreases^expression 19167446
185 96-48-0 BSG Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BSG mRNA affects^cotreatment|increases^expression 19167446
186 96-48-0 BSG Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BSG mRNA affects^cotreatment|increases^expression 19167446
187 96-48-0 BTG1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BTG1 mRNA affects^cotreatment|decreases^expression 19167446
188 96-48-0 BTG1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BTG1 mRNA affects^cotreatment|decreases^expression 19167446
189 96-48-0 BUB1B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BUB1B mRNA affects^cotreatment|increases^expression 19167446
190 96-48-0 BUB1B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BUB1B mRNA affects^cotreatment|increases^expression 19167446
191 96-48-0 C16ORF45 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of C16ORF45 mRNA affects^cotreatment|decreases^expression 19167446
192 96-48-0 C16ORF45 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of C16ORF45 mRNA affects^cotreatment|decreases^expression 19167446
193 96-48-0 C1ORF112 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of C1ORF112 mRNA affects^cotreatment|increases^expression 19167446
194 96-48-0 C1ORF112 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of C1ORF112 mRNA affects^cotreatment|increases^expression 19167446
195 96-48-0 C5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of C5 mRNA affects^cotreatment|increases^expression 19167446
196 96-48-0 C5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of C5 mRNA affects^cotreatment|increases^expression 19167446
197 96-48-0 C5ORF34 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of C5ORF34 mRNA affects^cotreatment|increases^expression 19167446
198 96-48-0 C5ORF34 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of C5ORF34 mRNA affects^cotreatment|increases^expression 19167446
199 96-48-0 C9ORF152 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of C9ORF152 mRNA affects^cotreatment|decreases^expression 19167446
200 96-48-0 C9ORF152 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of C9ORF152 mRNA affects^cotreatment|decreases^expression 19167446
201 96-48-0 C9ORF40 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of C9ORF40 mRNA affects^cotreatment|increases^expression 19167446
202 96-48-0 C9ORF40 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of C9ORF40 mRNA affects^cotreatment|increases^expression 19167446
203 96-48-0 CA12 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CA12 mRNA affects^cotreatment|increases^expression 19167446
204 96-48-0 CA12 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CA12 mRNA affects^cotreatment|increases^expression 19167446
205 96-48-0 CADM1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CADM1 mRNA affects^cotreatment|decreases^expression 19167446
206 96-48-0 CADM1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CADM1 mRNA affects^cotreatment|decreases^expression 19167446
207 96-48-0 CALM3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CALM3 mRNA affects^cotreatment|increases^expression 19167446
208 96-48-0 CALM3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CALM3 mRNA affects^cotreatment|increases^expression 19167446
209 96-48-0 CALU Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CALU mRNA affects^cotreatment|increases^expression 19167446
210 96-48-0 CALU Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CALU mRNA affects^cotreatment|increases^expression 19167446
211 96-48-0 CAMK2D Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CAMK2D mRNA affects^cotreatment|decreases^expression 19167446
212 96-48-0 CAMK2D Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CAMK2D mRNA affects^cotreatment|decreases^expression 19167446
213 96-48-0 CAMK2N1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CAMK2N1 mRNA affects^cotreatment|decreases^expression 19167446
214 96-48-0 CAMK2N1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CAMK2N1 mRNA affects^cotreatment|decreases^expression 19167446
215 96-48-0 CARHSP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CARHSP1 mRNA affects^cotreatment|increases^expression 19167446
216 96-48-0 CARHSP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CARHSP1 mRNA affects^cotreatment|increases^expression 19167446
217 96-48-0 CAST Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CAST mRNA affects^cotreatment|decreases^expression 19167446
218 96-48-0 CAST Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CAST mRNA affects^cotreatment|decreases^expression 19167446
219 96-48-0 CBFB Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CBFB mRNA affects^cotreatment|increases^expression 19167446
220 96-48-0 CBFB Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CBFB mRNA affects^cotreatment|increases^expression 19167446
221 96-48-0 CBLB Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CBLB mRNA affects^cotreatment|decreases^expression 19167446
222 96-48-0 CBLB Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CBLB mRNA affects^cotreatment|decreases^expression 19167446
223 96-48-0 CCDC14 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CCDC14 mRNA affects^cotreatment|increases^expression 19167446
224 96-48-0 CCDC14 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CCDC14 mRNA affects^cotreatment|increases^expression 19167446
225 96-48-0 CCDC34 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CCDC34 mRNA affects^cotreatment|increases^expression 19167446
226 96-48-0 CCDC34 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CCDC34 mRNA affects^cotreatment|increases^expression 19167446
227 96-48-0 CCNB1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CCNB1 mRNA affects^cotreatment|increases^expression 19167446
228 96-48-0 CCNB1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CCNB1 mRNA affects^cotreatment|increases^expression 19167446
229 96-48-0 CCNB2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CCNB2 mRNA affects^cotreatment|increases^expression 19167446
230 96-48-0 CCNB2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CCNB2 mRNA affects^cotreatment|increases^expression 19167446
231 96-48-0 CCNE2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CCNE2 mRNA affects^cotreatment|increases^expression 19167446
232 96-48-0 CCNE2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CCNE2 mRNA affects^cotreatment|increases^expression 19167446
233 96-48-0 CCNF Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CCNF mRNA affects^cotreatment|increases^expression 19167446
234 96-48-0 CCNF Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CCNF mRNA affects^cotreatment|increases^expression 19167446
235 96-48-0 CCPG1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CCPG1 mRNA affects^cotreatment|decreases^expression 19167446
236 96-48-0 CCPG1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CCPG1 mRNA affects^cotreatment|decreases^expression 19167446
237 96-48-0 CD55 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of CD55 mRNA decreases^expression 19167446
238 96-48-0 CD55 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of CD55 mRNA decreases^expression 19167446
239 96-48-0 CD55 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CD55 mRNA affects^cotreatment|decreases^expression 19167446
240 96-48-0 CD55 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CD55 mRNA affects^cotreatment|decreases^expression 19167446
241 96-48-0 CD59 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CD59 mRNA affects^cotreatment|decreases^expression 19167446
242 96-48-0 CD59 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CD59 mRNA affects^cotreatment|decreases^expression 19167446
243 96-48-0 CDC25A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDC25A mRNA affects^cotreatment|increases^expression 19167446
244 96-48-0 CDC25A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDC25A mRNA affects^cotreatment|increases^expression 19167446
245 96-48-0 CDC25C Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDC25C mRNA affects^cotreatment|increases^expression 19167446
246 96-48-0 CDC25C Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDC25C mRNA affects^cotreatment|increases^expression 19167446
247 96-48-0 CDC27 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDC27 mRNA affects^cotreatment|increases^expression 19167446
248 96-48-0 CDC27 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDC27 mRNA affects^cotreatment|increases^expression 19167446
249 96-48-0 CDC45L Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDC45L mRNA affects^cotreatment|increases^expression 19167446
250 96-48-0 CDC45L Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDC45L mRNA affects^cotreatment|increases^expression 19167446
251 96-48-0 CDC6 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDC6 mRNA affects^cotreatment|increases^expression 19167446
252 96-48-0 CDC6 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDC6 mRNA affects^cotreatment|increases^expression 19167446
253 96-48-0 CDC7 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDC7 mRNA affects^cotreatment|increases^expression 19167446
254 96-48-0 CDC7 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDC7 mRNA affects^cotreatment|increases^expression 19167446
255 96-48-0 CDCA2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDCA2 mRNA affects^cotreatment|increases^expression 19167446
256 96-48-0 CDCA2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDCA2 mRNA affects^cotreatment|increases^expression 19167446
257 96-48-0 CDCA3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDCA3 mRNA affects^cotreatment|increases^expression 19167446
258 96-48-0 CDCA3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDCA3 mRNA affects^cotreatment|increases^expression 19167446
259 96-48-0 CDCA4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDCA4 mRNA affects^cotreatment|increases^expression 19167446
260 96-48-0 CDCA4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDCA4 mRNA affects^cotreatment|increases^expression 19167446
261 96-48-0 CDCA5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDCA5 mRNA affects^cotreatment|increases^expression 19167446
262 96-48-0 CDCA5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDCA5 mRNA affects^cotreatment|increases^expression 19167446
263 96-48-0 CDCA7L Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDCA7L mRNA affects^cotreatment|increases^expression 19167446
264 96-48-0 CDCA7L Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDCA7L mRNA affects^cotreatment|increases^expression 19167446
265 96-48-0 CDCA8 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDCA8 mRNA affects^cotreatment|increases^expression 19167446
266 96-48-0 CDCA8 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDCA8 mRNA affects^cotreatment|increases^expression 19167446
267 96-48-0 CDH12 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDH12 mRNA affects^cotreatment|increases^expression 19167446
268 96-48-0 CDH12 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDH12 mRNA affects^cotreatment|increases^expression 19167446
269 96-48-0 CDK1 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of CDK1 mRNA increases^expression 19167446
270 96-48-0 CDK1 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of CDK1 mRNA increases^expression 19167446
271 96-48-0 CDK1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDK1 mRNA affects^cotreatment|increases^expression 19167446
272 96-48-0 CDK1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDK1 mRNA affects^cotreatment|increases^expression 19167446
273 96-48-0 CDK2AP2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDK2AP2 mRNA affects^cotreatment|increases^expression 19167446
274 96-48-0 CDK2AP2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDK2AP2 mRNA affects^cotreatment|increases^expression 19167446
275 96-48-0 CDK5RAP2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDK5RAP2 mRNA affects^cotreatment|increases^expression 19167446
276 96-48-0 CDK5RAP2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDK5RAP2 mRNA affects^cotreatment|increases^expression 19167446
277 96-48-0 CDKN1A Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of CDKN1A mRNA decreases^expression 19167446
278 96-48-0 CDKN1A Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of CDKN1A mRNA decreases^expression 19167446
279 96-48-0 CDKN1A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CDKN1A mRNA affects^cotreatment|decreases^expression 19167446
280 96-48-0 CDKN1A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CDKN1A mRNA affects^cotreatment|decreases^expression 19167446
281 96-48-0 CDKN2B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CDKN2B mRNA affects^cotreatment|decreases^expression 19167446
282 96-48-0 CDKN2B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CDKN2B mRNA affects^cotreatment|decreases^expression 19167446
283 96-48-0 CDKN2C Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDKN2C mRNA affects^cotreatment|increases^expression 19167446
284 96-48-0 CDKN2C Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDKN2C mRNA affects^cotreatment|increases^expression 19167446
285 96-48-0 CDKN3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDKN3 mRNA affects^cotreatment|increases^expression 19167446
286 96-48-0 CDKN3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDKN3 mRNA affects^cotreatment|increases^expression 19167446
287 96-48-0 CDS1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CDS1 mRNA affects^cotreatment|decreases^expression 19167446
288 96-48-0 CDS1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CDS1 mRNA affects^cotreatment|decreases^expression 19167446
289 96-48-0 CDT1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDT1 mRNA affects^cotreatment|increases^expression 19167446
290 96-48-0 CDT1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDT1 mRNA affects^cotreatment|increases^expression 19167446
291 96-48-0 CEBPD Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CEBPD mRNA affects^cotreatment|decreases^expression 19167446
292 96-48-0 CEBPD Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CEBPD mRNA affects^cotreatment|decreases^expression 19167446
293 96-48-0 CELSR2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CELSR2 mRNA affects^cotreatment|increases^expression 19167446
294 96-48-0 CELSR2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CELSR2 mRNA affects^cotreatment|increases^expression 19167446
295 96-48-0 CENPA Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPA mRNA affects^cotreatment|increases^expression 19167446
296 96-48-0 CENPA Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPA mRNA affects^cotreatment|increases^expression 19167446
297 96-48-0 CENPF Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPF mRNA affects^cotreatment|increases^expression 19167446
298 96-48-0 CENPF Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPF mRNA affects^cotreatment|increases^expression 19167446
299 96-48-0 CENPH Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPH mRNA affects^cotreatment|increases^expression 19167446
300 96-48-0 CENPH Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPH mRNA affects^cotreatment|increases^expression 19167446
301 96-48-0 CENPI Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPI mRNA affects^cotreatment|increases^expression 19167446
302 96-48-0 CENPI Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPI mRNA affects^cotreatment|increases^expression 19167446
303 96-48-0 CENPL Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPL mRNA affects^cotreatment|increases^expression 19167446
304 96-48-0 CENPL Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPL mRNA affects^cotreatment|increases^expression 19167446
305 96-48-0 CENPN Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPN mRNA affects^cotreatment|increases^expression 19167446
306 96-48-0 CENPN Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPN mRNA affects^cotreatment|increases^expression 19167446
307 96-48-0 CENPO Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPO mRNA affects^cotreatment|increases^expression 19167446
308 96-48-0 CENPO Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPO mRNA affects^cotreatment|increases^expression 19167446
309 96-48-0 CENPQ Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPQ mRNA affects^cotreatment|increases^expression 19167446
310 96-48-0 CENPQ Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPQ mRNA affects^cotreatment|increases^expression 19167446
311 96-48-0 CENPS Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPS mRNA affects^cotreatment|increases^expression 19167446
312 96-48-0 CENPS Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPS mRNA affects^cotreatment|increases^expression 19167446
313 96-48-0 CENPU Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPU mRNA affects^cotreatment|increases^expression 19167446
314 96-48-0 CENPU Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPU mRNA affects^cotreatment|increases^expression 19167446
315 96-48-0 CENPW Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPW mRNA affects^cotreatment|increases^expression 19167446
316 96-48-0 CENPW Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPW mRNA affects^cotreatment|increases^expression 19167446
317 96-48-0 CEP55 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of CEP55 mRNA increases^expression 19167446
318 96-48-0 CEP55 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of CEP55 mRNA increases^expression 19167446
319 96-48-0 CEP55 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CEP55 mRNA affects^cotreatment|increases^expression 19167446
320 96-48-0 CEP55 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CEP55 mRNA affects^cotreatment|increases^expression 19167446
321 96-48-0 CEP57 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of CEP57 mRNA increases^expression 19167446
322 96-48-0 CEP57 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of CEP57 mRNA increases^expression 19167446
323 96-48-0 CEP78 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CEP78 mRNA affects^cotreatment|increases^expression 19167446
324 96-48-0 CEP78 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CEP78 mRNA affects^cotreatment|increases^expression 19167446
325 96-48-0 CEP85 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CEP85 mRNA affects^cotreatment|increases^expression 19167446
326 96-48-0 CEP85 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CEP85 mRNA affects^cotreatment|increases^expression 19167446
327 96-48-0 CHAC2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CHAC2 mRNA affects^cotreatment|increases^expression 19167446
328 96-48-0 CHAC2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CHAC2 mRNA affects^cotreatment|increases^expression 19167446
329 96-48-0 CHAF1A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CHAF1A mRNA affects^cotreatment|increases^expression 19167446
330 96-48-0 CHAF1A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CHAF1A mRNA affects^cotreatment|increases^expression 19167446
331 96-48-0 CHAF1B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CHAF1B mRNA affects^cotreatment|increases^expression 19167446
332 96-48-0 CHAF1B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CHAF1B mRNA affects^cotreatment|increases^expression 19167446
333 96-48-0 CHD2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CHD2 mRNA affects^cotreatment|decreases^expression 19167446
334 96-48-0 CHD2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CHD2 mRNA affects^cotreatment|decreases^expression 19167446
335 96-48-0 CHEK1 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of CHEK1 mRNA increases^expression 19167446
336 96-48-0 CHEK1 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of CHEK1 mRNA increases^expression 19167446
337 96-48-0 CHEK1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CHEK1 mRNA affects^cotreatment|increases^expression 19167446
338 96-48-0 CHEK1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CHEK1 mRNA affects^cotreatment|increases^expression 19167446
339 96-48-0 CHEK2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CHEK2 mRNA affects^cotreatment|increases^expression 19167446
340 96-48-0 CHEK2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CHEK2 mRNA affects^cotreatment|increases^expression 19167446
341 96-48-0 CHES1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CHES1 mRNA affects^cotreatment|decreases^expression 19167446
342 96-48-0 CHES1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CHES1 mRNA affects^cotreatment|decreases^expression 19167446
343 96-48-0 CHPT1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CHPT1 mRNA affects^cotreatment|increases^expression 19167446
344 96-48-0 CHPT1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CHPT1 mRNA affects^cotreatment|increases^expression 19167446
345 96-48-0 CITED2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CITED2 mRNA affects^cotreatment|decreases^expression 19167446
346 96-48-0 CITED2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CITED2 mRNA affects^cotreatment|decreases^expression 19167446
347 96-48-0 CKAP5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CKAP5 mRNA affects^cotreatment|increases^expression 19167446
348 96-48-0 CKAP5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CKAP5 mRNA affects^cotreatment|increases^expression 19167446
349 96-48-0 CKLF Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CKLF mRNA affects^cotreatment|increases^expression 19167446
350 96-48-0 CKLF Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CKLF mRNA affects^cotreatment|increases^expression 19167446
351 96-48-0 CKS1B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CKS1B mRNA affects^cotreatment|increases^expression 19167446
352 96-48-0 CKS1B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CKS1B mRNA affects^cotreatment|increases^expression 19167446
353 96-48-0 CKS2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CKS2 mRNA affects^cotreatment|increases^expression 19167446
354 96-48-0 CKS2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CKS2 mRNA affects^cotreatment|increases^expression 19167446
355 96-48-0 CLDN1 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of CLDN1 mRNA decreases^expression 19167446
356 96-48-0 CLDN1 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of CLDN1 mRNA decreases^expression 19167446
357 96-48-0 CLDN1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CLDN1 mRNA affects^cotreatment|decreases^expression 19167446
358 96-48-0 CLDN1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CLDN1 mRNA affects^cotreatment|decreases^expression 19167446
359 96-48-0 CLDN4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CLDN4 mRNA affects^cotreatment|decreases^expression 19167446
360 96-48-0 CLDN4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CLDN4 mRNA affects^cotreatment|decreases^expression 19167446
361 96-48-0 CLIP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CLIP1 mRNA affects^cotreatment|decreases^expression 19167446
362 96-48-0 CLIP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CLIP1 mRNA affects^cotreatment|decreases^expression 19167446
363 96-48-0 CLN6 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CLN6 mRNA affects^cotreatment|increases^expression 19167446
364 96-48-0 CLN6 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CLN6 mRNA affects^cotreatment|increases^expression 19167446
365 96-48-0 CLU Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CLU mRNA affects^cotreatment|decreases^expression 19167446
366 96-48-0 CLU Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CLU mRNA affects^cotreatment|decreases^expression 19167446
367 96-48-0 CMC2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CMC2 mRNA affects^cotreatment|increases^expression 19167446
368 96-48-0 CMC2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CMC2 mRNA affects^cotreatment|increases^expression 19167446
369 96-48-0 COL21A1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of COL21A1 mRNA affects^cotreatment|increases^expression 19167446
370 96-48-0 COL21A1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of COL21A1 mRNA affects^cotreatment|increases^expression 19167446
371 96-48-0 COL5A1 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of COL5A1 mRNA decreases^expression 19167446
372 96-48-0 COL5A1 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of COL5A1 mRNA decreases^expression 19167446
373 96-48-0 CRY1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CRY1 mRNA affects^cotreatment|decreases^expression 19167446
374 96-48-0 CRY1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CRY1 mRNA affects^cotreatment|decreases^expression 19167446
375 96-48-0 CSE1L Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CSE1L mRNA affects^cotreatment|increases^expression 19167446
376 96-48-0 CSE1L Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CSE1L mRNA affects^cotreatment|increases^expression 19167446
377 96-48-0 CSPG5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CSPG5 mRNA affects^cotreatment|increases^expression 19167446
378 96-48-0 CSPG5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CSPG5 mRNA affects^cotreatment|increases^expression 19167446
379 96-48-0 CSRNP2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CSRNP2 mRNA affects^cotreatment|decreases^expression 19167446
380 96-48-0 CSRNP2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CSRNP2 mRNA affects^cotreatment|decreases^expression 19167446
381 96-48-0 CTDSPL2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CTDSPL2 mRNA affects^cotreatment|increases^expression 19167446
382 96-48-0 CTDSPL2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CTDSPL2 mRNA affects^cotreatment|increases^expression 19167446
383 96-48-0 CTNNAL1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CTNNAL1 mRNA affects^cotreatment|increases^expression 19167446
384 96-48-0 CTNNAL1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CTNNAL1 mRNA affects^cotreatment|increases^expression 19167446
385 96-48-0 CTR9 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CTR9 mRNA affects^cotreatment|increases^expression 19167446
386 96-48-0 CTR9 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CTR9 mRNA affects^cotreatment|increases^expression 19167446
387 96-48-0 CTTN Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CTTN mRNA affects^cotreatment|decreases^expression 19167446
388 96-48-0 CTTN Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CTTN mRNA affects^cotreatment|decreases^expression 19167446
389 96-48-0 CTTNBP2NL Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CTTNBP2NL mRNA affects^cotreatment|decreases^expression 19167446
390 96-48-0 CTTNBP2NL Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CTTNBP2NL mRNA affects^cotreatment|decreases^expression 19167446
391 96-48-0 CXXC5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CXXC5 mRNA affects^cotreatment|increases^expression 19167446
392 96-48-0 CXXC5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CXXC5 mRNA affects^cotreatment|increases^expression 19167446
393 96-48-0 CYB5R1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CYB5R1 mRNA affects^cotreatment|decreases^expression 19167446
394 96-48-0 CYB5R1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CYB5R1 mRNA affects^cotreatment|decreases^expression 19167446
395 96-48-0 CYP19A1 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased activity of CYP19A1 protein decreases^activity 15876411
396 96-48-0 CYP19A1 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased activity of CYP19A1 protein decreases^activity 15876411
397 96-48-0 CYP2R1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CYP2R1 mRNA affects^cotreatment|increases^expression 19167446
398 96-48-0 CYP2R1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CYP2R1 mRNA affects^cotreatment|increases^expression 19167446
399 96-48-0 CYR61 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CYR61 mRNA affects^cotreatment|decreases^expression 19167446
400 96-48-0 CYR61 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CYR61 mRNA affects^cotreatment|decreases^expression 19167446
401 96-48-0 DANCR Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DANCR mRNA affects^cotreatment|decreases^expression 19167446
402 96-48-0 DANCR Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DANCR mRNA affects^cotreatment|decreases^expression 19167446
403 96-48-0 DARS2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DARS2 mRNA affects^cotreatment|increases^expression 19167446
404 96-48-0 DARS2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DARS2 mRNA affects^cotreatment|increases^expression 19167446
405 96-48-0 DBF4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DBF4 mRNA affects^cotreatment|increases^expression 19167446
406 96-48-0 DBF4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DBF4 mRNA affects^cotreatment|increases^expression 19167446
407 96-48-0 DBN1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DBN1 mRNA affects^cotreatment|decreases^expression 19167446
408 96-48-0 DBN1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DBN1 mRNA affects^cotreatment|decreases^expression 19167446
409 96-48-0 DCAF15 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DCAF15 mRNA affects^cotreatment|increases^expression 19167446
410 96-48-0 DCAF15 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DCAF15 mRNA affects^cotreatment|increases^expression 19167446
411 96-48-0 DCAF4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DCAF4 mRNA affects^cotreatment|decreases^expression 19167446
412 96-48-0 DCAF4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DCAF4 mRNA affects^cotreatment|decreases^expression 19167446
413 96-48-0 DCAF5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DCAF5 mRNA affects^cotreatment|decreases^expression 19167446
414 96-48-0 DCAF5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DCAF5 mRNA affects^cotreatment|decreases^expression 19167446
415 96-48-0 DCLK1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DCLK1 mRNA affects^cotreatment|decreases^expression 19167446
416 96-48-0 DCLK1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DCLK1 mRNA affects^cotreatment|decreases^expression 19167446
417 96-48-0 DCLRE1A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DCLRE1A mRNA affects^cotreatment|increases^expression 19167446
418 96-48-0 DCLRE1A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DCLRE1A mRNA affects^cotreatment|increases^expression 19167446
419 96-48-0 DCLRE1B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DCLRE1B mRNA affects^cotreatment|increases^expression 19167446
420 96-48-0 DCLRE1B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DCLRE1B mRNA affects^cotreatment|increases^expression 19167446
421 96-48-0 DDAH2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DDAH2 mRNA affects^cotreatment|decreases^expression 19167446
422 96-48-0 DDAH2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DDAH2 mRNA affects^cotreatment|decreases^expression 19167446
423 96-48-0 DDB2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DDB2 mRNA affects^cotreatment|increases^expression 19167446
424 96-48-0 DDB2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DDB2 mRNA affects^cotreatment|increases^expression 19167446
425 96-48-0 DDEF1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DDEF1 mRNA affects^cotreatment|decreases^expression 19167446
426 96-48-0 DDEF1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DDEF1 mRNA affects^cotreatment|decreases^expression 19167446
427 96-48-0 DDIAS Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DDIAS mRNA affects^cotreatment|increases^expression 19167446
428 96-48-0 DDIAS Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DDIAS mRNA affects^cotreatment|increases^expression 19167446
429 96-48-0 DDX39B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DDX39B mRNA affects^cotreatment|increases^expression 19167446
430 96-48-0 DDX39B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DDX39B mRNA affects^cotreatment|increases^expression 19167446
431 96-48-0 DEPDC1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DEPDC1 mRNA affects^cotreatment|increases^expression 19167446
432 96-48-0 DEPDC1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DEPDC1 mRNA affects^cotreatment|increases^expression 19167446
433 96-48-0 DEPDC6 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DEPDC6 mRNA affects^cotreatment|increases^expression 19167446
434 96-48-0 DEPDC6 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DEPDC6 mRNA affects^cotreatment|increases^expression 19167446
435 96-48-0 DERA Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DERA mRNA affects^cotreatment|increases^expression 19167446
436 96-48-0 DERA Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DERA mRNA affects^cotreatment|increases^expression 19167446
437 96-48-0 DHFR Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of DHFR mRNA increases^expression 19167446
438 96-48-0 DHFR Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of DHFR mRNA increases^expression 19167446
439 96-48-0 DHFR Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DHFR mRNA affects^cotreatment|increases^expression 19167446
440 96-48-0 DHFR Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DHFR mRNA affects^cotreatment|increases^expression 19167446
441 96-48-0 DHRS2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DHRS2 mRNA affects^cotreatment|increases^expression 19167446
442 96-48-0 DHRS2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DHRS2 mRNA affects^cotreatment|increases^expression 19167446
443 96-48-0 DHTKD1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DHTKD1 mRNA affects^cotreatment|increases^expression 19167446
444 96-48-0 DHTKD1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DHTKD1 mRNA affects^cotreatment|increases^expression 19167446
445 96-48-0 DIAPH3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DIAPH3 mRNA affects^cotreatment|increases^expression 19167446
446 96-48-0 DIAPH3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DIAPH3 mRNA affects^cotreatment|increases^expression 19167446
447 96-48-0 DIP2C Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DIP2C mRNA affects^cotreatment|decreases^expression 19167446
448 96-48-0 DIP2C Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DIP2C mRNA affects^cotreatment|decreases^expression 19167446
449 96-48-0 DKC1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DKC1 mRNA affects^cotreatment|increases^expression 19167446
450 96-48-0 DKC1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DKC1 mRNA affects^cotreatment|increases^expression 19167446
451 96-48-0 DLGAP5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DLGAP5 mRNA affects^cotreatment|increases^expression 19167446
452 96-48-0 DLGAP5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DLGAP5 mRNA affects^cotreatment|increases^expression 19167446
453 96-48-0 DLX2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DLX2 mRNA affects^cotreatment|decreases^expression 19167446
454 96-48-0 DLX2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DLX2 mRNA affects^cotreatment|decreases^expression 19167446
455 96-48-0 DMXL1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DMXL1 mRNA affects^cotreatment|decreases^expression 19167446
456 96-48-0 DMXL1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DMXL1 mRNA affects^cotreatment|decreases^expression 19167446
457 96-48-0 DNAJA2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DNAJA2 mRNA affects^cotreatment|decreases^expression 19167446
458 96-48-0 DNAJA2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DNAJA2 mRNA affects^cotreatment|decreases^expression 19167446
459 96-48-0 DNAJB9 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DNAJB9 mRNA affects^cotreatment|decreases^expression 19167446
460 96-48-0 DNAJB9 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DNAJB9 mRNA affects^cotreatment|decreases^expression 19167446
461 96-48-0 DNAJC9 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DNAJC9 mRNA affects^cotreatment|increases^expression 19167446
462 96-48-0 DNAJC9 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DNAJC9 mRNA affects^cotreatment|increases^expression 19167446
463 96-48-0 DNASE2 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of DNASE2 mRNA increases^expression 19167446
464 96-48-0 DNASE2 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of DNASE2 mRNA increases^expression 19167446
465 96-48-0 DNASE2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DNASE2 mRNA affects^cotreatment|increases^expression 19167446
466 96-48-0 DNASE2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DNASE2 mRNA affects^cotreatment|increases^expression 19167446
467 96-48-0 DNM1L Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DNM1L mRNA affects^cotreatment|decreases^expression 19167446
468 96-48-0 DNM1L Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DNM1L mRNA affects^cotreatment|decreases^expression 19167446
469 96-48-0 DNMT1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DNMT1 mRNA affects^cotreatment|increases^expression 19167446
470 96-48-0 DNMT1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DNMT1 mRNA affects^cotreatment|increases^expression 19167446
471 96-48-0 DONSON Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DONSON mRNA affects^cotreatment|increases^expression 19167446
472 96-48-0 DONSON Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DONSON mRNA affects^cotreatment|increases^expression 19167446
473 96-48-0 DSCC1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DSCC1 mRNA affects^cotreatment|increases^expression 19167446
474 96-48-0 DSCC1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DSCC1 mRNA affects^cotreatment|increases^expression 19167446
475 96-48-0 DSCR1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DSCR1 mRNA affects^cotreatment|decreases^expression 19167446
476 96-48-0 DSCR1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DSCR1 mRNA affects^cotreatment|decreases^expression 19167446
477 96-48-0 DSN1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DSN1 mRNA affects^cotreatment|increases^expression 19167446
478 96-48-0 DSN1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DSN1 mRNA affects^cotreatment|increases^expression 19167446
479 96-48-0 DTNA Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DTNA mRNA affects^cotreatment|decreases^expression 19167446
480 96-48-0 DTNA Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DTNA mRNA affects^cotreatment|decreases^expression 19167446
481 96-48-0 DUSP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DUSP1 mRNA affects^cotreatment|decreases^expression 19167446
482 96-48-0 DUSP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DUSP1 mRNA affects^cotreatment|decreases^expression 19167446
483 96-48-0 DUT Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DUT mRNA affects^cotreatment|increases^expression 19167446
484 96-48-0 DUT Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DUT mRNA affects^cotreatment|increases^expression 19167446
485 96-48-0 DYNC1LI1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DYNC1LI1 mRNA affects^cotreatment|decreases^expression 19167446
486 96-48-0 DYNC1LI1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DYNC1LI1 mRNA affects^cotreatment|decreases^expression 19167446
487 96-48-0 E2F2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of E2F2 mRNA affects^cotreatment|increases^expression 19167446
488 96-48-0 E2F2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of E2F2 mRNA affects^cotreatment|increases^expression 19167446
489 96-48-0 E2F5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of E2F5 mRNA affects^cotreatment|decreases^expression 19167446
490 96-48-0 E2F5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of E2F5 mRNA affects^cotreatment|decreases^expression 19167446
491 96-48-0 E2F7 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of E2F7 mRNA affects^cotreatment|increases^expression 19167446
492 96-48-0 E2F7 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of E2F7 mRNA affects^cotreatment|increases^expression 19167446
493 96-48-0 E2F8 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of E2F8 mRNA affects^cotreatment|increases^expression 19167446
494 96-48-0 E2F8 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of E2F8 mRNA affects^cotreatment|increases^expression 19167446
495 96-48-0 EBP Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EBP mRNA affects^cotreatment|increases^expression 19167446
496 96-48-0 EBP Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EBP mRNA affects^cotreatment|increases^expression 19167446
497 96-48-0 ECT2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ECT2 mRNA affects^cotreatment|increases^expression 19167446
498 96-48-0 ECT2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ECT2 mRNA affects^cotreatment|increases^expression 19167446
499 96-48-0 EDIL3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EDIL3 mRNA affects^cotreatment|decreases^expression 19167446
500 96-48-0 EDIL3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EDIL3 mRNA affects^cotreatment|decreases^expression 19167446
501 96-48-0 EED Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EED mRNA affects^cotreatment|increases^expression 19167446
502 96-48-0 EED Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EED mRNA affects^cotreatment|increases^expression 19167446
503 96-48-0 EEF1A1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EEF1A1 mRNA affects^cotreatment|decreases^expression 19167446
504 96-48-0 EEF1A1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EEF1A1 mRNA affects^cotreatment|decreases^expression 19167446
505 96-48-0 EFEMP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EFEMP1 mRNA affects^cotreatment|decreases^expression 19167446
506 96-48-0 EFEMP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EFEMP1 mRNA affects^cotreatment|decreases^expression 19167446
507 96-48-0 EFHD1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EFHD1 mRNA affects^cotreatment|decreases^expression 19167446
508 96-48-0 EFHD1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EFHD1 mRNA affects^cotreatment|decreases^expression 19167446
509 96-48-0 EFNA1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EFNA1 mRNA affects^cotreatment|decreases^expression 19167446
510 96-48-0 EFNA1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EFNA1 mRNA affects^cotreatment|decreases^expression 19167446
511 96-48-0 EFNB2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EFNB2 mRNA affects^cotreatment|decreases^expression 19167446
512 96-48-0 EFNB2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EFNB2 mRNA affects^cotreatment|decreases^expression 19167446
513 96-48-0 EGR1 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of EGR1 mRNA decreases^expression 19167446
514 96-48-0 EGR1 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of EGR1 mRNA decreases^expression 19167446
515 96-48-0 EGR1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EGR1 mRNA affects^cotreatment|decreases^expression 19167446
516 96-48-0 EGR1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EGR1 mRNA affects^cotreatment|decreases^expression 19167446
517 96-48-0 EGR3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EGR3 mRNA affects^cotreatment|increases^expression 19167446
518 96-48-0 EGR3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EGR3 mRNA affects^cotreatment|increases^expression 19167446
519 96-48-0 ELF5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ELF5 mRNA affects^cotreatment|decreases^expression 19167446
520 96-48-0 ELF5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ELF5 mRNA affects^cotreatment|decreases^expression 19167446
521 96-48-0 ELK1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ELK1 mRNA affects^cotreatment|increases^expression 19167446
522 96-48-0 ELK1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ELK1 mRNA affects^cotreatment|increases^expression 19167446
523 96-48-0 ELOVL2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ELOVL2 mRNA affects^cotreatment|increases^expression 19167446
524 96-48-0 ELOVL2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ELOVL2 mRNA affects^cotreatment|increases^expression 19167446
525 96-48-0 ELOVL6 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ELOVL6 mRNA affects^cotreatment|increases^expression 19167446
526 96-48-0 ELOVL6 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ELOVL6 mRNA affects^cotreatment|increases^expression 19167446
527 96-48-0 ELOVL7 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ELOVL7 mRNA affects^cotreatment|increases^expression 19167446
528 96-48-0 ELOVL7 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ELOVL7 mRNA affects^cotreatment|increases^expression 19167446
529 96-48-0 ELP6 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ELP6 mRNA affects^cotreatment|increases^expression 19167446
530 96-48-0 ELP6 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ELP6 mRNA affects^cotreatment|increases^expression 19167446
531 96-48-0 EMC9 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EMC9 mRNA affects^cotreatment|increases^expression 19167446
532 96-48-0 EMC9 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EMC9 mRNA affects^cotreatment|increases^expression 19167446
533 96-48-0 EME1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EME1 mRNA affects^cotreatment|increases^expression 19167446
534 96-48-0 EME1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EME1 mRNA affects^cotreatment|increases^expression 19167446
535 96-48-0 ENC1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ENC1 mRNA affects^cotreatment|decreases^expression 19167446
536 96-48-0 ENC1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ENC1 mRNA affects^cotreatment|decreases^expression 19167446
537 96-48-0 ENDOD1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ENDOD1 mRNA affects^cotreatment|increases^expression 19167446
538 96-48-0 ENDOD1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ENDOD1 mRNA affects^cotreatment|increases^expression 19167446
539 96-48-0 ENOSF1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ENOSF1 mRNA affects^cotreatment|increases^expression 19167446
540 96-48-0 ENOSF1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ENOSF1 mRNA affects^cotreatment|increases^expression 19167446
541 96-48-0 EPB41L5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EPB41L5 mRNA affects^cotreatment|decreases^expression 19167446
542 96-48-0 EPB41L5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EPB41L5 mRNA affects^cotreatment|decreases^expression 19167446
543 96-48-0 EPHA4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EPHA4 mRNA affects^cotreatment|decreases^expression 19167446
544 96-48-0 EPHA4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EPHA4 mRNA affects^cotreatment|decreases^expression 19167446
545 96-48-0 EPS15L1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EPS15L1 mRNA affects^cotreatment|increases^expression 19167446
546 96-48-0 EPS15L1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EPS15L1 mRNA affects^cotreatment|increases^expression 19167446
547 96-48-0 ERCC6L Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ERCC6L mRNA affects^cotreatment|increases^expression 19167446
548 96-48-0 ERCC6L Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ERCC6L mRNA affects^cotreatment|increases^expression 19167446
549 96-48-0 ERI2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ERI2 mRNA affects^cotreatment|increases^expression 19167446
550 96-48-0 ERI2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ERI2 mRNA affects^cotreatment|increases^expression 19167446
551 96-48-0 ERRFI1 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of ERRFI1 mRNA decreases^expression 19167446
552 96-48-0 ERRFI1 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of ERRFI1 mRNA decreases^expression 19167446
553 96-48-0 ERRFI1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ERRFI1 mRNA affects^cotreatment|decreases^expression 19167446
554 96-48-0 ERRFI1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ERRFI1 mRNA affects^cotreatment|decreases^expression 19167446
555 96-48-0 ESPL1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ESPL1 mRNA affects^cotreatment|increases^expression 19167446
556 96-48-0 ESPL1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ESPL1 mRNA affects^cotreatment|increases^expression 19167446
557 96-48-0 EXO1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EXO1 mRNA affects^cotreatment|increases^expression 19167446
558 96-48-0 EXO1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EXO1 mRNA affects^cotreatment|increases^expression 19167446
559 96-48-0 EXOC2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EXOC2 mRNA affects^cotreatment|decreases^expression 19167446
560 96-48-0 EXOC2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EXOC2 mRNA affects^cotreatment|decreases^expression 19167446
561 96-48-0 EXT1 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of EXT1 mRNA decreases^expression 19167446
562 96-48-0 EXT1 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of EXT1 mRNA decreases^expression 19167446
563 96-48-0 EXT1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EXT1 mRNA affects^cotreatment|decreases^expression 19167446
564 96-48-0 EXT1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EXT1 mRNA affects^cotreatment|decreases^expression 19167446
565 96-48-0 EZH2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EZH2 mRNA affects^cotreatment|increases^expression 19167446
566 96-48-0 EZH2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EZH2 mRNA affects^cotreatment|increases^expression 19167446
567 96-48-0 EZR Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EZR mRNA affects^cotreatment|decreases^expression 19167446
568 96-48-0 EZR Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EZR mRNA affects^cotreatment|decreases^expression 19167446
569 96-48-0 F2RL1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of F2RL1 mRNA affects^cotreatment|decreases^expression 19167446
570 96-48-0 F2RL1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of F2RL1 mRNA affects^cotreatment|decreases^expression 19167446
571 96-48-0 FAM107B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM107B mRNA affects^cotreatment|decreases^expression 19167446
572 96-48-0 FAM107B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM107B mRNA affects^cotreatment|decreases^expression 19167446
573 96-48-0 FAM110B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM110B mRNA affects^cotreatment|decreases^expression 19167446
574 96-48-0 FAM110B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM110B mRNA affects^cotreatment|decreases^expression 19167446
575 96-48-0 FAM111A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FAM111A mRNA affects^cotreatment|increases^expression 19167446
576 96-48-0 FAM111A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FAM111A mRNA affects^cotreatment|increases^expression 19167446
577 96-48-0 FAM149B1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM149B1 mRNA affects^cotreatment|decreases^expression 19167446
578 96-48-0 FAM149B1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM149B1 mRNA affects^cotreatment|decreases^expression 19167446
579 96-48-0 FAM189A2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM189A2 mRNA affects^cotreatment|decreases^expression 19167446
580 96-48-0 FAM189A2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM189A2 mRNA affects^cotreatment|decreases^expression 19167446
581 96-48-0 FAM214A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM214A mRNA affects^cotreatment|decreases^expression 19167446
582 96-48-0 FAM214A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM214A mRNA affects^cotreatment|decreases^expression 19167446
583 96-48-0 FAM43A Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of FAM43A mRNA decreases^expression 19167446
584 96-48-0 FAM43A Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of FAM43A mRNA decreases^expression 19167446
585 96-48-0 FAM43A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM43A mRNA affects^cotreatment|decreases^expression 19167446
586 96-48-0 FAM43A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM43A mRNA affects^cotreatment|decreases^expression 19167446
587 96-48-0 FAM49B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM49B mRNA affects^cotreatment|decreases^expression 19167446
588 96-48-0 FAM49B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM49B mRNA affects^cotreatment|decreases^expression 19167446
589 96-48-0 FANCD2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FANCD2 mRNA affects^cotreatment|increases^expression 19167446
590 96-48-0 FANCD2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FANCD2 mRNA affects^cotreatment|increases^expression 19167446
591 96-48-0 FANCG Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FANCG mRNA affects^cotreatment|increases^expression 19167446
592 96-48-0 FANCG Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FANCG mRNA affects^cotreatment|increases^expression 19167446
593 96-48-0 FANCI Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FANCI mRNA affects^cotreatment|increases^expression 19167446
594 96-48-0 FANCI Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FANCI mRNA affects^cotreatment|increases^expression 19167446
595 96-48-0 FANCL Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FANCL mRNA affects^cotreatment|increases^expression 19167446
596 96-48-0 FANCL Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FANCL mRNA affects^cotreatment|increases^expression 19167446
597 96-48-0 FBXO38 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FBXO38 mRNA affects^cotreatment|decreases^expression 19167446
598 96-48-0 FBXO38 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FBXO38 mRNA affects^cotreatment|decreases^expression 19167446
599 96-48-0 FBXO5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FBXO5 mRNA affects^cotreatment|increases^expression 19167446
600 96-48-0 FBXO5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FBXO5 mRNA affects^cotreatment|increases^expression 19167446
601 96-48-0 FCMR Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FCMR mRNA affects^cotreatment|increases^expression 19167446
602 96-48-0 FCMR Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FCMR mRNA affects^cotreatment|increases^expression 19167446
603 96-48-0 FDFT1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FDFT1 mRNA affects^cotreatment|increases^expression 19167446
604 96-48-0 FDFT1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FDFT1 mRNA affects^cotreatment|increases^expression 19167446
605 96-48-0 FEN1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FEN1 mRNA affects^cotreatment|increases^expression 19167446
606 96-48-0 FEN1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FEN1 mRNA affects^cotreatment|increases^expression 19167446
607 96-48-0 FERMT2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FERMT2 mRNA affects^cotreatment|decreases^expression 19167446
608 96-48-0 FERMT2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FERMT2 mRNA affects^cotreatment|decreases^expression 19167446
609 96-48-0 FIBP Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FIBP mRNA affects^cotreatment|increases^expression 19167446
610 96-48-0 FIBP Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FIBP mRNA affects^cotreatment|increases^expression 19167446
611 96-48-0 FIGNL1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FIGNL1 mRNA affects^cotreatment|increases^expression 19167446
612 96-48-0 FIGNL1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FIGNL1 mRNA affects^cotreatment|increases^expression 19167446
613 96-48-0 FILIP1L Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FILIP1L mRNA affects^cotreatment|decreases^expression 19167446
614 96-48-0 FILIP1L Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FILIP1L mRNA affects^cotreatment|decreases^expression 19167446
615 96-48-0 FKBP11 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FKBP11 mRNA affects^cotreatment|increases^expression 19167446
616 96-48-0 FKBP11 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FKBP11 mRNA affects^cotreatment|increases^expression 19167446
617 96-48-0 FKBP4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FKBP4 mRNA affects^cotreatment|increases^expression 19167446
618 96-48-0 FKBP4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FKBP4 mRNA affects^cotreatment|increases^expression 19167446
619 96-48-0 FLCN Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FLCN mRNA affects^cotreatment|decreases^expression 19167446
620 96-48-0 FLCN Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FLCN mRNA affects^cotreatment|decreases^expression 19167446
621 96-48-0 FNBP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FNBP1 mRNA affects^cotreatment|decreases^expression 19167446
622 96-48-0 FNBP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FNBP1 mRNA affects^cotreatment|decreases^expression 19167446
623 96-48-0 FNBP1L Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FNBP1L mRNA affects^cotreatment|decreases^expression 19167446
624 96-48-0 FNBP1L Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FNBP1L mRNA affects^cotreatment|decreases^expression 19167446
625 96-48-0 FOS Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FOS mRNA affects^cotreatment|decreases^expression 19167446
626 96-48-0 FOS Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FOS mRNA affects^cotreatment|decreases^expression 19167446
627 96-48-0 FOXM1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FOXM1 mRNA affects^cotreatment|increases^expression 19167446
628 96-48-0 FOXM1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FOXM1 mRNA affects^cotreatment|increases^expression 19167446
629 96-48-0 FOXO3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FOXO3 mRNA affects^cotreatment|decreases^expression 19167446
630 96-48-0 FOXO3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FOXO3 mRNA affects^cotreatment|decreases^expression 19167446
631 96-48-0 FOXP2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FOXP2 mRNA affects^cotreatment|decreases^expression 19167446
632 96-48-0 FOXP2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FOXP2 mRNA affects^cotreatment|decreases^expression 19167446
633 96-48-0 FRMD6 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FRMD6 mRNA affects^cotreatment|decreases^expression 19167446
634 96-48-0 FRMD6 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FRMD6 mRNA affects^cotreatment|decreases^expression 19167446
635 96-48-0 FSCN1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FSCN1 mRNA affects^cotreatment|decreases^expression 19167446
636 96-48-0 FSCN1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FSCN1 mRNA affects^cotreatment|decreases^expression 19167446
637 96-48-0 FYCO1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FYCO1 mRNA affects^cotreatment|decreases^expression 19167446
638 96-48-0 FYCO1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FYCO1 mRNA affects^cotreatment|decreases^expression 19167446
639 96-48-0 G2E3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of G2E3 mRNA affects^cotreatment|increases^expression 19167446
640 96-48-0 G2E3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of G2E3 mRNA affects^cotreatment|increases^expression 19167446
641 96-48-0 G3BP2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of G3BP2 mRNA affects^cotreatment|increases^expression 19167446
642 96-48-0 G3BP2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of G3BP2 mRNA affects^cotreatment|increases^expression 19167446
643 96-48-0 GABPB2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GABPB2 mRNA affects^cotreatment|increases^expression 19167446
644 96-48-0 GABPB2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GABPB2 mRNA affects^cotreatment|increases^expression 19167446
645 96-48-0 GADD45A Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of GADD45A mRNA decreases^expression 19167446
646 96-48-0 GADD45A Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of GADD45A mRNA decreases^expression 19167446
647 96-48-0 GADD45A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GADD45A mRNA affects^cotreatment|decreases^expression 19167446
648 96-48-0 GADD45A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GADD45A mRNA affects^cotreatment|decreases^expression 19167446
649 96-48-0 GALNS Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GALNS mRNA affects^cotreatment|decreases^expression 19167446
650 96-48-0 GALNS Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GALNS mRNA affects^cotreatment|decreases^expression 19167446
651 96-48-0 GALNT1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GALNT1 mRNA affects^cotreatment|decreases^expression 19167446
652 96-48-0 GALNT1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GALNT1 mRNA affects^cotreatment|decreases^expression 19167446
653 96-48-0 GALNT10 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GALNT10 mRNA affects^cotreatment|decreases^expression 19167446
654 96-48-0 GALNT10 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GALNT10 mRNA affects^cotreatment|decreases^expression 19167446
655 96-48-0 GALNT7 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GALNT7 mRNA affects^cotreatment|decreases^expression 19167446
656 96-48-0 GALNT7 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GALNT7 mRNA affects^cotreatment|decreases^expression 19167446
657 96-48-0 GANAB Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GANAB mRNA affects^cotreatment|increases^expression 19167446
658 96-48-0 GANAB Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GANAB mRNA affects^cotreatment|increases^expression 19167446
659 96-48-0 GAS2L3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GAS2L3 mRNA affects^cotreatment|increases^expression 19167446
660 96-48-0 GAS2L3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GAS2L3 mRNA affects^cotreatment|increases^expression 19167446
661 96-48-0 GATA2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GATA2 mRNA affects^cotreatment|decreases^expression 19167446
662 96-48-0 GATA2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GATA2 mRNA affects^cotreatment|decreases^expression 19167446
663 96-48-0 GBP2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GBP2 mRNA affects^cotreatment|decreases^expression 19167446
664 96-48-0 GBP2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GBP2 mRNA affects^cotreatment|decreases^expression 19167446
665 96-48-0 GCHFR Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GCHFR mRNA affects^cotreatment|increases^expression 19167446
666 96-48-0 GCHFR Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GCHFR mRNA affects^cotreatment|increases^expression 19167446
667 96-48-0 GDF15 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GDF15 mRNA affects^cotreatment|decreases^expression 19167446
668 96-48-0 GDF15 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GDF15 mRNA affects^cotreatment|decreases^expression 19167446
669 96-48-0 GDPD3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GDPD3 mRNA affects^cotreatment|decreases^expression 19167446
670 96-48-0 GDPD3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GDPD3 mRNA affects^cotreatment|decreases^expression 19167446
671 96-48-0 GEMIN2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GEMIN2 mRNA affects^cotreatment|increases^expression 19167446
672 96-48-0 GEMIN2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GEMIN2 mRNA affects^cotreatment|increases^expression 19167446
673 96-48-0 GFRA1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GFRA1 mRNA affects^cotreatment|increases^expression 19167446
674 96-48-0 GFRA1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GFRA1 mRNA affects^cotreatment|increases^expression 19167446
675 96-48-0 GGCT Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GGCT mRNA affects^cotreatment|increases^expression 19167446
676 96-48-0 GGCT Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GGCT mRNA affects^cotreatment|increases^expression 19167446
677 96-48-0 GGH Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GGH mRNA affects^cotreatment|increases^expression 19167446
678 96-48-0 GGH Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GGH mRNA affects^cotreatment|increases^expression 19167446
679 96-48-0 GINS1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GINS1 mRNA affects^cotreatment|increases^expression 19167446
680 96-48-0 GINS1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GINS1 mRNA affects^cotreatment|increases^expression 19167446
681 96-48-0 GINS2 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of GINS2 mRNA increases^expression 19167446
682 96-48-0 GINS2 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of GINS2 mRNA increases^expression 19167446
683 96-48-0 GINS2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GINS2 mRNA affects^cotreatment|increases^expression 19167446
684 96-48-0 GINS2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GINS2 mRNA affects^cotreatment|increases^expression 19167446
685 96-48-0 GINS3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GINS3 mRNA affects^cotreatment|increases^expression 19167446
686 96-48-0 GINS3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GINS3 mRNA affects^cotreatment|increases^expression 19167446
687 96-48-0 GINS4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GINS4 mRNA affects^cotreatment|increases^expression 19167446
688 96-48-0 GINS4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GINS4 mRNA affects^cotreatment|increases^expression 19167446
689 96-48-0 GLE1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GLE1 mRNA affects^cotreatment|increases^expression 19167446
690 96-48-0 GLE1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GLE1 mRNA affects^cotreatment|increases^expression 19167446
691 96-48-0 GMNN Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GMNN mRNA affects^cotreatment|increases^expression 19167446
692 96-48-0 GMNN Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GMNN mRNA affects^cotreatment|increases^expression 19167446
693 96-48-0 GMPS Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GMPS mRNA affects^cotreatment|increases^expression 19167446
694 96-48-0 GMPS Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GMPS mRNA affects^cotreatment|increases^expression 19167446
695 96-48-0 GNAS Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of GNAS mRNA decreases^expression 19167446
696 96-48-0 GNAS Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of GNAS mRNA decreases^expression 19167446
697 96-48-0 GOLGA2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GOLGA2 mRNA affects^cotreatment|decreases^expression 19167446
698 96-48-0 GOLGA2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GOLGA2 mRNA affects^cotreatment|decreases^expression 19167446
699 96-48-0 GOT1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GOT1 mRNA affects^cotreatment|increases^expression 19167446
700 96-48-0 GOT1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GOT1 mRNA affects^cotreatment|increases^expression 19167446
701 96-48-0 GPAA1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GPAA1 mRNA affects^cotreatment|increases^expression 19167446
702 96-48-0 GPAA1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GPAA1 mRNA affects^cotreatment|increases^expression 19167446
703 96-48-0 GPAT4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GPAT4 mRNA affects^cotreatment|increases^expression 19167446
704 96-48-0 GPAT4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GPAT4 mRNA affects^cotreatment|increases^expression 19167446
705 96-48-0 GPRC5A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GPRC5A mRNA affects^cotreatment|decreases^expression 19167446
706 96-48-0 GPRC5A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GPRC5A mRNA affects^cotreatment|decreases^expression 19167446
707 96-48-0 GPRC5C Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GPRC5C mRNA affects^cotreatment|decreases^expression 19167446
708 96-48-0 GPRC5C Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GPRC5C mRNA affects^cotreatment|decreases^expression 19167446
709 96-48-0 GPSM2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GPSM2 mRNA affects^cotreatment|increases^expression 19167446
710 96-48-0 GPSM2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GPSM2 mRNA affects^cotreatment|increases^expression 19167446
711 96-48-0 GPSN2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GPSN2 mRNA affects^cotreatment|increases^expression 19167446
712 96-48-0 GPSN2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GPSN2 mRNA affects^cotreatment|increases^expression 19167446
713 96-48-0 GRAMD1A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GRAMD1A mRNA affects^cotreatment|decreases^expression 19167446
714 96-48-0 GRAMD1A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GRAMD1A mRNA affects^cotreatment|decreases^expression 19167446
715 96-48-0 GREB1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GREB1 mRNA affects^cotreatment|increases^expression 19167446
716 96-48-0 GREB1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GREB1 mRNA affects^cotreatment|increases^expression 19167446
717 96-48-0 GRHL3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GRHL3 mRNA affects^cotreatment|decreases^expression 19167446
718 96-48-0 GRHL3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GRHL3 mRNA affects^cotreatment|decreases^expression 19167446
719 96-48-0 GTF2IRD1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GTF2IRD1 mRNA affects^cotreatment|decreases^expression 19167446
720 96-48-0 GTF2IRD1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GTF2IRD1 mRNA affects^cotreatment|decreases^expression 19167446
721 96-48-0 GTSE1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GTSE1 mRNA affects^cotreatment|increases^expression 19167446
722 96-48-0 GTSE1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GTSE1 mRNA affects^cotreatment|increases^expression 19167446
723 96-48-0 GULP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GULP1 mRNA affects^cotreatment|decreases^expression 19167446
724 96-48-0 GULP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GULP1 mRNA affects^cotreatment|decreases^expression 19167446
725 96-48-0 H2AFV Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of H2AFV mRNA affects^cotreatment|increases^expression 19167446
726 96-48-0 H2AFV Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of H2AFV mRNA affects^cotreatment|increases^expression 19167446
727 96-48-0 H2AFX Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of H2AFX mRNA affects^cotreatment|increases^expression 19167446
728 96-48-0 H2AFX Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of H2AFX mRNA affects^cotreatment|increases^expression 19167446
729 96-48-0 H2AFZ Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of H2AFZ mRNA affects^cotreatment|increases^expression 19167446
730 96-48-0 H2AFZ Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of H2AFZ mRNA affects^cotreatment|increases^expression 19167446
731 96-48-0 H3F3B Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of H3F3B mRNA decreases^expression 19167446
732 96-48-0 H3F3B Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of H3F3B mRNA decreases^expression 19167446
733 96-48-0 H3F3B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of H3F3B mRNA affects^cotreatment|decreases^expression 19167446
734 96-48-0 H3F3B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of H3F3B mRNA affects^cotreatment|decreases^expression 19167446
735 96-48-0 HADH Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HADH mRNA affects^cotreatment|increases^expression 19167446
736 96-48-0 HADH Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HADH mRNA affects^cotreatment|increases^expression 19167446
737 96-48-0 HAUS1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HAUS1 mRNA affects^cotreatment|increases^expression 19167446
738 96-48-0 HAUS1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HAUS1 mRNA affects^cotreatment|increases^expression 19167446
739 96-48-0 HAUS4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HAUS4 mRNA affects^cotreatment|increases^expression 19167446
740 96-48-0 HAUS4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HAUS4 mRNA affects^cotreatment|increases^expression 19167446
741 96-48-0 HEBP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HEBP1 mRNA affects^cotreatment|decreases^expression 19167446
742 96-48-0 HEBP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HEBP1 mRNA affects^cotreatment|decreases^expression 19167446
743 96-48-0 HELLS Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HELLS mRNA affects^cotreatment|increases^expression 19167446
744 96-48-0 HELLS Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HELLS mRNA affects^cotreatment|increases^expression 19167446
745 96-48-0 HELZ2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HELZ2 mRNA affects^cotreatment|decreases^expression 19167446
746 96-48-0 HELZ2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HELZ2 mRNA affects^cotreatment|decreases^expression 19167446
747 96-48-0 HERC1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HERC1 mRNA affects^cotreatment|decreases^expression 19167446
748 96-48-0 HERC1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HERC1 mRNA affects^cotreatment|decreases^expression 19167446
749 96-48-0 HES1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HES1 mRNA affects^cotreatment|decreases^expression 19167446
750 96-48-0 HES1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HES1 mRNA affects^cotreatment|decreases^expression 19167446
751 96-48-0 HIRIP3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HIRIP3 mRNA affects^cotreatment|increases^expression 19167446
752 96-48-0 HIRIP3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HIRIP3 mRNA affects^cotreatment|increases^expression 19167446
753 96-48-0 HIST1H1C Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H1C mRNA affects^cotreatment|decreases^expression 19167446
754 96-48-0 HIST1H1C Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H1C mRNA affects^cotreatment|decreases^expression 19167446
755 96-48-0 HIST1H2AC Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H2AC mRNA affects^cotreatment|decreases^expression 19167446
756 96-48-0 HIST1H2AC Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H2AC mRNA affects^cotreatment|decreases^expression 19167446
757 96-48-0 HIST1H2AE Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H2AE mRNA affects^cotreatment|decreases^expression 19167446
758 96-48-0 HIST1H2AE Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H2AE mRNA affects^cotreatment|decreases^expression 19167446
759 96-48-0 HIST1H2BC Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H2BC mRNA affects^cotreatment|decreases^expression 19167446
760 96-48-0 HIST1H2BC Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H2BC mRNA affects^cotreatment|decreases^expression 19167446
761 96-48-0 HIST1H2BD Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H2BD mRNA affects^cotreatment|decreases^expression 19167446
762 96-48-0 HIST1H2BD Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H2BD mRNA affects^cotreatment|decreases^expression 19167446
763 96-48-0 HIST1H2BG Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H2BG mRNA affects^cotreatment|decreases^expression 19167446
764 96-48-0 HIST1H2BG Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H2BG mRNA affects^cotreatment|decreases^expression 19167446
765 96-48-0 HIST1H2BH Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H2BH mRNA affects^cotreatment|decreases^expression 19167446
766 96-48-0 HIST1H2BH Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H2BH mRNA affects^cotreatment|decreases^expression 19167446
767 96-48-0 HIST1H3D Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H3D mRNA affects^cotreatment|decreases^expression 19167446
768 96-48-0 HIST1H3D Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H3D mRNA affects^cotreatment|decreases^expression 19167446
769 96-48-0 HIST1H3H Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H3H mRNA affects^cotreatment|decreases^expression 19167446
770 96-48-0 HIST1H3H Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H3H mRNA affects^cotreatment|decreases^expression 19167446
771 96-48-0 HIST1H4H Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H4H mRNA affects^cotreatment|decreases^expression 19167446
772 96-48-0 HIST1H4H Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H4H mRNA affects^cotreatment|decreases^expression 19167446
773 96-48-0 HIST2H2BE Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST2H2BE mRNA affects^cotreatment|decreases^expression 19167446
774 96-48-0 HIST2H2BE Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST2H2BE mRNA affects^cotreatment|decreases^expression 19167446
775 96-48-0 HIST3H2A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST3H2A mRNA affects^cotreatment|decreases^expression 19167446
776 96-48-0 HIST3H2A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST3H2A mRNA affects^cotreatment|decreases^expression 19167446
777 96-48-0 HJURP Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HJURP mRNA affects^cotreatment|increases^expression 19167446
778 96-48-0 HJURP Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HJURP mRNA affects^cotreatment|increases^expression 19167446
779 96-48-0 HMGA1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HMGA1 mRNA affects^cotreatment|increases^expression 19167446
780 96-48-0 HMGA1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HMGA1 mRNA affects^cotreatment|increases^expression 19167446
781 96-48-0 HMGB1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HMGB1 mRNA affects^cotreatment|increases^expression 19167446
782 96-48-0 HMGB1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HMGB1 mRNA affects^cotreatment|increases^expression 19167446
783 96-48-0 HMGB2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HMGB2 mRNA affects^cotreatment|increases^expression 19167446
784 96-48-0 HMGB2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HMGB2 mRNA affects^cotreatment|increases^expression 19167446
785 96-48-0 HMGN3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HMGN3 mRNA affects^cotreatment|increases^expression 19167446
786 96-48-0 HMGN3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HMGN3 mRNA affects^cotreatment|increases^expression 19167446
787 96-48-0 HMMR Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HMMR mRNA affects^cotreatment|increases^expression 19167446
788 96-48-0 HMMR Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HMMR mRNA affects^cotreatment|increases^expression 19167446
789 96-48-0 HNRNPH1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HNRNPH1 mRNA affects^cotreatment|increases^expression 19167446
790 96-48-0 HNRNPH1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HNRNPH1 mRNA affects^cotreatment|increases^expression 19167446
791 96-48-0 HOXC6 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HOXC6 mRNA affects^cotreatment|increases^expression 19167446
792 96-48-0 HOXC6 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HOXC6 mRNA affects^cotreatment|increases^expression 19167446
793 96-48-0 HPRT1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HPRT1 mRNA affects^cotreatment|increases^expression 19167446
794 96-48-0 HPRT1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HPRT1 mRNA affects^cotreatment|increases^expression 19167446
795 96-48-0 HS6ST2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HS6ST2 mRNA affects^cotreatment|decreases^expression 19167446
796 96-48-0 HS6ST2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HS6ST2 mRNA affects^cotreatment|decreases^expression 19167446
797 96-48-0 HSD17B1 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased activity of HSD17B1 protein decreases^activity 15876411
798 96-48-0 HSD17B1 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased activity of HSD17B1 protein decreases^activity 15876411
799 96-48-0 HSD17B6 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HSD17B6 mRNA affects^cotreatment|increases^expression 19167446
800 96-48-0 HSD17B6 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HSD17B6 mRNA affects^cotreatment|increases^expression 19167446
801 96-48-0 HSPA4L Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HSPA4L mRNA affects^cotreatment|increases^expression 19167446
802 96-48-0 HSPA4L Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HSPA4L mRNA affects^cotreatment|increases^expression 19167446
803 96-48-0 HYLS1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HYLS1 mRNA affects^cotreatment|increases^expression 19167446
804 96-48-0 HYLS1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HYLS1 mRNA affects^cotreatment|increases^expression 19167446
805 96-48-0 ICA1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ICA1 mRNA affects^cotreatment|decreases^expression 19167446
806 96-48-0 ICA1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ICA1 mRNA affects^cotreatment|decreases^expression 19167446
807 96-48-0 ICE1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ICE1 mRNA affects^cotreatment|decreases^expression 19167446
808 96-48-0 ICE1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ICE1 mRNA affects^cotreatment|decreases^expression 19167446
809 96-48-0 ICMT Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ICMT mRNA affects^cotreatment|increases^expression 19167446
810 96-48-0 ICMT Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ICMT mRNA affects^cotreatment|increases^expression 19167446
811 96-48-0 ID3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ID3 mRNA affects^cotreatment|decreases^expression 19167446
812 96-48-0 ID3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ID3 mRNA affects^cotreatment|decreases^expression 19167446
813 96-48-0 IDS Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IDS mRNA affects^cotreatment|decreases^expression 19167446
814 96-48-0 IDS Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IDS mRNA affects^cotreatment|decreases^expression 19167446
815 96-48-0 IER2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IER2 mRNA affects^cotreatment|decreases^expression 19167446
816 96-48-0 IER2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IER2 mRNA affects^cotreatment|decreases^expression 19167446
817 96-48-0 IER5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IER5 mRNA affects^cotreatment|decreases^expression 19167446
818 96-48-0 IER5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IER5 mRNA affects^cotreatment|decreases^expression 19167446
819 96-48-0 IFI44L Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IFI44L mRNA affects^cotreatment|decreases^expression 19167446
820 96-48-0 IFI44L Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IFI44L mRNA affects^cotreatment|decreases^expression 19167446
821 96-48-0 IFIT2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IFIT2 mRNA affects^cotreatment|decreases^expression 19167446
822 96-48-0 IFIT2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IFIT2 mRNA affects^cotreatment|decreases^expression 19167446
823 96-48-0 IFRD2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of IFRD2 mRNA affects^cotreatment|increases^expression 19167446
824 96-48-0 IFRD2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of IFRD2 mRNA affects^cotreatment|increases^expression 19167446
825 96-48-0 IFT122 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IFT122 mRNA affects^cotreatment|decreases^expression 19167446
826 96-48-0 IFT122 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IFT122 mRNA affects^cotreatment|decreases^expression 19167446
827 96-48-0 IFT20 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IFT20 mRNA affects^cotreatment|decreases^expression 19167446
828 96-48-0 IFT20 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IFT20 mRNA affects^cotreatment|decreases^expression 19167446
829 96-48-0 IFT43 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IFT43 mRNA affects^cotreatment|decreases^expression 19167446
830 96-48-0 IFT43 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IFT43 mRNA affects^cotreatment|decreases^expression 19167446
831 96-48-0 IGFBP2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of IGFBP2 mRNA affects^cotreatment|increases^expression 19167446
832 96-48-0 IGFBP2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of IGFBP2 mRNA affects^cotreatment|increases^expression 19167446
833 96-48-0 IGFBP4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of IGFBP4 mRNA affects^cotreatment|increases^expression 19167446
834 96-48-0 IGFBP4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of IGFBP4 mRNA affects^cotreatment|increases^expression 19167446
835 96-48-0 IGFBP5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IGFBP5 mRNA affects^cotreatment|decreases^expression 19167446
836 96-48-0 IGFBP5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IGFBP5 mRNA affects^cotreatment|decreases^expression 19167446
837 96-48-0 IGFLR1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of IGFLR1 mRNA affects^cotreatment|increases^expression 19167446
838 96-48-0 IGFLR1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of IGFLR1 mRNA affects^cotreatment|increases^expression 19167446
839 96-48-0 IL1R1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IL1R1 mRNA affects^cotreatment|decreases^expression 19167446
840 96-48-0 IL1R1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IL1R1 mRNA affects^cotreatment|decreases^expression 19167446
841 96-48-0 IL20 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of IL20 mRNA affects^cotreatment|increases^expression 19167446
842 96-48-0 IL20 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of IL20 mRNA affects^cotreatment|increases^expression 19167446
843 96-48-0 ILF2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ILF2 mRNA affects^cotreatment|increases^expression 19167446
844 96-48-0 ILF2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ILF2 mRNA affects^cotreatment|increases^expression 19167446
845 96-48-0 ILVBL Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ILVBL mRNA affects^cotreatment|increases^expression 19167446
846 96-48-0 ILVBL Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ILVBL mRNA affects^cotreatment|increases^expression 19167446
847 96-48-0 INCENP Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of INCENP mRNA affects^cotreatment|increases^expression 19167446
848 96-48-0 INCENP Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of INCENP mRNA affects^cotreatment|increases^expression 19167446
849 96-48-0 INHBB Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of INHBB mRNA affects^cotreatment|decreases^expression 19167446
850 96-48-0 INHBB Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of INHBB mRNA affects^cotreatment|decreases^expression 19167446
851 96-48-0 INO80E Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of INO80E mRNA affects^cotreatment|increases^expression 19167446
852 96-48-0 INO80E Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of INO80E mRNA affects^cotreatment|increases^expression 19167446
853 96-48-0 INSIG1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of INSIG1 mRNA affects^cotreatment|increases^expression 19167446
854 96-48-0 INSIG1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of INSIG1 mRNA affects^cotreatment|increases^expression 19167446
855 96-48-0 IP6K2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IP6K2 mRNA affects^cotreatment|decreases^expression 19167446
856 96-48-0 IP6K2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IP6K2 mRNA affects^cotreatment|decreases^expression 19167446
857 96-48-0 IQCK Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IQCK mRNA affects^cotreatment|decreases^expression 19167446
858 96-48-0 IQCK Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IQCK mRNA affects^cotreatment|decreases^expression 19167446
859 96-48-0 IQGAP3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of IQGAP3 mRNA affects^cotreatment|increases^expression 19167446
860 96-48-0 IQGAP3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of IQGAP3 mRNA affects^cotreatment|increases^expression 19167446
861 96-48-0 IRF6 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IRF6 mRNA affects^cotreatment|decreases^expression 19167446
862 96-48-0 IRF6 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IRF6 mRNA affects^cotreatment|decreases^expression 19167446
863 96-48-0 IRF9 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IRF9 mRNA affects^cotreatment|decreases^expression 19167446
864 96-48-0 IRF9 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IRF9 mRNA affects^cotreatment|decreases^expression 19167446
865 96-48-0 IRS2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IRS2 mRNA affects^cotreatment|decreases^expression 19167446
866 96-48-0 IRS2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IRS2 mRNA affects^cotreatment|decreases^expression 19167446
867 96-48-0 ISYNA1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ISYNA1 mRNA affects^cotreatment|increases^expression 19167446
868 96-48-0 ISYNA1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ISYNA1 mRNA affects^cotreatment|increases^expression 19167446
869 96-48-0 ITGA2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ITGA2 mRNA affects^cotreatment|decreases^expression 19167446
870 96-48-0 ITGA2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ITGA2 mRNA affects^cotreatment|decreases^expression 19167446
871 96-48-0 ITGAE Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ITGAE mRNA affects^cotreatment|increases^expression 19167446
872 96-48-0 ITGAE Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ITGAE mRNA affects^cotreatment|increases^expression 19167446
873 96-48-0 ITGB3BP Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ITGB3BP mRNA affects^cotreatment|increases^expression 19167446
874 96-48-0 ITGB3BP Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ITGB3BP mRNA affects^cotreatment|increases^expression 19167446
875 96-48-0 ITPR1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ITPR1 mRNA affects^cotreatment|decreases^expression 19167446
876 96-48-0 ITPR1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ITPR1 mRNA affects^cotreatment|decreases^expression 19167446
877 96-48-0 JAG1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of JAG1 mRNA affects^cotreatment|decreases^expression 19167446
878 96-48-0 JAG1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of JAG1 mRNA affects^cotreatment|decreases^expression 19167446
879 96-48-0 JMY Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of JMY mRNA affects^cotreatment|decreases^expression 19167446
880 96-48-0 JMY Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of JMY mRNA affects^cotreatment|decreases^expression 19167446
881 96-48-0 JUN Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of JUN mRNA affects^cotreatment|decreases^expression 19167446
882 96-48-0 JUN Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of JUN mRNA affects^cotreatment|decreases^expression 19167446
883 96-48-0 JUNB Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of JUNB mRNA affects^cotreatment|decreases^expression 19167446
884 96-48-0 JUNB Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of JUNB mRNA affects^cotreatment|decreases^expression 19167446
885 96-48-0 KDM4B Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of KDM4B mRNA decreases^expression 19167446
886 96-48-0 KDM4B Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of KDM4B mRNA decreases^expression 19167446
887 96-48-0 KDM5A Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of KDM5A mRNA decreases^expression 19167446
888 96-48-0 KDM5A Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of KDM5A mRNA decreases^expression 19167446
889 96-48-0 KDM5B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KDM5B mRNA affects^cotreatment|decreases^expression 19167446
890 96-48-0 KDM5B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KDM5B mRNA affects^cotreatment|decreases^expression 19167446
891 96-48-0 KDR Mus musculus 2,3-bis(3'-hydroxybenzyl)butyrolactone inhibits the reaction [Estradiol results in increased expression of KDR protein] decreases^reaction|increases^expression 17289903
892 96-48-0 KDR Mus musculus 2,3-bis(3'-hydroxybenzyl)butyrolactone inhibits the reaction [Estradiol results in increased expression of KDR protein] decreases^reaction|increases^expression 17289903
893 96-48-0 KIAA0100 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KIAA0100 mRNA affects^cotreatment|increases^expression 19167446
894 96-48-0 KIAA0100 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KIAA0100 mRNA affects^cotreatment|increases^expression 19167446
895 96-48-0 KIAA0513 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KIAA0513 mRNA affects^cotreatment|decreases^expression 19167446
896 96-48-0 KIAA0513 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KIAA0513 mRNA affects^cotreatment|decreases^expression 19167446
897 96-48-0 KIAA1147 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KIAA1147 mRNA affects^cotreatment|decreases^expression 19167446
898 96-48-0 KIAA1147 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KIAA1147 mRNA affects^cotreatment|decreases^expression 19167446
899 96-48-0 KIAA1211 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KIAA1211 mRNA affects^cotreatment|decreases^expression 19167446
900 96-48-0 KIAA1211 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KIAA1211 mRNA affects^cotreatment|decreases^expression 19167446
901 96-48-0 KIDINS220 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KIDINS220 mRNA affects^cotreatment|decreases^expression 19167446
902 96-48-0 KIDINS220 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KIDINS220 mRNA affects^cotreatment|decreases^expression 19167446
903 96-48-0 KIF11 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KIF11 mRNA affects^cotreatment|increases^expression 19167446
904 96-48-0 KIF11 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KIF11 mRNA affects^cotreatment|increases^expression 19167446
905 96-48-0 KIF14 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KIF14 mRNA affects^cotreatment|increases^expression 19167446
906 96-48-0 KIF14 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KIF14 mRNA affects^cotreatment|increases^expression 19167446
907 96-48-0 KIF18A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KIF18A mRNA affects^cotreatment|increases^expression 19167446
908 96-48-0 KIF18A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KIF18A mRNA affects^cotreatment|increases^expression 19167446
909 96-48-0 KIF20A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KIF20A mRNA affects^cotreatment|increases^expression 19167446
910 96-48-0 KIF20A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KIF20A mRNA affects^cotreatment|increases^expression 19167446
911 96-48-0 KIF2C Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KIF2C mRNA affects^cotreatment|increases^expression 19167446
912 96-48-0 KIF2C Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KIF2C mRNA affects^cotreatment|increases^expression 19167446
913 96-48-0 KIF5C Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KIF5C mRNA affects^cotreatment|decreases^expression 19167446
914 96-48-0 KIF5C Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KIF5C mRNA affects^cotreatment|decreases^expression 19167446
915 96-48-0 KIFC1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KIFC1 mRNA affects^cotreatment|increases^expression 19167446
916 96-48-0 KIFC1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KIFC1 mRNA affects^cotreatment|increases^expression 19167446
917 96-48-0 KLF12 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KLF12 mRNA affects^cotreatment|decreases^expression 19167446
918 96-48-0 KLF12 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KLF12 mRNA affects^cotreatment|decreases^expression 19167446
919 96-48-0 KLF6 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KLF6 mRNA affects^cotreatment|decreases^expression 19167446
920 96-48-0 KLF6 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KLF6 mRNA affects^cotreatment|decreases^expression 19167446
921 96-48-0 KLF9 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KLF9 mRNA affects^cotreatment|decreases^expression 19167446
922 96-48-0 KLF9 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KLF9 mRNA affects^cotreatment|decreases^expression 19167446
923 96-48-0 KLHDC3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KLHDC3 mRNA affects^cotreatment|increases^expression 19167446
924 96-48-0 KLHDC3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KLHDC3 mRNA affects^cotreatment|increases^expression 19167446
925 96-48-0 KLHL24 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KLHL24 mRNA affects^cotreatment|decreases^expression 19167446
926 96-48-0 KLHL24 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KLHL24 mRNA affects^cotreatment|decreases^expression 19167446
927 96-48-0 KLHL5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KLHL5 mRNA affects^cotreatment|decreases^expression 19167446
928 96-48-0 KLHL5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KLHL5 mRNA affects^cotreatment|decreases^expression 19167446
929 96-48-0 KMT2E Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KMT2E mRNA affects^cotreatment|decreases^expression 19167446
930 96-48-0 KMT2E Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KMT2E mRNA affects^cotreatment|decreases^expression 19167446
931 96-48-0 KNSTRN Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KNSTRN mRNA affects^cotreatment|increases^expression 19167446
932 96-48-0 KNSTRN Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KNSTRN mRNA affects^cotreatment|increases^expression 19167446
933 96-48-0 KNTC2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KNTC2 mRNA affects^cotreatment|increases^expression 19167446
934 96-48-0 KNTC2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KNTC2 mRNA affects^cotreatment|increases^expression 19167446
935 96-48-0 KPNA4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KPNA4 mRNA affects^cotreatment|decreases^expression 19167446
936 96-48-0 KPNA4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KPNA4 mRNA affects^cotreatment|decreases^expression 19167446
937 96-48-0 KRT80 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KRT80 mRNA affects^cotreatment|decreases^expression 19167446
938 96-48-0 KRT80 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KRT80 mRNA affects^cotreatment|decreases^expression 19167446
939 96-48-0 L1CAM Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of L1CAM mRNA affects^cotreatment|decreases^expression 19167446
940 96-48-0 L1CAM Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of L1CAM mRNA affects^cotreatment|decreases^expression 19167446
941 96-48-0 L2HGDH Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of L2HGDH mRNA affects^cotreatment|increases^expression 19167446
942 96-48-0 L2HGDH Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of L2HGDH mRNA affects^cotreatment|increases^expression 19167446
943 96-48-0 LAGE3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LAGE3 mRNA affects^cotreatment|increases^expression 19167446
944 96-48-0 LAGE3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LAGE3 mRNA affects^cotreatment|increases^expression 19167446
945 96-48-0 LARP6 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of LARP6 mRNA affects^cotreatment|decreases^expression 19167446
946 96-48-0 LARP6 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of LARP6 mRNA affects^cotreatment|decreases^expression 19167446
947 96-48-0 LCMT2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LCMT2 mRNA affects^cotreatment|increases^expression 19167446
948 96-48-0 LCMT2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LCMT2 mRNA affects^cotreatment|increases^expression 19167446
949 96-48-0 LDLR Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LDLR mRNA affects^cotreatment|increases^expression 19167446
950 96-48-0 LDLR Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LDLR mRNA affects^cotreatment|increases^expression 19167446
951 96-48-0 LEPR Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of LEPR mRNA affects^cotreatment|decreases^expression 19167446
952 96-48-0 LEPR Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of LEPR mRNA affects^cotreatment|decreases^expression 19167446
953 96-48-0 LGALS1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of LGALS1 mRNA affects^cotreatment|decreases^expression 19167446
954 96-48-0 LGALS1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of LGALS1 mRNA affects^cotreatment|decreases^expression 19167446
955 96-48-0 LIG1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LIG1 mRNA affects^cotreatment|increases^expression 19167446
956 96-48-0 LIG1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LIG1 mRNA affects^cotreatment|increases^expression 19167446
957 96-48-0 LINC00052 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LINC00052 mRNA affects^cotreatment|increases^expression 19167446
958 96-48-0 LINC00052 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LINC00052 mRNA affects^cotreatment|increases^expression 19167446
959 96-48-0 LMNB1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LMNB1 mRNA affects^cotreatment|increases^expression 19167446
960 96-48-0 LMNB1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LMNB1 mRNA affects^cotreatment|increases^expression 19167446
961 96-48-0 LMNB2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LMNB2 mRNA affects^cotreatment|increases^expression 19167446
962 96-48-0 LMNB2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LMNB2 mRNA affects^cotreatment|increases^expression 19167446
963 96-48-0 LRIG1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LRIG1 mRNA affects^cotreatment|increases^expression 19167446
964 96-48-0 LRIG1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LRIG1 mRNA affects^cotreatment|increases^expression 19167446
965 96-48-0 LRR1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LRR1 mRNA affects^cotreatment|increases^expression 19167446
966 96-48-0 LRR1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LRR1 mRNA affects^cotreatment|increases^expression 19167446
967 96-48-0 LSM2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LSM2 mRNA affects^cotreatment|increases^expression 19167446
968 96-48-0 LSM2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LSM2 mRNA affects^cotreatment|increases^expression 19167446
969 96-48-0 MAD2L1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MAD2L1 mRNA affects^cotreatment|increases^expression 19167446
970 96-48-0 MAD2L1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MAD2L1 mRNA affects^cotreatment|increases^expression 19167446
971 96-48-0 MAFF Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MAFF mRNA affects^cotreatment|decreases^expression 19167446
972 96-48-0 MAFF Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MAFF mRNA affects^cotreatment|decreases^expression 19167446
973 96-48-0 MAGI1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MAGI1 mRNA affects^cotreatment|decreases^expression 19167446
974 96-48-0 MAGI1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MAGI1 mRNA affects^cotreatment|decreases^expression 19167446
975 96-48-0 MALAT1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MALAT1 mRNA affects^cotreatment|decreases^expression 19167446
976 96-48-0 MALAT1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MALAT1 mRNA affects^cotreatment|decreases^expression 19167446
977 96-48-0 MAP1B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MAP1B mRNA affects^cotreatment|decreases^expression 19167446
978 96-48-0 MAP1B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MAP1B mRNA affects^cotreatment|decreases^expression 19167446
979 96-48-0 MAP4K4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MAP4K4 mRNA affects^cotreatment|decreases^expression 19167446
980 96-48-0 MAP4K4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MAP4K4 mRNA affects^cotreatment|decreases^expression 19167446
981 96-48-0 MAST4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MAST4 mRNA affects^cotreatment|increases^expression 19167446
982 96-48-0 MAST4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MAST4 mRNA affects^cotreatment|increases^expression 19167446
983 96-48-0 MASTL Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MASTL mRNA affects^cotreatment|increases^expression 19167446
984 96-48-0 MASTL Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MASTL mRNA affects^cotreatment|increases^expression 19167446
985 96-48-0 MATN3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MATN3 mRNA affects^cotreatment|decreases^expression 19167446
986 96-48-0 MATN3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MATN3 mRNA affects^cotreatment|decreases^expression 19167446
987 96-48-0 MAZ Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MAZ mRNA affects^cotreatment|increases^expression 19167446
988 96-48-0 MAZ Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MAZ mRNA affects^cotreatment|increases^expression 19167446
989 96-48-0 MB21D2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MB21D2 mRNA affects^cotreatment|decreases^expression 19167446
990 96-48-0 MB21D2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MB21D2 mRNA affects^cotreatment|decreases^expression 19167446
991 96-48-0 MCAM Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCAM mRNA affects^cotreatment|increases^expression 19167446
992 96-48-0 MCAM Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCAM mRNA affects^cotreatment|increases^expression 19167446
993 96-48-0 MCM10 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of MCM10 mRNA increases^expression 19167446
994 96-48-0 MCM10 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of MCM10 mRNA increases^expression 19167446
995 96-48-0 MCM10 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM10 mRNA affects^cotreatment|increases^expression 19167446
996 96-48-0 MCM10 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM10 mRNA affects^cotreatment|increases^expression 19167446
997 96-48-0 MCM2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM2 mRNA affects^cotreatment|increases^expression 19167446
998 96-48-0 MCM2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM2 mRNA affects^cotreatment|increases^expression 19167446
999 96-48-0 MCM3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM3 mRNA affects^cotreatment|increases^expression 19167446
1000 96-48-0 MCM3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM3 mRNA affects^cotreatment|increases^expression 19167446
1001 96-48-0 MCM4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM4 mRNA affects^cotreatment|increases^expression 19167446
1002 96-48-0 MCM4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM4 mRNA affects^cotreatment|increases^expression 19167446
1003 96-48-0 MCM5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM5 mRNA affects^cotreatment|increases^expression 19167446
1004 96-48-0 MCM5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM5 mRNA affects^cotreatment|increases^expression 19167446
1005 96-48-0 MCM6 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM6 mRNA affects^cotreatment|increases^expression 19167446
1006 96-48-0 MCM6 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM6 mRNA affects^cotreatment|increases^expression 19167446
1007 96-48-0 MCM7 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM7 mRNA affects^cotreatment|increases^expression 19167446
1008 96-48-0 MCM7 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM7 mRNA affects^cotreatment|increases^expression 19167446
1009 96-48-0 MCM8 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM8 mRNA affects^cotreatment|increases^expression 19167446
1010 96-48-0 MCM8 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM8 mRNA affects^cotreatment|increases^expression 19167446
1011 96-48-0 MCUB Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCUB mRNA affects^cotreatment|increases^expression 19167446
1012 96-48-0 MCUB Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCUB mRNA affects^cotreatment|increases^expression 19167446
1013 96-48-0 MDC1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MDC1 mRNA affects^cotreatment|increases^expression 19167446
1014 96-48-0 MDC1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MDC1 mRNA affects^cotreatment|increases^expression 19167446
1015 96-48-0 MEA1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MEA1 mRNA affects^cotreatment|increases^expression 19167446
1016 96-48-0 MEA1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MEA1 mRNA affects^cotreatment|increases^expression 19167446
1017 96-48-0 MEAF6 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MEAF6 mRNA affects^cotreatment|decreases^expression 19167446
1018 96-48-0 MEAF6 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MEAF6 mRNA affects^cotreatment|decreases^expression 19167446
1019 96-48-0 MEF2A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MEF2A mRNA affects^cotreatment|decreases^expression 19167446
1020 96-48-0 MEF2A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MEF2A mRNA affects^cotreatment|decreases^expression 19167446
1021 96-48-0 MELK Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MELK mRNA affects^cotreatment|increases^expression 19167446
1022 96-48-0 MELK Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MELK mRNA affects^cotreatment|increases^expression 19167446
1023 96-48-0 MEPCE Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MEPCE mRNA affects^cotreatment|increases^expression 19167446
1024 96-48-0 MEPCE Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MEPCE mRNA affects^cotreatment|increases^expression 19167446
1025 96-48-0 METAP2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of METAP2 mRNA affects^cotreatment|decreases^expression 19167446
1026 96-48-0 METAP2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of METAP2 mRNA affects^cotreatment|decreases^expression 19167446
1027 96-48-0 METTL7A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of METTL7A mRNA affects^cotreatment|increases^expression 19167446
1028 96-48-0 METTL7A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of METTL7A mRNA affects^cotreatment|increases^expression 19167446
1029 96-48-0 MGAT4B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MGAT4B mRNA affects^cotreatment|decreases^expression 19167446
1030 96-48-0 MGAT4B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MGAT4B mRNA affects^cotreatment|decreases^expression 19167446
1031 96-48-0 MGLL Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MGLL mRNA affects^cotreatment|decreases^expression 19167446
1032 96-48-0 MGLL Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MGLL mRNA affects^cotreatment|decreases^expression 19167446
1033 96-48-0 MGP Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MGP mRNA affects^cotreatment|increases^expression 19167446
1034 96-48-0 MGP Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MGP mRNA affects^cotreatment|increases^expression 19167446
1035 96-48-0 MIR21 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MIR21 mRNA affects^cotreatment|decreases^expression 19167446
1036 96-48-0 MIR21 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MIR21 mRNA affects^cotreatment|decreases^expression 19167446
1037 96-48-0 MIS18BP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MIS18BP1 mRNA affects^cotreatment|increases^expression 19167446
1038 96-48-0 MIS18BP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MIS18BP1 mRNA affects^cotreatment|increases^expression 19167446
1039 96-48-0 MKI67 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MKI67 mRNA affects^cotreatment|increases^expression 19167446
1040 96-48-0 MKI67 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MKI67 mRNA affects^cotreatment|increases^expression 19167446
1041 96-48-0 MKNK2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MKNK2 mRNA affects^cotreatment|decreases^expression 19167446
1042 96-48-0 MKNK2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MKNK2 mRNA affects^cotreatment|decreases^expression 19167446
1043 96-48-0 MLH1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MLH1 mRNA affects^cotreatment|increases^expression 19167446
1044 96-48-0 MLH1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MLH1 mRNA affects^cotreatment|increases^expression 19167446
1045 96-48-0 MOAP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MOAP1 mRNA affects^cotreatment|decreases^expression 19167446
1046 96-48-0 MOAP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MOAP1 mRNA affects^cotreatment|decreases^expression 19167446
1047 96-48-0 MPHOSPH9 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MPHOSPH9 mRNA affects^cotreatment|increases^expression 19167446
1048 96-48-0 MPHOSPH9 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MPHOSPH9 mRNA affects^cotreatment|increases^expression 19167446
1049 96-48-0 MRE11 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MRE11 mRNA affects^cotreatment|increases^expression 19167446
1050 96-48-0 MRE11 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MRE11 mRNA affects^cotreatment|increases^expression 19167446
1051 96-48-0 MRM2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MRM2 mRNA affects^cotreatment|increases^expression 19167446
1052 96-48-0 MRM2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MRM2 mRNA affects^cotreatment|increases^expression 19167446
1053 96-48-0 MRPL37 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MRPL37 mRNA affects^cotreatment|increases^expression 19167446
1054 96-48-0 MRPL37 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MRPL37 mRNA affects^cotreatment|increases^expression 19167446
1055 96-48-0 MRPS26 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MRPS26 mRNA affects^cotreatment|increases^expression 19167446
1056 96-48-0 MRPS26 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MRPS26 mRNA affects^cotreatment|increases^expression 19167446
1057 96-48-0 MRPS27 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MRPS27 mRNA affects^cotreatment|increases^expression 19167446
1058 96-48-0 MRPS27 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MRPS27 mRNA affects^cotreatment|increases^expression 19167446
1059 96-48-0 MSH6 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MSH6 mRNA affects^cotreatment|increases^expression 19167446
1060 96-48-0 MSH6 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MSH6 mRNA affects^cotreatment|increases^expression 19167446
1061 96-48-0 MTCP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MTCP1 mRNA affects^cotreatment|increases^expression 19167446
1062 96-48-0 MTCP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MTCP1 mRNA affects^cotreatment|increases^expression 19167446
1063 96-48-0 MTFP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MTFP1 mRNA affects^cotreatment|increases^expression 19167446
1064 96-48-0 MTFP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MTFP1 mRNA affects^cotreatment|increases^expression 19167446
1065 96-48-0 MTHFD1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MTHFD1 mRNA affects^cotreatment|increases^expression 19167446
1066 96-48-0 MTHFD1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MTHFD1 mRNA affects^cotreatment|increases^expression 19167446
1067 96-48-0 MTMR4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MTMR4 mRNA affects^cotreatment|increases^expression 19167446
1068 96-48-0 MTMR4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MTMR4 mRNA affects^cotreatment|increases^expression 19167446
1069 96-48-0 MTUS1 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of MTUS1 mRNA decreases^expression 19167446
1070 96-48-0 MTUS1 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of MTUS1 mRNA decreases^expression 19167446
1071 96-48-0 MTUS1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MTUS1 mRNA affects^cotreatment|decreases^expression 19167446
1072 96-48-0 MTUS1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MTUS1 mRNA affects^cotreatment|decreases^expression 19167446
1073 96-48-0 MVP Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MVP mRNA affects^cotreatment|decreases^expression 19167446
1074 96-48-0 MVP Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MVP mRNA affects^cotreatment|decreases^expression 19167446
1075 96-48-0 MXD4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MXD4 mRNA affects^cotreatment|decreases^expression 19167446
1076 96-48-0 MXD4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MXD4 mRNA affects^cotreatment|decreases^expression 19167446
1077 96-48-0 MYB Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MYB mRNA affects^cotreatment|increases^expression 19167446
1078 96-48-0 MYB Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MYB mRNA affects^cotreatment|increases^expression 19167446
1079 96-48-0 MYBL2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MYBL2 mRNA affects^cotreatment|increases^expression 19167446
1080 96-48-0 MYBL2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MYBL2 mRNA affects^cotreatment|increases^expression 19167446
1081 96-48-0 MYCBP Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MYCBP mRNA affects^cotreatment|increases^expression 19167446
1082 96-48-0 MYCBP Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MYCBP mRNA affects^cotreatment|increases^expression 19167446
1083 96-48-0 MYLIP Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MYLIP mRNA affects^cotreatment|decreases^expression 19167446
1084 96-48-0 MYLIP Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MYLIP mRNA affects^cotreatment|decreases^expression 19167446
1085 96-48-0 MYO1B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MYO1B mRNA affects^cotreatment|decreases^expression 19167446
1086 96-48-0 MYO1B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MYO1B mRNA affects^cotreatment|decreases^expression 19167446
1087 96-48-0 MYO5A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MYO5A mRNA affects^cotreatment|decreases^expression 19167446
1088 96-48-0 MYO5A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MYO5A mRNA affects^cotreatment|decreases^expression 19167446
1089 96-48-0 MYO5B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MYO5B mRNA affects^cotreatment|decreases^expression 19167446
1090 96-48-0 MYO5B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MYO5B mRNA affects^cotreatment|decreases^expression 19167446
1091 96-48-0 MYO6 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MYO6 mRNA affects^cotreatment|decreases^expression 19167446
1092 96-48-0 MYO6 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MYO6 mRNA affects^cotreatment|decreases^expression 19167446
1093 96-48-0 MZT1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MZT1 mRNA affects^cotreatment|increases^expression 19167446
1094 96-48-0 MZT1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MZT1 mRNA affects^cotreatment|increases^expression 19167446
1095 96-48-0 N4BP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of N4BP1 mRNA affects^cotreatment|decreases^expression 19167446
1096 96-48-0 N4BP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of N4BP1 mRNA affects^cotreatment|decreases^expression 19167446
1097 96-48-0 NAA50 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NAA50 mRNA affects^cotreatment|increases^expression 19167446
1098 96-48-0 NAA50 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NAA50 mRNA affects^cotreatment|increases^expression 19167446
1099 96-48-0 NANOS1 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of NANOS1 mRNA decreases^expression 19167446
1100 96-48-0 NANOS1 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of NANOS1 mRNA decreases^expression 19167446
1101 96-48-0 NANOS1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NANOS1 mRNA affects^cotreatment|decreases^expression 19167446
1102 96-48-0 NANOS1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NANOS1 mRNA affects^cotreatment|decreases^expression 19167446
1103 96-48-0 NASP Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NASP mRNA affects^cotreatment|increases^expression 19167446
1104 96-48-0 NASP Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NASP mRNA affects^cotreatment|increases^expression 19167446
1105 96-48-0 NBEA Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NBEA mRNA affects^cotreatment|decreases^expression 19167446
1106 96-48-0 NBEA Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NBEA mRNA affects^cotreatment|decreases^expression 19167446
1107 96-48-0 NBEAL1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NBEAL1 mRNA affects^cotreatment|decreases^expression 19167446
1108 96-48-0 NBEAL1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NBEAL1 mRNA affects^cotreatment|decreases^expression 19167446
1109 96-48-0 NBPF1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NBPF1 mRNA affects^cotreatment|increases^expression 19167446
1110 96-48-0 NBPF1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NBPF1 mRNA affects^cotreatment|increases^expression 19167446
1111 96-48-0 NCAPG Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NCAPG mRNA affects^cotreatment|increases^expression 19167446
1112 96-48-0 NCAPG Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NCAPG mRNA affects^cotreatment|increases^expression 19167446
1113 96-48-0 NCAPG2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NCAPG2 mRNA affects^cotreatment|increases^expression 19167446
1114 96-48-0 NCAPG2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NCAPG2 mRNA affects^cotreatment|increases^expression 19167446
1115 96-48-0 NCOA1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NCOA1 mRNA affects^cotreatment|decreases^expression 19167446
1116 96-48-0 NCOA1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NCOA1 mRNA affects^cotreatment|decreases^expression 19167446
1117 96-48-0 NCOA7 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NCOA7 mRNA affects^cotreatment|decreases^expression 19167446
1118 96-48-0 NCOA7 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NCOA7 mRNA affects^cotreatment|decreases^expression 19167446
1119 96-48-0 NDC1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NDC1 mRNA affects^cotreatment|increases^expression 19167446
1120 96-48-0 NDC1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NDC1 mRNA affects^cotreatment|increases^expression 19167446
1121 96-48-0 NDE1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NDE1 mRNA affects^cotreatment|increases^expression 19167446
1122 96-48-0 NDE1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NDE1 mRNA affects^cotreatment|increases^expression 19167446
1123 96-48-0 NDFIP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NDFIP1 mRNA affects^cotreatment|decreases^expression 19167446
1124 96-48-0 NDFIP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NDFIP1 mRNA affects^cotreatment|decreases^expression 19167446
1125 96-48-0 NEAT1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NEAT1 mRNA affects^cotreatment|decreases^expression 19167446
1126 96-48-0 NEAT1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NEAT1 mRNA affects^cotreatment|decreases^expression 19167446
1127 96-48-0 NEBL Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NEBL mRNA affects^cotreatment|decreases^expression 19167446
1128 96-48-0 NEBL Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NEBL mRNA affects^cotreatment|decreases^expression 19167446
1129 96-48-0 NEDD4L Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NEDD4L mRNA affects^cotreatment|decreases^expression 19167446
1130 96-48-0 NEDD4L Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NEDD4L mRNA affects^cotreatment|decreases^expression 19167446
1131 96-48-0 NEDD9 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NEDD9 mRNA affects^cotreatment|decreases^expression 19167446
1132 96-48-0 NEDD9 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NEDD9 mRNA affects^cotreatment|decreases^expression 19167446
1133 96-48-0 NEIL3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NEIL3 mRNA affects^cotreatment|increases^expression 19167446
1134 96-48-0 NEIL3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NEIL3 mRNA affects^cotreatment|increases^expression 19167446
1135 96-48-0 NEURL1B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NEURL1B mRNA affects^cotreatment|increases^expression 19167446
1136 96-48-0 NEURL1B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NEURL1B mRNA affects^cotreatment|increases^expression 19167446
1137 96-48-0 NFATC2IP Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NFATC2IP mRNA affects^cotreatment|increases^expression 19167446
1138 96-48-0 NFATC2IP Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NFATC2IP mRNA affects^cotreatment|increases^expression 19167446
1139 96-48-0 NFIL3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NFIL3 mRNA affects^cotreatment|decreases^expression 19167446
1140 96-48-0 NFIL3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NFIL3 mRNA affects^cotreatment|decreases^expression 19167446
1141 96-48-0 NINL Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NINL mRNA affects^cotreatment|decreases^expression 19167446
1142 96-48-0 NINL Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NINL mRNA affects^cotreatment|decreases^expression 19167446
1143 96-48-0 NMT2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NMT2 mRNA affects^cotreatment|decreases^expression 19167446
1144 96-48-0 NMT2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NMT2 mRNA affects^cotreatment|decreases^expression 19167446
1145 96-48-0 NMU Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NMU mRNA affects^cotreatment|increases^expression 19167446
1146 96-48-0 NMU Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NMU mRNA affects^cotreatment|increases^expression 19167446
1147 96-48-0 NOM1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NOM1 mRNA affects^cotreatment|increases^expression 19167446
1148 96-48-0 NOM1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NOM1 mRNA affects^cotreatment|increases^expression 19167446
1149 96-48-0 NPAS3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NPAS3 mRNA affects^cotreatment|decreases^expression 19167446
1150 96-48-0 NPAS3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NPAS3 mRNA affects^cotreatment|decreases^expression 19167446
1151 96-48-0 NPEPPS Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NPEPPS mRNA affects^cotreatment|increases^expression 19167446
1152 96-48-0 NPEPPS Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NPEPPS mRNA affects^cotreatment|increases^expression 19167446
1153 96-48-0 NPHP3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NPHP3 mRNA affects^cotreatment|decreases^expression 19167446
1154 96-48-0 NPHP3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NPHP3 mRNA affects^cotreatment|decreases^expression 19167446
1155 96-48-0 NPNT Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NPNT mRNA affects^cotreatment|decreases^expression 19167446
1156 96-48-0 NPNT Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NPNT mRNA affects^cotreatment|decreases^expression 19167446
1157 96-48-0 NPY1R Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NPY1R mRNA affects^cotreatment|increases^expression 19167446
1158 96-48-0 NPY1R Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NPY1R mRNA affects^cotreatment|increases^expression 19167446
1159 96-48-0 NQO1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NQO1 mRNA affects^cotreatment|decreases^expression 19167446
1160 96-48-0 NQO1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NQO1 mRNA affects^cotreatment|decreases^expression 19167446
1161 96-48-0 NQO2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NQO2 mRNA affects^cotreatment|increases^expression 19167446
1162 96-48-0 NQO2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NQO2 mRNA affects^cotreatment|increases^expression 19167446
1163 96-48-0 NR1I2 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased activity of NR1I2 protein increases^activity 15885729
1164 96-48-0 NR1I2 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased activity of NR1I2 protein increases^activity 15885729
1165 96-48-0 NR2F6 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NR2F6 mRNA affects^cotreatment|increases^expression 19167446
1166 96-48-0 NR2F6 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NR2F6 mRNA affects^cotreatment|increases^expression 19167446
1167 96-48-0 NR4A2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NR4A2 mRNA affects^cotreatment|decreases^expression 19167446
1168 96-48-0 NR4A2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NR4A2 mRNA affects^cotreatment|decreases^expression 19167446
1169 96-48-0 NRCAM Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NRCAM mRNA affects^cotreatment|decreases^expression 19167446
1170 96-48-0 NRCAM Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NRCAM mRNA affects^cotreatment|decreases^expression 19167446
1171 96-48-0 NRM Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NRM mRNA affects^cotreatment|increases^expression 19167446
1172 96-48-0 NRM Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NRM mRNA affects^cotreatment|increases^expression 19167446
1173 96-48-0 NSD2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NSD2 mRNA affects^cotreatment|increases^expression 19167446
1174 96-48-0 NSD2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NSD2 mRNA affects^cotreatment|increases^expression 19167446
1175 96-48-0 NT5E Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NT5E mRNA affects^cotreatment|decreases^expression 19167446
1176 96-48-0 NT5E Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NT5E mRNA affects^cotreatment|decreases^expression 19167446
1177 96-48-0 NTN4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NTN4 mRNA affects^cotreatment|decreases^expression 19167446
1178 96-48-0 NTN4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NTN4 mRNA affects^cotreatment|decreases^expression 19167446
1179 96-48-0 NUAK1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NUAK1 mRNA affects^cotreatment|decreases^expression 19167446
1180 96-48-0 NUAK1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NUAK1 mRNA affects^cotreatment|decreases^expression 19167446
1181 96-48-0 NUDT1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NUDT1 mRNA affects^cotreatment|increases^expression 19167446
1182 96-48-0 NUDT1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NUDT1 mRNA affects^cotreatment|increases^expression 19167446
1183 96-48-0 NUP107 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NUP107 mRNA affects^cotreatment|increases^expression 19167446
1184 96-48-0 NUP107 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NUP107 mRNA affects^cotreatment|increases^expression 19167446
1185 96-48-0 NUP155 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NUP155 mRNA affects^cotreatment|increases^expression 19167446
1186 96-48-0 NUP155 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NUP155 mRNA affects^cotreatment|increases^expression 19167446
1187 96-48-0 NUP210 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NUP210 mRNA affects^cotreatment|increases^expression 19167446
1188 96-48-0 NUP210 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NUP210 mRNA affects^cotreatment|increases^expression 19167446
1189 96-48-0 NUP62CL Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NUP62CL mRNA affects^cotreatment|increases^expression 19167446
1190 96-48-0 NUP62CL Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NUP62CL mRNA affects^cotreatment|increases^expression 19167446
1191 96-48-0 NUSAP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NUSAP1 mRNA affects^cotreatment|increases^expression 19167446
1192 96-48-0 NUSAP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NUSAP1 mRNA affects^cotreatment|increases^expression 19167446
1193 96-48-0 OAZ2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of OAZ2 mRNA affects^cotreatment|increases^expression 19167446
1194 96-48-0 OAZ2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of OAZ2 mRNA affects^cotreatment|increases^expression 19167446
1195 96-48-0 ODF2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ODF2 mRNA affects^cotreatment|increases^expression 19167446
1196 96-48-0 ODF2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ODF2 mRNA affects^cotreatment|increases^expression 19167446
1197 96-48-0 OIP5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of OIP5 mRNA affects^cotreatment|increases^expression 19167446
1198 96-48-0 OIP5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of OIP5 mRNA affects^cotreatment|increases^expression 19167446
1199 96-48-0 OLFM1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of OLFM1 mRNA affects^cotreatment|increases^expression 19167446
1200 96-48-0 OLFM1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of OLFM1 mRNA affects^cotreatment|increases^expression 19167446
1201 96-48-0 OPTN Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of OPTN mRNA affects^cotreatment|decreases^expression 19167446
1202 96-48-0 OPTN Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of OPTN mRNA affects^cotreatment|decreases^expression 19167446
1203 96-48-0 ORC1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ORC1 mRNA affects^cotreatment|increases^expression 19167446
1204 96-48-0 ORC1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ORC1 mRNA affects^cotreatment|increases^expression 19167446
1205 96-48-0 ORC6 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ORC6 mRNA affects^cotreatment|increases^expression 19167446
1206 96-48-0 ORC6 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ORC6 mRNA affects^cotreatment|increases^expression 19167446
1207 96-48-0 OSBPL2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of OSBPL2 mRNA affects^cotreatment|decreases^expression 19167446
1208 96-48-0 OSBPL2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of OSBPL2 mRNA affects^cotreatment|decreases^expression 19167446
1209 96-48-0 OSER1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of OSER1 mRNA affects^cotreatment|decreases^expression 19167446
1210 96-48-0 OSER1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of OSER1 mRNA affects^cotreatment|decreases^expression 19167446
1211 96-48-0 OTUD1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of OTUD1 mRNA affects^cotreatment|decreases^expression 19167446
1212 96-48-0 OTUD1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of OTUD1 mRNA affects^cotreatment|decreases^expression 19167446
1213 96-48-0 OXCT1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of OXCT1 mRNA affects^cotreatment|increases^expression 19167446
1214 96-48-0 OXCT1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of OXCT1 mRNA affects^cotreatment|increases^expression 19167446
1215 96-48-0 OXTR Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of OXTR mRNA affects^cotreatment|decreases^expression 19167446
1216 96-48-0 OXTR Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of OXTR mRNA affects^cotreatment|decreases^expression 19167446
1217 96-48-0 P4HB Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of P4HB mRNA affects^cotreatment|increases^expression 19167446
1218 96-48-0 P4HB Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of P4HB mRNA affects^cotreatment|increases^expression 19167446
1219 96-48-0 PAICS Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PAICS mRNA affects^cotreatment|increases^expression 19167446
1220 96-48-0 PAICS Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PAICS mRNA affects^cotreatment|increases^expression 19167446
1221 96-48-0 PAPSS2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PAPSS2 mRNA affects^cotreatment|decreases^expression 19167446
1222 96-48-0 PAPSS2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PAPSS2 mRNA affects^cotreatment|decreases^expression 19167446
1223 96-48-0 PARP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PARP1 mRNA affects^cotreatment|increases^expression 19167446
1224 96-48-0 PARP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PARP1 mRNA affects^cotreatment|increases^expression 19167446
1225 96-48-0 PARP2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PARP2 mRNA affects^cotreatment|increases^expression 19167446
1226 96-48-0 PARP2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PARP2 mRNA affects^cotreatment|increases^expression 19167446
1227 96-48-0 PARPBP Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PARPBP mRNA affects^cotreatment|increases^expression 19167446
1228 96-48-0 PARPBP Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PARPBP mRNA affects^cotreatment|increases^expression 19167446
1229 96-48-0 PARVA Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PARVA mRNA affects^cotreatment|decreases^expression 19167446
1230 96-48-0 PARVA Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PARVA mRNA affects^cotreatment|decreases^expression 19167446
1231 96-48-0 PAWR Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PAWR mRNA affects^cotreatment|decreases^expression 19167446
1232 96-48-0 PAWR Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PAWR mRNA affects^cotreatment|decreases^expression 19167446
1233 96-48-0 PBK Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PBK mRNA affects^cotreatment|increases^expression 19167446
1234 96-48-0 PBK Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PBK mRNA affects^cotreatment|increases^expression 19167446
1235 96-48-0 PCK2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PCK2 mRNA affects^cotreatment|increases^expression 19167446
1236 96-48-0 PCK2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PCK2 mRNA affects^cotreatment|increases^expression 19167446
1237 96-48-0 PCLAF Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of PCLAF mRNA increases^expression 19167446
1238 96-48-0 PCLAF Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of PCLAF mRNA increases^expression 19167446
1239 96-48-0 PCLAF Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PCLAF mRNA affects^cotreatment|increases^expression 19167446
1240 96-48-0 PCLAF Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PCLAF mRNA affects^cotreatment|increases^expression 19167446
1241 96-48-0 PCMTD1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PCMTD1 mRNA affects^cotreatment|decreases^expression 19167446
1242 96-48-0 PCMTD1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PCMTD1 mRNA affects^cotreatment|decreases^expression 19167446
1243 96-48-0 PCNA Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PCNA mRNA affects^cotreatment|increases^expression 19167446
1244 96-48-0 PCNA Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PCNA mRNA affects^cotreatment|increases^expression 19167446
1245 96-48-0 PCNT Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PCNT mRNA affects^cotreatment|increases^expression 19167446
1246 96-48-0 PCNT Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PCNT mRNA affects^cotreatment|increases^expression 19167446
1247 96-48-0 PCSK6 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PCSK6 mRNA affects^cotreatment|decreases^expression 19167446
1248 96-48-0 PCSK6 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PCSK6 mRNA affects^cotreatment|decreases^expression 19167446
1249 96-48-0 PCTK2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PCTK2 mRNA affects^cotreatment|decreases^expression 19167446
1250 96-48-0 PCTK2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PCTK2 mRNA affects^cotreatment|decreases^expression 19167446
1251 96-48-0 PDCD4 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of PDCD4 mRNA increases^expression 19167446
1252 96-48-0 PDCD4 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of PDCD4 mRNA increases^expression 19167446
1253 96-48-0 PDCD6IP Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PDCD6IP mRNA affects^cotreatment|decreases^expression 19167446
1254 96-48-0 PDCD6IP Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PDCD6IP mRNA affects^cotreatment|decreases^expression 19167446
1255 96-48-0 PDIA3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PDIA3 mRNA affects^cotreatment|increases^expression 19167446
1256 96-48-0 PDIA3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PDIA3 mRNA affects^cotreatment|increases^expression 19167446
1257 96-48-0 PDIA6 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PDIA6 mRNA affects^cotreatment|increases^expression 19167446
1258 96-48-0 PDIA6 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PDIA6 mRNA affects^cotreatment|increases^expression 19167446
1259 96-48-0 PDLIM1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PDLIM1 mRNA affects^cotreatment|decreases^expression 19167446
1260 96-48-0 PDLIM1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PDLIM1 mRNA affects^cotreatment|decreases^expression 19167446
1261 96-48-0 PDZK1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PDZK1 mRNA affects^cotreatment|increases^expression 19167446
1262 96-48-0 PDZK1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PDZK1 mRNA affects^cotreatment|increases^expression 19167446
1263 96-48-0 PFKL Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PFKL mRNA affects^cotreatment|increases^expression 19167446
1264 96-48-0 PFKL Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PFKL mRNA affects^cotreatment|increases^expression 19167446
1265 96-48-0 PGGT1B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PGGT1B mRNA affects^cotreatment|decreases^expression 19167446
1266 96-48-0 PGGT1B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PGGT1B mRNA affects^cotreatment|decreases^expression 19167446
1267 96-48-0 PGM2L1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PGM2L1 mRNA affects^cotreatment|decreases^expression 19167446
1268 96-48-0 PGM2L1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PGM2L1 mRNA affects^cotreatment|decreases^expression 19167446
1269 96-48-0 PGM3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PGM3 mRNA affects^cotreatment|decreases^expression 19167446
1270 96-48-0 PGM3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PGM3 mRNA affects^cotreatment|decreases^expression 19167446
1271 96-48-0 PGRMC1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PGRMC1 mRNA affects^cotreatment|increases^expression 19167446
1272 96-48-0 PGRMC1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PGRMC1 mRNA affects^cotreatment|increases^expression 19167446
1273 96-48-0 PGRMC2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PGRMC2 mRNA affects^cotreatment|decreases^expression 19167446
1274 96-48-0 PGRMC2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PGRMC2 mRNA affects^cotreatment|decreases^expression 19167446
1275 96-48-0 PHACTR2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PHACTR2 mRNA affects^cotreatment|decreases^expression 19167446
1276 96-48-0 PHACTR2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PHACTR2 mRNA affects^cotreatment|decreases^expression 19167446
1277 96-48-0 PHF19 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PHF19 mRNA affects^cotreatment|increases^expression 19167446
1278 96-48-0 PHF19 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PHF19 mRNA affects^cotreatment|increases^expression 19167446
1279 96-48-0 PHF20L1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PHF20L1 mRNA affects^cotreatment|decreases^expression 19167446
1280 96-48-0 PHF20L1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PHF20L1 mRNA affects^cotreatment|decreases^expression 19167446
1281 96-48-0 PHLDA2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PHLDA2 mRNA affects^cotreatment|decreases^expression 19167446
1282 96-48-0 PHLDA2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PHLDA2 mRNA affects^cotreatment|decreases^expression 19167446
1283 96-48-0 PHLDB2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PHLDB2 mRNA affects^cotreatment|decreases^expression 19167446
1284 96-48-0 PHLDB2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PHLDB2 mRNA affects^cotreatment|decreases^expression 19167446
1285 96-48-0 PIK3C3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PIK3C3 mRNA affects^cotreatment|decreases^expression 19167446
1286 96-48-0 PIK3C3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PIK3C3 mRNA affects^cotreatment|decreases^expression 19167446
1287 96-48-0 PIMREG Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PIMREG mRNA affects^cotreatment|increases^expression 19167446
1288 96-48-0 PIMREG Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PIMREG mRNA affects^cotreatment|increases^expression 19167446
1289 96-48-0 PKIB Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PKIB mRNA affects^cotreatment|increases^expression 19167446
1290 96-48-0 PKIB Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PKIB mRNA affects^cotreatment|increases^expression 19167446
1291 96-48-0 PKM Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PKM mRNA affects^cotreatment|increases^expression 19167446
1292 96-48-0 PKM Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PKM mRNA affects^cotreatment|increases^expression 19167446
1293 96-48-0 PKMYT1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PKMYT1 mRNA affects^cotreatment|increases^expression 19167446
1294 96-48-0 PKMYT1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PKMYT1 mRNA affects^cotreatment|increases^expression 19167446
1295 96-48-0 PLCXD1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PLCXD1 mRNA affects^cotreatment|increases^expression 19167446
1296 96-48-0 PLCXD1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PLCXD1 mRNA affects^cotreatment|increases^expression 19167446
1297 96-48-0 PLEKHA5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PLEKHA5 mRNA affects^cotreatment|decreases^expression 19167446
1298 96-48-0 PLEKHA5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PLEKHA5 mRNA affects^cotreatment|decreases^expression 19167446
1299 96-48-0 PLEKHB2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PLEKHB2 mRNA affects^cotreatment|decreases^expression 19167446
1300 96-48-0 PLEKHB2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PLEKHB2 mRNA affects^cotreatment|decreases^expression 19167446
1301 96-48-0 PLK1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PLK1 mRNA affects^cotreatment|increases^expression 19167446
1302 96-48-0 PLK1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PLK1 mRNA affects^cotreatment|increases^expression 19167446
1303 96-48-0 PLK4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PLK4 mRNA affects^cotreatment|increases^expression 19167446
1304 96-48-0 PLK4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PLK4 mRNA affects^cotreatment|increases^expression 19167446
1305 96-48-0 PLOD2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PLOD2 mRNA affects^cotreatment|increases^expression 19167446
1306 96-48-0 PLOD2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PLOD2 mRNA affects^cotreatment|increases^expression 19167446
1307 96-48-0 PMEPA1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PMEPA1 mRNA affects^cotreatment|decreases^expression 19167446
1308 96-48-0 PMEPA1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PMEPA1 mRNA affects^cotreatment|decreases^expression 19167446
1309 96-48-0 PMPCB Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PMPCB mRNA affects^cotreatment|decreases^expression 19167446
1310 96-48-0 PMPCB Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PMPCB mRNA affects^cotreatment|decreases^expression 19167446
1311 96-48-0 PNP Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PNP mRNA affects^cotreatment|increases^expression 19167446
1312 96-48-0 PNP Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PNP mRNA affects^cotreatment|increases^expression 19167446
1313 96-48-0 POLA1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLA1 mRNA affects^cotreatment|increases^expression 19167446
1314 96-48-0 POLA1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLA1 mRNA affects^cotreatment|increases^expression 19167446
1315 96-48-0 POLA2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLA2 mRNA affects^cotreatment|increases^expression 19167446
1316 96-48-0 POLA2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLA2 mRNA affects^cotreatment|increases^expression 19167446
1317 96-48-0 POLD1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLD1 mRNA affects^cotreatment|increases^expression 19167446
1318 96-48-0 POLD1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLD1 mRNA affects^cotreatment|increases^expression 19167446
1319 96-48-0 POLD2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLD2 mRNA affects^cotreatment|increases^expression 19167446
1320 96-48-0 POLD2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLD2 mRNA affects^cotreatment|increases^expression 19167446
1321 96-48-0 POLD3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLD3 mRNA affects^cotreatment|increases^expression 19167446
1322 96-48-0 POLD3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLD3 mRNA affects^cotreatment|increases^expression 19167446
1323 96-48-0 POLE Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLE mRNA affects^cotreatment|increases^expression 19167446
1324 96-48-0 POLE Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLE mRNA affects^cotreatment|increases^expression 19167446
1325 96-48-0 POLE2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLE2 mRNA affects^cotreatment|increases^expression 19167446
1326 96-48-0 POLE2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLE2 mRNA affects^cotreatment|increases^expression 19167446
1327 96-48-0 POLE3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLE3 mRNA affects^cotreatment|increases^expression 19167446
1328 96-48-0 POLE3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLE3 mRNA affects^cotreatment|increases^expression 19167446
1329 96-48-0 PPAT Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PPAT mRNA affects^cotreatment|increases^expression 19167446
1330 96-48-0 PPAT Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PPAT mRNA affects^cotreatment|increases^expression 19167446
1331 96-48-0 PPIF Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PPIF mRNA affects^cotreatment|increases^expression 19167446
1332 96-48-0 PPIF Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PPIF mRNA affects^cotreatment|increases^expression 19167446
1333 96-48-0 PPL Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PPL mRNA affects^cotreatment|decreases^expression 19167446
1334 96-48-0 PPL Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PPL mRNA affects^cotreatment|decreases^expression 19167446
1335 96-48-0 PPP1R10 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PPP1R10 mRNA affects^cotreatment|increases^expression 19167446
1336 96-48-0 PPP1R10 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PPP1R10 mRNA affects^cotreatment|increases^expression 19167446
1337 96-48-0 PPP2R2A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PPP2R2A mRNA affects^cotreatment|decreases^expression 19167446
1338 96-48-0 PPP2R2A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PPP2R2A mRNA affects^cotreatment|decreases^expression 19167446
1339 96-48-0 PPP2R3A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PPP2R3A mRNA affects^cotreatment|decreases^expression 19167446
1340 96-48-0 PPP2R3A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PPP2R3A mRNA affects^cotreatment|decreases^expression 19167446
1341 96-48-0 PPP3CC Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PPP3CC mRNA affects^cotreatment|decreases^expression 19167446
1342 96-48-0 PPP3CC Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PPP3CC mRNA affects^cotreatment|decreases^expression 19167446
1343 96-48-0 PRDX4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PRDX4 mRNA affects^cotreatment|increases^expression 19167446
1344 96-48-0 PRDX4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PRDX4 mRNA affects^cotreatment|increases^expression 19167446
1345 96-48-0 PREX1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PREX1 mRNA affects^cotreatment|increases^expression 19167446
1346 96-48-0 PREX1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PREX1 mRNA affects^cotreatment|increases^expression 19167446
1347 96-48-0 PRIM1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PRIM1 mRNA affects^cotreatment|increases^expression 19167446
1348 96-48-0 PRIM1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PRIM1 mRNA affects^cotreatment|increases^expression 19167446
1349 96-48-0 PRIM2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PRIM2 mRNA affects^cotreatment|increases^expression 19167446
1350 96-48-0 PRIM2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PRIM2 mRNA affects^cotreatment|increases^expression 19167446
1351 96-48-0 PRKDC Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PRKDC mRNA affects^cotreatment|increases^expression 19167446
1352 96-48-0 PRKDC Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PRKDC mRNA affects^cotreatment|increases^expression 19167446
1353 96-48-0 PRPF4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PRPF4 mRNA affects^cotreatment|increases^expression 19167446
1354 96-48-0 PRPF4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PRPF4 mRNA affects^cotreatment|increases^expression 19167446
1355 96-48-0 PRR14 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PRR14 mRNA affects^cotreatment|increases^expression 19167446
1356 96-48-0 PRR14 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PRR14 mRNA affects^cotreatment|increases^expression 19167446
1357 96-48-0 PRRC2A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PRRC2A mRNA affects^cotreatment|increases^expression 19167446
1358 96-48-0 PRRC2A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PRRC2A mRNA affects^cotreatment|increases^expression 19167446
1359 96-48-0 PRRC2C Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PRRC2C mRNA affects^cotreatment|decreases^expression 19167446
1360 96-48-0 PRRC2C Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PRRC2C mRNA affects^cotreatment|decreases^expression 19167446
1361 96-48-0 PRRT3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PRRT3 mRNA affects^cotreatment|decreases^expression 19167446
1362 96-48-0 PRRT3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PRRT3 mRNA affects^cotreatment|decreases^expression 19167446
1363 96-48-0 PRSS23 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of PRSS23 mRNA decreases^expression 19167446
1364 96-48-0 PRSS23 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of PRSS23 mRNA decreases^expression 19167446
1365 96-48-0 PRSS23 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PRSS23 mRNA affects^cotreatment|decreases^expression 19167446
1366 96-48-0 PRSS23 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PRSS23 mRNA affects^cotreatment|decreases^expression 19167446
1367 96-48-0 PSIP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PSIP1 mRNA affects^cotreatment|increases^expression 19167446
1368 96-48-0 PSIP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PSIP1 mRNA affects^cotreatment|increases^expression 19167446
1369 96-48-0 PSMC3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PSMC3 mRNA affects^cotreatment|increases^expression 19167446
1370 96-48-0 PSMC3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PSMC3 mRNA affects^cotreatment|increases^expression 19167446
1371 96-48-0 PSRC1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PSRC1 mRNA affects^cotreatment|increases^expression 19167446
1372 96-48-0 PSRC1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PSRC1 mRNA affects^cotreatment|increases^expression 19167446
1373 96-48-0 PTBP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PTBP1 mRNA affects^cotreatment|increases^expression 19167446
1374 96-48-0 PTBP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PTBP1 mRNA affects^cotreatment|increases^expression 19167446
1375 96-48-0 PTGES Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PTGES mRNA affects^cotreatment|increases^expression 19167446
1376 96-48-0 PTGES Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PTGES mRNA affects^cotreatment|increases^expression 19167446
1377 96-48-0 PTP4A1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PTP4A1 mRNA affects^cotreatment|increases^expression 19167446
1378 96-48-0 PTP4A1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PTP4A1 mRNA affects^cotreatment|increases^expression 19167446
1379 96-48-0 PTPN12 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PTPN12 mRNA affects^cotreatment|decreases^expression 19167446
1380 96-48-0 PTPN12 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PTPN12 mRNA affects^cotreatment|decreases^expression 19167446
1381 96-48-0 PTPN21 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PTPN21 mRNA affects^cotreatment|decreases^expression 19167446
1382 96-48-0 PTPN21 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PTPN21 mRNA affects^cotreatment|decreases^expression 19167446
1383 96-48-0 PTTG1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PTTG1 mRNA affects^cotreatment|increases^expression 19167446
1384 96-48-0 PTTG1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PTTG1 mRNA affects^cotreatment|increases^expression 19167446
1385 96-48-0 PUS3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PUS3 mRNA affects^cotreatment|decreases^expression 19167446
1386 96-48-0 PUS3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PUS3 mRNA affects^cotreatment|decreases^expression 19167446
1387 96-48-0 PYROXD1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PYROXD1 mRNA affects^cotreatment|decreases^expression 19167446
1388 96-48-0 PYROXD1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PYROXD1 mRNA affects^cotreatment|decreases^expression 19167446
1389 96-48-0 QSER1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of QSER1 mRNA affects^cotreatment|increases^expression 19167446
1390 96-48-0 QSER1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of QSER1 mRNA affects^cotreatment|increases^expression 19167446
1391 96-48-0 RAB2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RAB2 mRNA affects^cotreatment|decreases^expression 19167446
1392 96-48-0 RAB2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RAB2 mRNA affects^cotreatment|decreases^expression 19167446
1393 96-48-0 RAB31 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAB31 mRNA affects^cotreatment|increases^expression 19167446
1394 96-48-0 RAB31 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAB31 mRNA affects^cotreatment|increases^expression 19167446
1395 96-48-0 RAB32 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RAB32 mRNA affects^cotreatment|decreases^expression 19167446
1396 96-48-0 RAB32 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RAB32 mRNA affects^cotreatment|decreases^expression 19167446
1397 96-48-0 RAB40B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RAB40B mRNA affects^cotreatment|decreases^expression 19167446
1398 96-48-0 RAB40B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RAB40B mRNA affects^cotreatment|decreases^expression 19167446
1399 96-48-0 RAB8A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAB8A mRNA affects^cotreatment|increases^expression 19167446
1400 96-48-0 RAB8A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAB8A mRNA affects^cotreatment|increases^expression 19167446
1401 96-48-0 RACGAP1 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of RACGAP1 mRNA increases^expression 19167446
1402 96-48-0 RACGAP1 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of RACGAP1 mRNA increases^expression 19167446
1403 96-48-0 RACGAP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RACGAP1 mRNA affects^cotreatment|increases^expression 19167446
1404 96-48-0 RACGAP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RACGAP1 mRNA affects^cotreatment|increases^expression 19167446
1405 96-48-0 RAD21 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAD21 mRNA affects^cotreatment|increases^expression 19167446
1406 96-48-0 RAD21 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAD21 mRNA affects^cotreatment|increases^expression 19167446
1407 96-48-0 RAD51 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAD51 mRNA affects^cotreatment|increases^expression 19167446
1408 96-48-0 RAD51 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAD51 mRNA affects^cotreatment|increases^expression 19167446
1409 96-48-0 RAD51AP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAD51AP1 mRNA affects^cotreatment|increases^expression 19167446
1410 96-48-0 RAD51AP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAD51AP1 mRNA affects^cotreatment|increases^expression 19167446
1411 96-48-0 RAD51C Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAD51C mRNA affects^cotreatment|increases^expression 19167446
1412 96-48-0 RAD51C Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAD51C mRNA affects^cotreatment|increases^expression 19167446
1413 96-48-0 RAD54B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAD54B mRNA affects^cotreatment|increases^expression 19167446
1414 96-48-0 RAD54B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAD54B mRNA affects^cotreatment|increases^expression 19167446
1415 96-48-0 RAD54L Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAD54L mRNA affects^cotreatment|increases^expression 19167446
1416 96-48-0 RAD54L Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAD54L mRNA affects^cotreatment|increases^expression 19167446
1417 96-48-0 RANBP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RANBP1 mRNA affects^cotreatment|increases^expression 19167446
1418 96-48-0 RANBP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RANBP1 mRNA affects^cotreatment|increases^expression 19167446
1419 96-48-0 RANGAP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RANGAP1 mRNA affects^cotreatment|increases^expression 19167446
1420 96-48-0 RANGAP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RANGAP1 mRNA affects^cotreatment|increases^expression 19167446
1421 96-48-0 RAPGEF2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RAPGEF2 mRNA affects^cotreatment|decreases^expression 19167446
1422 96-48-0 RAPGEF2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RAPGEF2 mRNA affects^cotreatment|decreases^expression 19167446
1423 96-48-0 RAPGEFL1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAPGEFL1 mRNA affects^cotreatment|increases^expression 19167446
1424 96-48-0 RAPGEFL1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAPGEFL1 mRNA affects^cotreatment|increases^expression 19167446
1425 96-48-0 RASD1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RASD1 mRNA affects^cotreatment|decreases^expression 19167446
1426 96-48-0 RASD1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RASD1 mRNA affects^cotreatment|decreases^expression 19167446
1427 96-48-0 RASEF Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RASEF mRNA affects^cotreatment|decreases^expression 19167446
1428 96-48-0 RASEF Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RASEF mRNA affects^cotreatment|decreases^expression 19167446
1429 96-48-0 RASL11B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RASL11B mRNA affects^cotreatment|decreases^expression 19167446
1430 96-48-0 RASL11B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RASL11B mRNA affects^cotreatment|decreases^expression 19167446
1431 96-48-0 RASSF3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RASSF3 mRNA affects^cotreatment|decreases^expression 19167446
1432 96-48-0 RASSF3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RASSF3 mRNA affects^cotreatment|decreases^expression 19167446
1433 96-48-0 RAVER1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAVER1 mRNA affects^cotreatment|increases^expression 19167446
1434 96-48-0 RAVER1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAVER1 mRNA affects^cotreatment|increases^expression 19167446
1435 96-48-0 RB1CC1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RB1CC1 mRNA affects^cotreatment|decreases^expression 19167446
1436 96-48-0 RB1CC1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RB1CC1 mRNA affects^cotreatment|decreases^expression 19167446
1437 96-48-0 RBBP4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RBBP4 mRNA affects^cotreatment|increases^expression 19167446
1438 96-48-0 RBBP4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RBBP4 mRNA affects^cotreatment|increases^expression 19167446
1439 96-48-0 RBBP8 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RBBP8 mRNA affects^cotreatment|increases^expression 19167446
1440 96-48-0 RBBP8 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RBBP8 mRNA affects^cotreatment|increases^expression 19167446
1441 96-48-0 RBBP9 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RBBP9 mRNA affects^cotreatment|increases^expression 19167446
1442 96-48-0 RBBP9 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RBBP9 mRNA affects^cotreatment|increases^expression 19167446
1443 96-48-0 RBFOX2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RBFOX2 mRNA affects^cotreatment|decreases^expression 19167446
1444 96-48-0 RBFOX2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RBFOX2 mRNA affects^cotreatment|decreases^expression 19167446
1445 96-48-0 RBM10 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RBM10 mRNA affects^cotreatment|increases^expression 19167446
1446 96-48-0 RBM10 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RBM10 mRNA affects^cotreatment|increases^expression 19167446
1447 96-48-0 RBM15 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RBM15 mRNA affects^cotreatment|increases^expression 19167446
1448 96-48-0 RBM15 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RBM15 mRNA affects^cotreatment|increases^expression 19167446
1449 96-48-0 RBMS1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RBMS1 mRNA affects^cotreatment|decreases^expression 19167446
1450 96-48-0 RBMS1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RBMS1 mRNA affects^cotreatment|decreases^expression 19167446
1451 96-48-0 RCCD1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RCCD1 mRNA affects^cotreatment|increases^expression 19167446
1452 96-48-0 RCCD1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RCCD1 mRNA affects^cotreatment|increases^expression 19167446
1453 96-48-0 RCOR3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RCOR3 mRNA affects^cotreatment|decreases^expression 19167446
1454 96-48-0 RCOR3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RCOR3 mRNA affects^cotreatment|decreases^expression 19167446
1455 96-48-0 RDM1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RDM1 mRNA affects^cotreatment|increases^expression 19167446
1456 96-48-0 RDM1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RDM1 mRNA affects^cotreatment|increases^expression 19167446
1457 96-48-0 RECQL4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RECQL4 mRNA affects^cotreatment|increases^expression 19167446
1458 96-48-0 RECQL4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RECQL4 mRNA affects^cotreatment|increases^expression 19167446
1459 96-48-0 REEP3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of REEP3 mRNA affects^cotreatment|increases^expression 19167446
1460 96-48-0 REEP3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of REEP3 mRNA affects^cotreatment|increases^expression 19167446
1461 96-48-0 REEP5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of REEP5 mRNA affects^cotreatment|decreases^expression 19167446
1462 96-48-0 REEP5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of REEP5 mRNA affects^cotreatment|decreases^expression 19167446
1463 96-48-0 RERG Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RERG mRNA affects^cotreatment|increases^expression 19167446
1464 96-48-0 RERG Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RERG mRNA affects^cotreatment|increases^expression 19167446
1465 96-48-0 RET Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RET mRNA affects^cotreatment|increases^expression 19167446
1466 96-48-0 RET Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RET mRNA affects^cotreatment|increases^expression 19167446
1467 96-48-0 RFC2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RFC2 mRNA affects^cotreatment|increases^expression 19167446
1468 96-48-0 RFC2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RFC2 mRNA affects^cotreatment|increases^expression 19167446
1469 96-48-0 RFC3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RFC3 mRNA affects^cotreatment|increases^expression 19167446
1470 96-48-0 RFC3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RFC3 mRNA affects^cotreatment|increases^expression 19167446
1471 96-48-0 RFC4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RFC4 mRNA affects^cotreatment|increases^expression 19167446
1472 96-48-0 RFC4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RFC4 mRNA affects^cotreatment|increases^expression 19167446
1473 96-48-0 RFC5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RFC5 mRNA affects^cotreatment|increases^expression 19167446
1474 96-48-0 RFC5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RFC5 mRNA affects^cotreatment|increases^expression 19167446
1475 96-48-0 RFTN1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RFTN1 mRNA affects^cotreatment|decreases^expression 19167446
1476 96-48-0 RFTN1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RFTN1 mRNA affects^cotreatment|decreases^expression 19167446
1477 96-48-0 RGS2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RGS2 mRNA affects^cotreatment|decreases^expression 19167446
1478 96-48-0 RGS2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RGS2 mRNA affects^cotreatment|decreases^expression 19167446
1479 96-48-0 RHBDF1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RHBDF1 mRNA affects^cotreatment|decreases^expression 19167446
1480 96-48-0 RHBDF1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RHBDF1 mRNA affects^cotreatment|decreases^expression 19167446
1481 96-48-0 RHNO1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RHNO1 mRNA affects^cotreatment|increases^expression 19167446
1482 96-48-0 RHNO1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RHNO1 mRNA affects^cotreatment|increases^expression 19167446
1483 96-48-0 RHOQ Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RHOQ mRNA affects^cotreatment|decreases^expression 19167446
1484 96-48-0 RHOQ Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RHOQ mRNA affects^cotreatment|decreases^expression 19167446
1485 96-48-0 RHOT1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RHOT1 mRNA affects^cotreatment|decreases^expression 19167446
1486 96-48-0 RHOT1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RHOT1 mRNA affects^cotreatment|decreases^expression 19167446
1487 96-48-0 RMDN2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RMDN2 mRNA affects^cotreatment|decreases^expression 19167446
1488 96-48-0 RMDN2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RMDN2 mRNA affects^cotreatment|decreases^expression 19167446
1489 96-48-0 RMI1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RMI1 mRNA affects^cotreatment|increases^expression 19167446
1490 96-48-0 RMI1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RMI1 mRNA affects^cotreatment|increases^expression 19167446
1491 96-48-0 RMI2 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of RMI2 mRNA increases^expression 19167446
1492 96-48-0 RMI2 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of RMI2 mRNA increases^expression 19167446
1493 96-48-0 RMI2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RMI2 mRNA affects^cotreatment|increases^expression 19167446
1494 96-48-0 RMI2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RMI2 mRNA affects^cotreatment|increases^expression 19167446
1495 96-48-0 RNASEH2A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RNASEH2A mRNA affects^cotreatment|increases^expression 19167446
1496 96-48-0 RNASEH2A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RNASEH2A mRNA affects^cotreatment|increases^expression 19167446
1497 96-48-0 RNF187 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RNF187 mRNA affects^cotreatment|increases^expression 19167446
1498 96-48-0 RNF187 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RNF187 mRNA affects^cotreatment|increases^expression 19167446
1499 96-48-0 RNF19A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RNF19A mRNA affects^cotreatment|decreases^expression 19167446
1500 96-48-0 RNF19A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RNF19A mRNA affects^cotreatment|decreases^expression 19167446
1501 96-48-0 RNF26 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RNF26 mRNA affects^cotreatment|increases^expression 19167446
1502 96-48-0 RNF26 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RNF26 mRNA affects^cotreatment|increases^expression 19167446
1503 96-48-0 ROCK2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ROCK2 mRNA affects^cotreatment|decreases^expression 19167446
1504 96-48-0 ROCK2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ROCK2 mRNA affects^cotreatment|decreases^expression 19167446
1505 96-48-0 RPA1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RPA1 mRNA affects^cotreatment|increases^expression 19167446
1506 96-48-0 RPA1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RPA1 mRNA affects^cotreatment|increases^expression 19167446
1507 96-48-0 RPA3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RPA3 mRNA affects^cotreatment|increases^expression 19167446
1508 96-48-0 RPA3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RPA3 mRNA affects^cotreatment|increases^expression 19167446
1509 96-48-0 RPL39L Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RPL39L mRNA affects^cotreatment|increases^expression 19167446
1510 96-48-0 RPL39L Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RPL39L mRNA affects^cotreatment|increases^expression 19167446
1511 96-48-0 RRAGC Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RRAGC mRNA affects^cotreatment|decreases^expression 19167446
1512 96-48-0 RRAGC Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RRAGC mRNA affects^cotreatment|decreases^expression 19167446
1513 96-48-0 RRM1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RRM1 mRNA affects^cotreatment|increases^expression 19167446
1514 96-48-0 RRM1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RRM1 mRNA affects^cotreatment|increases^expression 19167446
1515 96-48-0 RRM2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RRM2 mRNA affects^cotreatment|increases^expression 19167446
1516 96-48-0 RRM2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RRM2 mRNA affects^cotreatment|increases^expression 19167446
1517 96-48-0 RSRC1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RSRC1 mRNA affects^cotreatment|increases^expression 19167446
1518 96-48-0 RSRC1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RSRC1 mRNA affects^cotreatment|increases^expression 19167446
1519 96-48-0 RSU1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RSU1 mRNA affects^cotreatment|decreases^expression 19167446
1520 96-48-0 RSU1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RSU1 mRNA affects^cotreatment|decreases^expression 19167446
1521 96-48-0 RUNDC3B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RUNDC3B mRNA affects^cotreatment|decreases^expression 19167446
1522 96-48-0 RUNDC3B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RUNDC3B mRNA affects^cotreatment|decreases^expression 19167446
1523 96-48-0 S100A10 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of S100A10 mRNA affects^cotreatment|decreases^expression 19167446
1524 96-48-0 S100A10 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of S100A10 mRNA affects^cotreatment|decreases^expression 19167446
1525 96-48-0 S1PR3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of S1PR3 mRNA affects^cotreatment|decreases^expression 19167446
1526 96-48-0 S1PR3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of S1PR3 mRNA affects^cotreatment|decreases^expression 19167446
1527 96-48-0 SAE1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SAE1 mRNA affects^cotreatment|increases^expression 19167446
1528 96-48-0 SAE1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SAE1 mRNA affects^cotreatment|increases^expression 19167446
1529 96-48-0 SALL4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SALL4 mRNA affects^cotreatment|decreases^expression 19167446
1530 96-48-0 SALL4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SALL4 mRNA affects^cotreatment|decreases^expression 19167446
1531 96-48-0 SASH1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SASH1 mRNA affects^cotreatment|decreases^expression 19167446
1532 96-48-0 SASH1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SASH1 mRNA affects^cotreatment|decreases^expression 19167446
1533 96-48-0 SAT1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SAT1 mRNA affects^cotreatment|decreases^expression 19167446
1534 96-48-0 SAT1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SAT1 mRNA affects^cotreatment|decreases^expression 19167446
1535 96-48-0 SCARB1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SCARB1 mRNA affects^cotreatment|increases^expression 19167446
1536 96-48-0 SCARB1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SCARB1 mRNA affects^cotreatment|increases^expression 19167446
1537 96-48-0 SCARB2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SCARB2 mRNA affects^cotreatment|decreases^expression 19167446
1538 96-48-0 SCARB2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SCARB2 mRNA affects^cotreatment|decreases^expression 19167446
1539 96-48-0 SCCPDH Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SCCPDH mRNA affects^cotreatment|decreases^expression 19167446
1540 96-48-0 SCCPDH Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SCCPDH mRNA affects^cotreatment|decreases^expression 19167446
1541 96-48-0 SELENOP Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SELENOP mRNA affects^cotreatment|decreases^expression 19167446
1542 96-48-0 SELENOP Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SELENOP mRNA affects^cotreatment|decreases^expression 19167446
1543 96-48-0 SEPHS1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SEPHS1 mRNA affects^cotreatment|increases^expression 19167446
1544 96-48-0 SEPHS1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SEPHS1 mRNA affects^cotreatment|increases^expression 19167446
1545 96-48-0 SERINC5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SERINC5 mRNA affects^cotreatment|decreases^expression 19167446
1546 96-48-0 SERINC5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SERINC5 mRNA affects^cotreatment|decreases^expression 19167446
1547 96-48-0 SF1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SF1 mRNA affects^cotreatment|increases^expression 19167446
1548 96-48-0 SF1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SF1 mRNA affects^cotreatment|increases^expression 19167446
1549 96-48-0 SF3B3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SF3B3 mRNA affects^cotreatment|increases^expression 19167446
1550 96-48-0 SF3B3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SF3B3 mRNA affects^cotreatment|increases^expression 19167446
1551 96-48-0 SFN Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SFN mRNA affects^cotreatment|increases^expression 19167446
1552 96-48-0 SFN Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SFN mRNA affects^cotreatment|increases^expression 19167446
1553 96-48-0 SFXN2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SFXN2 mRNA affects^cotreatment|increases^expression 19167446
1554 96-48-0 SFXN2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SFXN2 mRNA affects^cotreatment|increases^expression 19167446
1555 96-48-0 SGCG Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SGCG mRNA affects^cotreatment|decreases^expression 19167446
1556 96-48-0 SGCG Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SGCG mRNA affects^cotreatment|decreases^expression 19167446
1557 96-48-0 SGK3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SGK3 mRNA affects^cotreatment|increases^expression 19167446
1558 96-48-0 SGK3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SGK3 mRNA affects^cotreatment|increases^expression 19167446
1559 96-48-0 SGO1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SGO1 mRNA affects^cotreatment|increases^expression 19167446
1560 96-48-0 SGO1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SGO1 mRNA affects^cotreatment|increases^expression 19167446
1561 96-48-0 SGO2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SGO2 mRNA affects^cotreatment|increases^expression 19167446
1562 96-48-0 SGO2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SGO2 mRNA affects^cotreatment|increases^expression 19167446
1563 96-48-0 SH3BGRL Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of SH3BGRL mRNA decreases^expression 19167446
1564 96-48-0 SH3BGRL Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of SH3BGRL mRNA decreases^expression 19167446
1565 96-48-0 SH3BGRL Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SH3BGRL mRNA affects^cotreatment|decreases^expression 19167446
1566 96-48-0 SH3BGRL Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SH3BGRL mRNA affects^cotreatment|decreases^expression 19167446
1567 96-48-0 SH3BP4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SH3BP4 mRNA affects^cotreatment|decreases^expression 19167446
1568 96-48-0 SH3BP4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SH3BP4 mRNA affects^cotreatment|decreases^expression 19167446
1569 96-48-0 SH3KBP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SH3KBP1 mRNA affects^cotreatment|decreases^expression 19167446
1570 96-48-0 SH3KBP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SH3KBP1 mRNA affects^cotreatment|decreases^expression 19167446
1571 96-48-0 SHCBP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SHCBP1 mRNA affects^cotreatment|increases^expression 19167446
1572 96-48-0 SHCBP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SHCBP1 mRNA affects^cotreatment|increases^expression 19167446
1573 96-48-0 SHISA2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SHISA2 mRNA affects^cotreatment|decreases^expression 19167446
1574 96-48-0 SHISA2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SHISA2 mRNA affects^cotreatment|decreases^expression 19167446
1575 96-48-0 SHMT1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SHMT1 mRNA affects^cotreatment|increases^expression 19167446
1576 96-48-0 SHMT1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SHMT1 mRNA affects^cotreatment|increases^expression 19167446
1577 96-48-0 SHMT2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SHMT2 mRNA affects^cotreatment|increases^expression 19167446
1578 96-48-0 SHMT2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SHMT2 mRNA affects^cotreatment|increases^expression 19167446
1579 96-48-0 SKA1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SKA1 mRNA affects^cotreatment|increases^expression 19167446
1580 96-48-0 SKA1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SKA1 mRNA affects^cotreatment|increases^expression 19167446
1581 96-48-0 SKA2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SKA2 mRNA affects^cotreatment|increases^expression 19167446
1582 96-48-0 SKA2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SKA2 mRNA affects^cotreatment|increases^expression 19167446
1583 96-48-0 SKA3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SKA3 mRNA affects^cotreatment|increases^expression 19167446
1584 96-48-0 SKA3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SKA3 mRNA affects^cotreatment|increases^expression 19167446
1585 96-48-0 SKP2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SKP2 mRNA affects^cotreatment|increases^expression 19167446
1586 96-48-0 SKP2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SKP2 mRNA affects^cotreatment|increases^expression 19167446
1587 96-48-0 SLBP Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLBP mRNA affects^cotreatment|increases^expression 19167446
1588 96-48-0 SLBP Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLBP mRNA affects^cotreatment|increases^expression 19167446
1589 96-48-0 SLC12A2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SLC12A2 mRNA affects^cotreatment|decreases^expression 19167446
1590 96-48-0 SLC12A2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SLC12A2 mRNA affects^cotreatment|decreases^expression 19167446
1591 96-48-0 SLC12A4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC12A4 mRNA affects^cotreatment|increases^expression 19167446
1592 96-48-0 SLC12A4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC12A4 mRNA affects^cotreatment|increases^expression 19167446
1593 96-48-0 SLC12A8 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SLC12A8 mRNA affects^cotreatment|decreases^expression 19167446
1594 96-48-0 SLC12A8 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SLC12A8 mRNA affects^cotreatment|decreases^expression 19167446
1595 96-48-0 SLC1A4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC1A4 mRNA affects^cotreatment|increases^expression 19167446
1596 96-48-0 SLC1A4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC1A4 mRNA affects^cotreatment|increases^expression 19167446
1597 96-48-0 SLC25A11 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC25A11 mRNA affects^cotreatment|increases^expression 19167446
1598 96-48-0 SLC25A11 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC25A11 mRNA affects^cotreatment|increases^expression 19167446
1599 96-48-0 SLC25A39 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC25A39 mRNA affects^cotreatment|increases^expression 19167446
1600 96-48-0 SLC25A39 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC25A39 mRNA affects^cotreatment|increases^expression 19167446
1601 96-48-0 SLC26A11 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SLC26A11 mRNA affects^cotreatment|decreases^expression 19167446
1602 96-48-0 SLC26A11 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SLC26A11 mRNA affects^cotreatment|decreases^expression 19167446
1603 96-48-0 SLC27A2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC27A2 mRNA affects^cotreatment|increases^expression 19167446
1604 96-48-0 SLC27A2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC27A2 mRNA affects^cotreatment|increases^expression 19167446
1605 96-48-0 SLC27A3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC27A3 mRNA affects^cotreatment|increases^expression 19167446
1606 96-48-0 SLC27A3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC27A3 mRNA affects^cotreatment|increases^expression 19167446
1607 96-48-0 SLC29A1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC29A1 mRNA affects^cotreatment|increases^expression 19167446
1608 96-48-0 SLC29A1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC29A1 mRNA affects^cotreatment|increases^expression 19167446
1609 96-48-0 SLC2A4RG Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC2A4RG mRNA affects^cotreatment|increases^expression 19167446
1610 96-48-0 SLC2A4RG Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC2A4RG mRNA affects^cotreatment|increases^expression 19167446
1611 96-48-0 SLC35D2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SLC35D2 mRNA affects^cotreatment|decreases^expression 19167446
1612 96-48-0 SLC35D2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SLC35D2 mRNA affects^cotreatment|decreases^expression 19167446
1613 96-48-0 SLC37A4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC37A4 mRNA affects^cotreatment|increases^expression 19167446
1614 96-48-0 SLC37A4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC37A4 mRNA affects^cotreatment|increases^expression 19167446
1615 96-48-0 SLC39A8 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC39A8 mRNA affects^cotreatment|increases^expression 19167446
1616 96-48-0 SLC39A8 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC39A8 mRNA affects^cotreatment|increases^expression 19167446
1617 96-48-0 SLC6A14 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC6A14 mRNA affects^cotreatment|increases^expression 19167446
1618 96-48-0 SLC6A14 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC6A14 mRNA affects^cotreatment|increases^expression 19167446
1619 96-48-0 SLC7A1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC7A1 mRNA affects^cotreatment|increases^expression 19167446
1620 96-48-0 SLC7A1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC7A1 mRNA affects^cotreatment|increases^expression 19167446
1621 96-48-0 SLC7A11 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of SLC7A11 mRNA decreases^expression 19167446
1622 96-48-0 SLC7A11 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of SLC7A11 mRNA decreases^expression 19167446
1623 96-48-0 SLC7A11 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SLC7A11 mRNA affects^cotreatment|decreases^expression 19167446
1624 96-48-0 SLC7A11 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SLC7A11 mRNA affects^cotreatment|decreases^expression 19167446
1625 96-48-0 SLC7A5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC7A5 mRNA affects^cotreatment|increases^expression 19167446
1626 96-48-0 SLC7A5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC7A5 mRNA affects^cotreatment|increases^expression 19167446
1627 96-48-0 SLC9A3R1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC9A3R1 mRNA affects^cotreatment|increases^expression 19167446
1628 96-48-0 SLC9A3R1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC9A3R1 mRNA affects^cotreatment|increases^expression 19167446
1629 96-48-0 SLF1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLF1 mRNA affects^cotreatment|increases^expression 19167446
1630 96-48-0 SLF1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLF1 mRNA affects^cotreatment|increases^expression 19167446
1631 96-48-0 SMAD2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SMAD2 mRNA affects^cotreatment|decreases^expression 19167446
1632 96-48-0 SMAD2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SMAD2 mRNA affects^cotreatment|decreases^expression 19167446
1633 96-48-0 SMAD3 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of SMAD3 mRNA decreases^expression 19167446
1634 96-48-0 SMAD3 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of SMAD3 mRNA decreases^expression 19167446
1635 96-48-0 SMAD3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SMAD3 mRNA affects^cotreatment|decreases^expression 19167446
1636 96-48-0 SMAD3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SMAD3 mRNA affects^cotreatment|decreases^expression 19167446
1637 96-48-0 SMC1A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SMC1A mRNA affects^cotreatment|increases^expression 19167446
1638 96-48-0 SMC1A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SMC1A mRNA affects^cotreatment|increases^expression 19167446
1639 96-48-0 SMC2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SMC2 mRNA affects^cotreatment|increases^expression 19167446
1640 96-48-0 SMC2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SMC2 mRNA affects^cotreatment|increases^expression 19167446
1641 96-48-0 SMC4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SMC4 mRNA affects^cotreatment|increases^expression 19167446
1642 96-48-0 SMC4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SMC4 mRNA affects^cotreatment|increases^expression 19167446
1643 96-48-0 SMYD2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SMYD2 mRNA affects^cotreatment|decreases^expression 19167446
1644 96-48-0 SMYD2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SMYD2 mRNA affects^cotreatment|decreases^expression 19167446
1645 96-48-0 SNHG7 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SNHG7 mRNA affects^cotreatment|decreases^expression 19167446
1646 96-48-0 SNHG7 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SNHG7 mRNA affects^cotreatment|decreases^expression 19167446
1647 96-48-0 SNN Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SNN mRNA affects^cotreatment|decreases^expression 19167446
1648 96-48-0 SNN Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SNN mRNA affects^cotreatment|decreases^expression 19167446
1649 96-48-0 SNORA24 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SNORA24 mRNA affects^cotreatment|decreases^expression 19167446
1650 96-48-0 SNORA24 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SNORA24 mRNA affects^cotreatment|decreases^expression 19167446
1651 96-48-0 SNORD52 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SNORD52 mRNA affects^cotreatment|decreases^expression 19167446
1652 96-48-0 SNORD52 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SNORD52 mRNA affects^cotreatment|decreases^expression 19167446
1653 96-48-0 SNRNP25 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SNRNP25 mRNA affects^cotreatment|increases^expression 19167446
1654 96-48-0 SNRNP25 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SNRNP25 mRNA affects^cotreatment|increases^expression 19167446
1655 96-48-0 SNRPA1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SNRPA1 mRNA affects^cotreatment|increases^expression 19167446
1656 96-48-0 SNRPA1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SNRPA1 mRNA affects^cotreatment|increases^expression 19167446
1657 96-48-0 SNRPB Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SNRPB mRNA affects^cotreatment|increases^expression 19167446
1658 96-48-0 SNRPB Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SNRPB mRNA affects^cotreatment|increases^expression 19167446
1659 96-48-0 SNX10 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SNX10 mRNA affects^cotreatment|increases^expression 19167446
1660 96-48-0 SNX10 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SNX10 mRNA affects^cotreatment|increases^expression 19167446
1661 96-48-0 SNX24 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SNX24 mRNA affects^cotreatment|increases^expression 19167446
1662 96-48-0 SNX24 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SNX24 mRNA affects^cotreatment|increases^expression 19167446
1663 96-48-0 SNX29 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SNX29 mRNA affects^cotreatment|decreases^expression 19167446
1664 96-48-0 SNX29 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SNX29 mRNA affects^cotreatment|decreases^expression 19167446
1665 96-48-0 SNX6 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SNX6 mRNA affects^cotreatment|decreases^expression 19167446
1666 96-48-0 SNX6 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SNX6 mRNA affects^cotreatment|decreases^expression 19167446
1667 96-48-0 SNX9 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SNX9 mRNA affects^cotreatment|decreases^expression 19167446
1668 96-48-0 SNX9 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SNX9 mRNA affects^cotreatment|decreases^expression 19167446
1669 96-48-0 SOCS2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SOCS2 mRNA affects^cotreatment|decreases^expression 19167446
1670 96-48-0 SOCS2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SOCS2 mRNA affects^cotreatment|decreases^expression 19167446
1671 96-48-0 SOX3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SOX3 mRNA affects^cotreatment|increases^expression 19167446
1672 96-48-0 SOX3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SOX3 mRNA affects^cotreatment|increases^expression 19167446
1673 96-48-0 SOX4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SOX4 mRNA affects^cotreatment|decreases^expression 19167446
1674 96-48-0 SOX4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SOX4 mRNA affects^cotreatment|decreases^expression 19167446
1675 96-48-0 SOX9 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SOX9 mRNA affects^cotreatment|decreases^expression 19167446
1676 96-48-0 SOX9 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SOX9 mRNA affects^cotreatment|decreases^expression 19167446
1677 96-48-0 SPAG5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SPAG5 mRNA affects^cotreatment|increases^expression 19167446
1678 96-48-0 SPAG5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SPAG5 mRNA affects^cotreatment|increases^expression 19167446
1679 96-48-0 SPATA7 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SPATA7 mRNA affects^cotreatment|decreases^expression 19167446
1680 96-48-0 SPATA7 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SPATA7 mRNA affects^cotreatment|decreases^expression 19167446
1681 96-48-0 SPC24 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SPC24 mRNA affects^cotreatment|increases^expression 19167446
1682 96-48-0 SPC24 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SPC24 mRNA affects^cotreatment|increases^expression 19167446
1683 96-48-0 SPC25 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SPC25 mRNA affects^cotreatment|increases^expression 19167446
1684 96-48-0 SPC25 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SPC25 mRNA affects^cotreatment|increases^expression 19167446
1685 96-48-0 SPDL1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SPDL1 mRNA affects^cotreatment|increases^expression 19167446
1686 96-48-0 SPDL1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SPDL1 mRNA affects^cotreatment|increases^expression 19167446
1687 96-48-0 SPIN4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SPIN4 mRNA affects^cotreatment|increases^expression 19167446
1688 96-48-0 SPIN4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SPIN4 mRNA affects^cotreatment|increases^expression 19167446
1689 96-48-0 SPRED2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SPRED2 mRNA affects^cotreatment|decreases^expression 19167446
1690 96-48-0 SPRED2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SPRED2 mRNA affects^cotreatment|decreases^expression 19167446
1691 96-48-0 SQOR Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SQOR mRNA affects^cotreatment|decreases^expression 19167446
1692 96-48-0 SQOR Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SQOR mRNA affects^cotreatment|decreases^expression 19167446
1693 96-48-0 SQSTM1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SQSTM1 mRNA affects^cotreatment|decreases^expression 19167446
1694 96-48-0 SQSTM1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SQSTM1 mRNA affects^cotreatment|decreases^expression 19167446
1695 96-48-0 SRD5A3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SRD5A3 mRNA affects^cotreatment|increases^expression 19167446
1696 96-48-0 SRD5A3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SRD5A3 mRNA affects^cotreatment|increases^expression 19167446
1697 96-48-0 SRI Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SRI mRNA affects^cotreatment|decreases^expression 19167446
1698 96-48-0 SRI Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SRI mRNA affects^cotreatment|decreases^expression 19167446
1699 96-48-0 SRM Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SRM mRNA affects^cotreatment|increases^expression 19167446
1700 96-48-0 SRM Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SRM mRNA affects^cotreatment|increases^expression 19167446
1701 96-48-0 SRPRB Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SRPRB mRNA affects^cotreatment|increases^expression 19167446
1702 96-48-0 SRPRB Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SRPRB mRNA affects^cotreatment|increases^expression 19167446
1703 96-48-0 SRSF1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SRSF1 mRNA affects^cotreatment|increases^expression 19167446
1704 96-48-0 SRSF1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SRSF1 mRNA affects^cotreatment|increases^expression 19167446
1705 96-48-0 SSBP2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SSBP2 mRNA affects^cotreatment|decreases^expression 19167446
1706 96-48-0 SSBP2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SSBP2 mRNA affects^cotreatment|decreases^expression 19167446
1707 96-48-0 SSRP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SSRP1 mRNA affects^cotreatment|increases^expression 19167446
1708 96-48-0 SSRP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SSRP1 mRNA affects^cotreatment|increases^expression 19167446
1709 96-48-0 ST8SIA4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ST8SIA4 mRNA affects^cotreatment|decreases^expression 19167446
1710 96-48-0 ST8SIA4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ST8SIA4 mRNA affects^cotreatment|decreases^expression 19167446
1711 96-48-0 STIL Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of STIL mRNA affects^cotreatment|increases^expression 19167446
1712 96-48-0 STIL Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of STIL mRNA affects^cotreatment|increases^expression 19167446
1713 96-48-0 STK38L Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of STK38L mRNA affects^cotreatment|decreases^expression 19167446
1714 96-48-0 STK38L Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of STK38L mRNA affects^cotreatment|decreases^expression 19167446
1715 96-48-0 STMN1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of STMN1 mRNA affects^cotreatment|increases^expression 19167446
1716 96-48-0 STMN1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of STMN1 mRNA affects^cotreatment|increases^expression 19167446
1717 96-48-0 STON2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of STON2 mRNA affects^cotreatment|decreases^expression 19167446
1718 96-48-0 STON2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of STON2 mRNA affects^cotreatment|decreases^expression 19167446
1719 96-48-0 STRN3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of STRN3 mRNA affects^cotreatment|decreases^expression 19167446
1720 96-48-0 STRN3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of STRN3 mRNA affects^cotreatment|decreases^expression 19167446
1721 96-48-0 STX3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of STX3 mRNA affects^cotreatment|decreases^expression 19167446
1722 96-48-0 STX3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of STX3 mRNA affects^cotreatment|decreases^expression 19167446
1723 96-48-0 STX7 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of STX7 mRNA affects^cotreatment|decreases^expression 19167446
1724 96-48-0 STX7 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of STX7 mRNA affects^cotreatment|decreases^expression 19167446
1725 96-48-0 SULF2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SULF2 mRNA affects^cotreatment|increases^expression 19167446
1726 96-48-0 SULF2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SULF2 mRNA affects^cotreatment|increases^expression 19167446
1727 96-48-0 SUPT16H Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SUPT16H mRNA affects^cotreatment|increases^expression 19167446
1728 96-48-0 SUPT16H Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SUPT16H mRNA affects^cotreatment|increases^expression 19167446
1729 96-48-0 SUV39H2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SUV39H2 mRNA affects^cotreatment|increases^expression 19167446
1730 96-48-0 SUV39H2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SUV39H2 mRNA affects^cotreatment|increases^expression 19167446
1731 96-48-0 SWAP70 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SWAP70 mRNA affects^cotreatment|decreases^expression 19167446
1732 96-48-0 SWAP70 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SWAP70 mRNA affects^cotreatment|decreases^expression 19167446
1733 96-48-0 SYCE2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SYCE2 mRNA affects^cotreatment|increases^expression 19167446
1734 96-48-0 SYCE2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SYCE2 mRNA affects^cotreatment|increases^expression 19167446
1735 96-48-0 SYDE2 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of SYDE2 mRNA decreases^expression 19167446
1736 96-48-0 SYDE2 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of SYDE2 mRNA decreases^expression 19167446
1737 96-48-0 SYDE2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SYDE2 mRNA affects^cotreatment|decreases^expression 19167446
1738 96-48-0 SYDE2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SYDE2 mRNA affects^cotreatment|decreases^expression 19167446
1739 96-48-0 SYNGR3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SYNGR3 mRNA affects^cotreatment|decreases^expression 19167446
1740 96-48-0 SYNGR3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SYNGR3 mRNA affects^cotreatment|decreases^expression 19167446
1741 96-48-0 SYTL2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SYTL2 mRNA affects^cotreatment|decreases^expression 19167446
1742 96-48-0 SYTL2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SYTL2 mRNA affects^cotreatment|decreases^expression 19167446
1743 96-48-0 SYTL4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SYTL4 mRNA affects^cotreatment|increases^expression 19167446
1744 96-48-0 SYTL4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SYTL4 mRNA affects^cotreatment|increases^expression 19167446
1745 96-48-0 SYTL5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SYTL5 mRNA affects^cotreatment|increases^expression 19167446
1746 96-48-0 SYTL5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SYTL5 mRNA affects^cotreatment|increases^expression 19167446
1747 96-48-0 TACC3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TACC3 mRNA affects^cotreatment|increases^expression 19167446
1748 96-48-0 TACC3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TACC3 mRNA affects^cotreatment|increases^expression 19167446
1749 96-48-0 TACSTD2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TACSTD2 mRNA affects^cotreatment|decreases^expression 19167446
1750 96-48-0 TACSTD2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TACSTD2 mRNA affects^cotreatment|decreases^expression 19167446
1751 96-48-0 TAF5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TAF5 mRNA affects^cotreatment|increases^expression 19167446
1752 96-48-0 TAF5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TAF5 mRNA affects^cotreatment|increases^expression 19167446
1753 96-48-0 TANC2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TANC2 mRNA affects^cotreatment|decreases^expression 19167446
1754 96-48-0 TANC2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TANC2 mRNA affects^cotreatment|decreases^expression 19167446
1755 96-48-0 TAOK3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TAOK3 mRNA affects^cotreatment|decreases^expression 19167446
1756 96-48-0 TAOK3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TAOK3 mRNA affects^cotreatment|decreases^expression 19167446
1757 96-48-0 TARS2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TARS2 mRNA affects^cotreatment|increases^expression 19167446
1758 96-48-0 TARS2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TARS2 mRNA affects^cotreatment|increases^expression 19167446
1759 96-48-0 TBCD Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TBCD mRNA affects^cotreatment|increases^expression 19167446
1760 96-48-0 TBCD Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TBCD mRNA affects^cotreatment|increases^expression 19167446
1761 96-48-0 TBL1X Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of TBL1X mRNA decreases^expression 19167446
1762 96-48-0 TBL1X Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of TBL1X mRNA decreases^expression 19167446
1763 96-48-0 TCF19 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of TCF19 mRNA increases^expression 19167446
1764 96-48-0 TCF19 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of TCF19 mRNA increases^expression 19167446
1765 96-48-0 TCF19 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TCF19 mRNA affects^cotreatment|increases^expression 19167446
1766 96-48-0 TCF19 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TCF19 mRNA affects^cotreatment|increases^expression 19167446
1767 96-48-0 TCF7L1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TCF7L1 mRNA affects^cotreatment|decreases^expression 19167446
1768 96-48-0 TCF7L1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TCF7L1 mRNA affects^cotreatment|decreases^expression 19167446
1769 96-48-0 TDP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TDP1 mRNA affects^cotreatment|increases^expression 19167446
1770 96-48-0 TDP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TDP1 mRNA affects^cotreatment|increases^expression 19167446
1771 96-48-0 TEX30 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TEX30 mRNA affects^cotreatment|increases^expression 19167446
1772 96-48-0 TEX30 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TEX30 mRNA affects^cotreatment|increases^expression 19167446
1773 96-48-0 TFAP2C Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TFAP2C mRNA affects^cotreatment|decreases^expression 19167446
1774 96-48-0 TFAP2C Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TFAP2C mRNA affects^cotreatment|decreases^expression 19167446
1775 96-48-0 TFDP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TFDP1 mRNA affects^cotreatment|increases^expression 19167446
1776 96-48-0 TFDP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TFDP1 mRNA affects^cotreatment|increases^expression 19167446
1777 96-48-0 TFF1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TFF1 mRNA affects^cotreatment|increases^expression 19167446
1778 96-48-0 TFF1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TFF1 mRNA affects^cotreatment|increases^expression 19167446
1779 96-48-0 TFF3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TFF3 mRNA affects^cotreatment|increases^expression 19167446
1780 96-48-0 TFF3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TFF3 mRNA affects^cotreatment|increases^expression 19167446
1781 96-48-0 TFPI Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TFPI mRNA affects^cotreatment|decreases^expression 19167446
1782 96-48-0 TFPI Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TFPI mRNA affects^cotreatment|decreases^expression 19167446
1783 96-48-0 TGFB2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TGFB2 mRNA affects^cotreatment|decreases^expression 19167446
1784 96-48-0 TGFB2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TGFB2 mRNA affects^cotreatment|decreases^expression 19167446
1785 96-48-0 TGFBR1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TGFBR1 mRNA affects^cotreatment|decreases^expression 19167446
1786 96-48-0 TGFBR1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TGFBR1 mRNA affects^cotreatment|decreases^expression 19167446
1787 96-48-0 TGIF1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TGIF1 mRNA affects^cotreatment|decreases^expression 19167446
1788 96-48-0 TGIF1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TGIF1 mRNA affects^cotreatment|decreases^expression 19167446
1789 96-48-0 TGIF2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TGIF2 mRNA affects^cotreatment|increases^expression 19167446
1790 96-48-0 TGIF2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TGIF2 mRNA affects^cotreatment|increases^expression 19167446
1791 96-48-0 THBS1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of THBS1 mRNA affects^cotreatment|increases^expression 19167446
1792 96-48-0 THBS1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of THBS1 mRNA affects^cotreatment|increases^expression 19167446
1793 96-48-0 THEM6 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of THEM6 mRNA affects^cotreatment|increases^expression 19167446
1794 96-48-0 THEM6 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of THEM6 mRNA affects^cotreatment|increases^expression 19167446
1795 96-48-0 THSD4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of THSD4 mRNA affects^cotreatment|increases^expression 19167446
1796 96-48-0 THSD4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of THSD4 mRNA affects^cotreatment|increases^expression 19167446
1797 96-48-0 TICRR Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TICRR mRNA affects^cotreatment|increases^expression 19167446
1798 96-48-0 TICRR Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TICRR mRNA affects^cotreatment|increases^expression 19167446
1799 96-48-0 TIGAR Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TIGAR mRNA affects^cotreatment|decreases^expression 19167446
1800 96-48-0 TIGAR Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TIGAR mRNA affects^cotreatment|decreases^expression 19167446
1801 96-48-0 TIMELESS Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TIMELESS mRNA affects^cotreatment|increases^expression 19167446
1802 96-48-0 TIMELESS Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TIMELESS mRNA affects^cotreatment|increases^expression 19167446
1803 96-48-0 TIMP2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TIMP2 mRNA affects^cotreatment|decreases^expression 19167446
1804 96-48-0 TIMP2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TIMP2 mRNA affects^cotreatment|decreases^expression 19167446
1805 96-48-0 TIPIN Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TIPIN mRNA affects^cotreatment|increases^expression 19167446
1806 96-48-0 TIPIN Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TIPIN mRNA affects^cotreatment|increases^expression 19167446
1807 96-48-0 TK1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TK1 mRNA affects^cotreatment|increases^expression 19167446
1808 96-48-0 TK1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TK1 mRNA affects^cotreatment|increases^expression 19167446
1809 96-48-0 TKFC Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TKFC mRNA affects^cotreatment|increases^expression 19167446
1810 96-48-0 TKFC Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TKFC mRNA affects^cotreatment|increases^expression 19167446
1811 96-48-0 TLE1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TLE1 mRNA affects^cotreatment|decreases^expression 19167446
1812 96-48-0 TLE1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TLE1 mRNA affects^cotreatment|decreases^expression 19167446
1813 96-48-0 TM4SF1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TM4SF1 mRNA affects^cotreatment|decreases^expression 19167446
1814 96-48-0 TM4SF1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TM4SF1 mRNA affects^cotreatment|decreases^expression 19167446
1815 96-48-0 TMCC1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TMCC1 mRNA affects^cotreatment|decreases^expression 19167446
1816 96-48-0 TMCC1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TMCC1 mRNA affects^cotreatment|decreases^expression 19167446
1817 96-48-0 TMED8 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMED8 mRNA affects^cotreatment|increases^expression 19167446
1818 96-48-0 TMED8 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMED8 mRNA affects^cotreatment|increases^expression 19167446
1819 96-48-0 TMEM106C Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMEM106C mRNA affects^cotreatment|increases^expression 19167446
1820 96-48-0 TMEM106C Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMEM106C mRNA affects^cotreatment|increases^expression 19167446
1821 96-48-0 TMEM164 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMEM164 mRNA affects^cotreatment|increases^expression 19167446
1822 96-48-0 TMEM164 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMEM164 mRNA affects^cotreatment|increases^expression 19167446
1823 96-48-0 TMEM237 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMEM237 mRNA affects^cotreatment|increases^expression 19167446
1824 96-48-0 TMEM237 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMEM237 mRNA affects^cotreatment|increases^expression 19167446
1825 96-48-0 TMEM38B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMEM38B mRNA affects^cotreatment|increases^expression 19167446
1826 96-48-0 TMEM38B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMEM38B mRNA affects^cotreatment|increases^expression 19167446
1827 96-48-0 TMEM45B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TMEM45B mRNA affects^cotreatment|decreases^expression 19167446
1828 96-48-0 TMEM45B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TMEM45B mRNA affects^cotreatment|decreases^expression 19167446
1829 96-48-0 TMEM64 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMEM64 mRNA affects^cotreatment|increases^expression 19167446
1830 96-48-0 TMEM64 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMEM64 mRNA affects^cotreatment|increases^expression 19167446
1831 96-48-0 TMEM65 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TMEM65 mRNA affects^cotreatment|decreases^expression 19167446
1832 96-48-0 TMEM65 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TMEM65 mRNA affects^cotreatment|decreases^expression 19167446
1833 96-48-0 TMEM97 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMEM97 mRNA affects^cotreatment|increases^expression 19167446
1834 96-48-0 TMEM97 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMEM97 mRNA affects^cotreatment|increases^expression 19167446
1835 96-48-0 TMPO Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMPO mRNA affects^cotreatment|increases^expression 19167446
1836 96-48-0 TMPO Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMPO mRNA affects^cotreatment|increases^expression 19167446
1837 96-48-0 TMPRSS3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMPRSS3 mRNA affects^cotreatment|increases^expression 19167446
1838 96-48-0 TMPRSS3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMPRSS3 mRNA affects^cotreatment|increases^expression 19167446
1839 96-48-0 TMSB15A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMSB15A mRNA affects^cotreatment|increases^expression 19167446
1840 96-48-0 TMSB15A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMSB15A mRNA affects^cotreatment|increases^expression 19167446
1841 96-48-0 TMTC2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TMTC2 mRNA affects^cotreatment|decreases^expression 19167446
1842 96-48-0 TMTC2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TMTC2 mRNA affects^cotreatment|decreases^expression 19167446
1843 96-48-0 TNFAIP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TNFAIP1 mRNA affects^cotreatment|decreases^expression 19167446
1844 96-48-0 TNFAIP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TNFAIP1 mRNA affects^cotreatment|decreases^expression 19167446
1845 96-48-0 TNFRSF12A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TNFRSF12A mRNA affects^cotreatment|decreases^expression 19167446
1846 96-48-0 TNFRSF12A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TNFRSF12A mRNA affects^cotreatment|decreases^expression 19167446
1847 96-48-0 TNFRSF21 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TNFRSF21 mRNA affects^cotreatment|decreases^expression 19167446
1848 96-48-0 TNFRSF21 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TNFRSF21 mRNA affects^cotreatment|decreases^expression 19167446
1849 96-48-0 TOP2A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TOP2A mRNA affects^cotreatment|increases^expression 19167446
1850 96-48-0 TOP2A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TOP2A mRNA affects^cotreatment|increases^expression 19167446
1851 96-48-0 TOPBP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TOPBP1 mRNA affects^cotreatment|increases^expression 19167446
1852 96-48-0 TOPBP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TOPBP1 mRNA affects^cotreatment|increases^expression 19167446
1853 96-48-0 TP53INP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TP53INP1 mRNA affects^cotreatment|decreases^expression 19167446
1854 96-48-0 TP53INP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TP53INP1 mRNA affects^cotreatment|decreases^expression 19167446
1855 96-48-0 TPD52 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TPD52 mRNA affects^cotreatment|decreases^expression 19167446
1856 96-48-0 TPD52 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TPD52 mRNA affects^cotreatment|decreases^expression 19167446
1857 96-48-0 TPD52L1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TPD52L1 mRNA affects^cotreatment|increases^expression 19167446
1858 96-48-0 TPD52L1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TPD52L1 mRNA affects^cotreatment|increases^expression 19167446
1859 96-48-0 TPI1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TPI1 mRNA affects^cotreatment|increases^expression 19167446
1860 96-48-0 TPI1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TPI1 mRNA affects^cotreatment|increases^expression 19167446
1861 96-48-0 TPM1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TPM1 mRNA affects^cotreatment|decreases^expression 19167446
1862 96-48-0 TPM1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TPM1 mRNA affects^cotreatment|decreases^expression 19167446
1863 96-48-0 TPX2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TPX2 mRNA affects^cotreatment|increases^expression 19167446
1864 96-48-0 TPX2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TPX2 mRNA affects^cotreatment|increases^expression 19167446
1865 96-48-0 TRERF1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TRERF1 mRNA affects^cotreatment|decreases^expression 19167446
1866 96-48-0 TRERF1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TRERF1 mRNA affects^cotreatment|decreases^expression 19167446
1867 96-48-0 TRIB1 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of TRIB1 mRNA decreases^expression 19167446
1868 96-48-0 TRIB1 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of TRIB1 mRNA decreases^expression 19167446
1869 96-48-0 TRIB1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TRIB1 mRNA affects^cotreatment|decreases^expression 19167446
1870 96-48-0 TRIB1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TRIB1 mRNA affects^cotreatment|decreases^expression 19167446
1871 96-48-0 TRIM59 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TRIM59 mRNA affects^cotreatment|increases^expression 19167446
1872 96-48-0 TRIM59 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TRIM59 mRNA affects^cotreatment|increases^expression 19167446
1873 96-48-0 TRIP13 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TRIP13 mRNA affects^cotreatment|increases^expression 19167446
1874 96-48-0 TRIP13 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TRIP13 mRNA affects^cotreatment|increases^expression 19167446
1875 96-48-0 TSC22D3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TSC22D3 mRNA affects^cotreatment|decreases^expression 19167446
1876 96-48-0 TSC22D3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TSC22D3 mRNA affects^cotreatment|decreases^expression 19167446
1877 96-48-0 TSN Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TSN mRNA affects^cotreatment|increases^expression 19167446
1878 96-48-0 TSN Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TSN mRNA affects^cotreatment|increases^expression 19167446
1879 96-48-0 TSPAN31 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TSPAN31 mRNA affects^cotreatment|decreases^expression 19167446
1880 96-48-0 TSPAN31 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TSPAN31 mRNA affects^cotreatment|decreases^expression 19167446
1881 96-48-0 TSPYL1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TSPYL1 mRNA affects^cotreatment|decreases^expression 19167446
1882 96-48-0 TSPYL1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TSPYL1 mRNA affects^cotreatment|decreases^expression 19167446
1883 96-48-0 TTC39B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TTC39B mRNA affects^cotreatment|decreases^expression 19167446
1884 96-48-0 TTC39B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TTC39B mRNA affects^cotreatment|decreases^expression 19167446
1885 96-48-0 TTK Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of TTK mRNA increases^expression 19167446
1886 96-48-0 TTK Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of TTK mRNA increases^expression 19167446
1887 96-48-0 TTK Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TTK mRNA affects^cotreatment|increases^expression 19167446
1888 96-48-0 TTK Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TTK mRNA affects^cotreatment|increases^expression 19167446
1889 96-48-0 TUBA2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TUBA2 mRNA affects^cotreatment|increases^expression 19167446
1890 96-48-0 TUBA2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TUBA2 mRNA affects^cotreatment|increases^expression 19167446
1891 96-48-0 TUBB Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TUBB mRNA affects^cotreatment|increases^expression 19167446
1892 96-48-0 TUBB Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TUBB mRNA affects^cotreatment|increases^expression 19167446
1893 96-48-0 TUBB2A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TUBB2A mRNA affects^cotreatment|decreases^expression 19167446
1894 96-48-0 TUBB2A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TUBB2A mRNA affects^cotreatment|decreases^expression 19167446
1895 96-48-0 TUBB4B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TUBB4B mRNA affects^cotreatment|increases^expression 19167446
1896 96-48-0 TUBB4B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TUBB4B mRNA affects^cotreatment|increases^expression 19167446
1897 96-48-0 TUBD1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TUBD1 mRNA affects^cotreatment|increases^expression 19167446
1898 96-48-0 TUBD1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TUBD1 mRNA affects^cotreatment|increases^expression 19167446
1899 96-48-0 TUBG1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TUBG1 mRNA affects^cotreatment|increases^expression 19167446
1900 96-48-0 TUBG1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TUBG1 mRNA affects^cotreatment|increases^expression 19167446
1901 96-48-0 TUBGCP4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TUBGCP4 mRNA affects^cotreatment|increases^expression 19167446
1902 96-48-0 TUBGCP4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TUBGCP4 mRNA affects^cotreatment|increases^expression 19167446
1903 96-48-0 TUFT1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TUFT1 mRNA affects^cotreatment|decreases^expression 19167446
1904 96-48-0 TUFT1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TUFT1 mRNA affects^cotreatment|decreases^expression 19167446
1905 96-48-0 TULP4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TULP4 mRNA affects^cotreatment|decreases^expression 19167446
1906 96-48-0 TULP4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TULP4 mRNA affects^cotreatment|decreases^expression 19167446
1907 96-48-0 TWIST1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TWIST1 mRNA affects^cotreatment|decreases^expression 19167446
1908 96-48-0 TWIST1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TWIST1 mRNA affects^cotreatment|decreases^expression 19167446
1909 96-48-0 TYMS Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of TYMS mRNA increases^expression 19167446
1910 96-48-0 TYMS Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of TYMS mRNA increases^expression 19167446
1911 96-48-0 TYMS Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TYMS mRNA affects^cotreatment|increases^expression 19167446
1912 96-48-0 TYMS Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TYMS mRNA affects^cotreatment|increases^expression 19167446
1913 96-48-0 UBE2B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of UBE2B mRNA affects^cotreatment|decreases^expression 19167446
1914 96-48-0 UBE2B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of UBE2B mRNA affects^cotreatment|decreases^expression 19167446
1915 96-48-0 UBE2H Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of UBE2H mRNA affects^cotreatment|decreases^expression 19167446
1916 96-48-0 UBE2H Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of UBE2H mRNA affects^cotreatment|decreases^expression 19167446
1917 96-48-0 UBE2J1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of UBE2J1 mRNA affects^cotreatment|decreases^expression 19167446
1918 96-48-0 UBE2J1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of UBE2J1 mRNA affects^cotreatment|decreases^expression 19167446
1919 96-48-0 UBE2QL1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of UBE2QL1 mRNA affects^cotreatment|decreases^expression 19167446
1920 96-48-0 UBE2QL1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of UBE2QL1 mRNA affects^cotreatment|decreases^expression 19167446
1921 96-48-0 UBE2T Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of UBE2T mRNA affects^cotreatment|increases^expression 19167446
1922 96-48-0 UBE2T Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of UBE2T mRNA affects^cotreatment|increases^expression 19167446
1923 96-48-0 UBE2W Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of UBE2W mRNA affects^cotreatment|decreases^expression 19167446
1924 96-48-0 UBE2W Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of UBE2W mRNA affects^cotreatment|decreases^expression 19167446
1925 96-48-0 UBR7 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of UBR7 mRNA affects^cotreatment|increases^expression 19167446
1926 96-48-0 UBR7 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of UBR7 mRNA affects^cotreatment|increases^expression 19167446
1927 96-48-0 UCHL5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of UCHL5 mRNA affects^cotreatment|increases^expression 19167446
1928 96-48-0 UCHL5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of UCHL5 mRNA affects^cotreatment|increases^expression 19167446
1929 96-48-0 UCK2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of UCK2 mRNA affects^cotreatment|increases^expression 19167446
1930 96-48-0 UCK2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of UCK2 mRNA affects^cotreatment|increases^expression 19167446
1931 96-48-0 UHRF1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of UHRF1 mRNA affects^cotreatment|increases^expression 19167446
1932 96-48-0 UHRF1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of UHRF1 mRNA affects^cotreatment|increases^expression 19167446
1933 96-48-0 UNG Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of UNG mRNA affects^cotreatment|increases^expression 19167446
1934 96-48-0 UNG Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of UNG mRNA affects^cotreatment|increases^expression 19167446
1935 96-48-0 UPF3B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of UPF3B mRNA affects^cotreatment|increases^expression 19167446
1936 96-48-0 UPF3B Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of UPF3B mRNA affects^cotreatment|increases^expression 19167446
1937 96-48-0 USP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of USP1 mRNA affects^cotreatment|increases^expression 19167446
1938 96-48-0 USP1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of USP1 mRNA affects^cotreatment|increases^expression 19167446
1939 96-48-0 USP3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of USP3 mRNA affects^cotreatment|decreases^expression 19167446
1940 96-48-0 USP3 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of USP3 mRNA affects^cotreatment|decreases^expression 19167446
1941 96-48-0 UST Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of UST mRNA affects^cotreatment|decreases^expression 19167446
1942 96-48-0 UST Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of UST mRNA affects^cotreatment|decreases^expression 19167446
1943 96-48-0 VARS2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of VARS2 mRNA affects^cotreatment|increases^expression 19167446
1944 96-48-0 VARS2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of VARS2 mRNA affects^cotreatment|increases^expression 19167446
1945 96-48-0 VEGFA Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of VEGFA mRNA affects^cotreatment|decreases^expression 19167446
1946 96-48-0 VEGFA Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of VEGFA mRNA affects^cotreatment|decreases^expression 19167446
1947 96-48-0 VKORC1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of VKORC1 mRNA affects^cotreatment|increases^expression 19167446
1948 96-48-0 VKORC1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of VKORC1 mRNA affects^cotreatment|increases^expression 19167446
1949 96-48-0 VRK1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of VRK1 mRNA affects^cotreatment|increases^expression 19167446
1950 96-48-0 VRK1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of VRK1 mRNA affects^cotreatment|increases^expression 19167446
1951 96-48-0 WDHD1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of WDHD1 mRNA affects^cotreatment|increases^expression 19167446
1952 96-48-0 WDHD1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of WDHD1 mRNA affects^cotreatment|increases^expression 19167446
1953 96-48-0 WDR34 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of WDR34 mRNA affects^cotreatment|increases^expression 19167446
1954 96-48-0 WDR34 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of WDR34 mRNA affects^cotreatment|increases^expression 19167446
1955 96-48-0 WDR54 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of WDR54 mRNA affects^cotreatment|increases^expression 19167446
1956 96-48-0 WDR54 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of WDR54 mRNA affects^cotreatment|increases^expression 19167446
1957 96-48-0 WDR76 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of WDR76 mRNA affects^cotreatment|increases^expression 19167446
1958 96-48-0 WDR76 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of WDR76 mRNA affects^cotreatment|increases^expression 19167446
1959 96-48-0 WIPI1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of WIPI1 mRNA affects^cotreatment|decreases^expression 19167446
1960 96-48-0 WIPI1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of WIPI1 mRNA affects^cotreatment|decreases^expression 19167446
1961 96-48-0 WISP2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of WISP2 mRNA affects^cotreatment|increases^expression 19167446
1962 96-48-0 WISP2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of WISP2 mRNA affects^cotreatment|increases^expression 19167446
1963 96-48-0 WIZ Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of WIZ mRNA affects^cotreatment|increases^expression 19167446
1964 96-48-0 WIZ Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of WIZ mRNA affects^cotreatment|increases^expression 19167446
1965 96-48-0 YPEL2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of YPEL2 mRNA affects^cotreatment|decreases^expression 19167446
1966 96-48-0 YPEL2 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of YPEL2 mRNA affects^cotreatment|decreases^expression 19167446
1967 96-48-0 YPEL5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of YPEL5 mRNA affects^cotreatment|decreases^expression 19167446
1968 96-48-0 YPEL5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of YPEL5 mRNA affects^cotreatment|decreases^expression 19167446
1969 96-48-0 YWHAE Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of YWHAE mRNA affects^cotreatment|increases^expression 19167446
1970 96-48-0 YWHAE Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of YWHAE mRNA affects^cotreatment|increases^expression 19167446
1971 96-48-0 ZBTB26 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZBTB26 mRNA affects^cotreatment|decreases^expression 19167446
1972 96-48-0 ZBTB26 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZBTB26 mRNA affects^cotreatment|decreases^expression 19167446
1973 96-48-0 ZBTB4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZBTB4 mRNA affects^cotreatment|decreases^expression 19167446
1974 96-48-0 ZBTB4 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZBTB4 mRNA affects^cotreatment|decreases^expression 19167446
1975 96-48-0 ZC2HC1A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZC2HC1A mRNA affects^cotreatment|decreases^expression 19167446
1976 96-48-0 ZC2HC1A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZC2HC1A mRNA affects^cotreatment|decreases^expression 19167446
1977 96-48-0 ZC3H12A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZC3H12A mRNA affects^cotreatment|decreases^expression 19167446
1978 96-48-0 ZC3H12A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZC3H12A mRNA affects^cotreatment|decreases^expression 19167446
1979 96-48-0 ZDHHC7 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZDHHC7 mRNA affects^cotreatment|decreases^expression 19167446
1980 96-48-0 ZDHHC7 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZDHHC7 mRNA affects^cotreatment|decreases^expression 19167446
1981 96-48-0 ZFAND2A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZFAND2A mRNA affects^cotreatment|decreases^expression 19167446
1982 96-48-0 ZFAND2A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZFAND2A mRNA affects^cotreatment|decreases^expression 19167446
1983 96-48-0 ZFYVE1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZFYVE1 mRNA affects^cotreatment|decreases^expression 19167446
1984 96-48-0 ZFYVE1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZFYVE1 mRNA affects^cotreatment|decreases^expression 19167446
1985 96-48-0 ZKSCAN1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZKSCAN1 mRNA affects^cotreatment|decreases^expression 19167446
1986 96-48-0 ZKSCAN1 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZKSCAN1 mRNA affects^cotreatment|decreases^expression 19167446
1987 96-48-0 ZMYM5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZMYM5 mRNA affects^cotreatment|decreases^expression 19167446
1988 96-48-0 ZMYM5 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZMYM5 mRNA affects^cotreatment|decreases^expression 19167446
1989 96-48-0 ZNF160 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of ZNF160 mRNA decreases^expression 19167446
1990 96-48-0 ZNF160 Homo sapiens 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of ZNF160 mRNA decreases^expression 19167446
1991 96-48-0 ZNF277 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZNF277 mRNA affects^cotreatment|decreases^expression 19167446
1992 96-48-0 ZNF277 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZNF277 mRNA affects^cotreatment|decreases^expression 19167446
1993 96-48-0 ZNF292 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZNF292 mRNA affects^cotreatment|decreases^expression 19167446
1994 96-48-0 ZNF292 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZNF292 mRNA affects^cotreatment|decreases^expression 19167446
1995 96-48-0 ZNF354A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZNF354A mRNA affects^cotreatment|decreases^expression 19167446
1996 96-48-0 ZNF354A Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZNF354A mRNA affects^cotreatment|decreases^expression 19167446
1997 96-48-0 ZNF367 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ZNF367 mRNA affects^cotreatment|increases^expression 19167446
1998 96-48-0 ZNF367 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ZNF367 mRNA affects^cotreatment|increases^expression 19167446
1999 96-48-0 ZNF467 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZNF467 mRNA affects^cotreatment|decreases^expression 19167446
2000 96-48-0 ZNF467 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZNF467 mRNA affects^cotreatment|decreases^expression 19167446
2001 96-48-0 ZNF641 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZNF641 mRNA affects^cotreatment|decreases^expression 19167446
2002 96-48-0 ZNF641 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZNF641 mRNA affects^cotreatment|decreases^expression 19167446
2003 96-48-0 ZNF703 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ZNF703 mRNA affects^cotreatment|increases^expression 19167446
2004 96-48-0 ZNF703 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ZNF703 mRNA affects^cotreatment|increases^expression 19167446
2005 96-48-0 ZNF718 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ZNF718 mRNA affects^cotreatment|increases^expression 19167446
2006 96-48-0 ZNF718 Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ZNF718 mRNA affects^cotreatment|increases^expression 19167446
2007 96-48-0 ZWILCH Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ZWILCH mRNA affects^cotreatment|increases^expression 19167446
2008 96-48-0 ZWILCH Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ZWILCH mRNA affects^cotreatment|increases^expression 19167446
2009 96-48-0 ZWINT Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ZWINT mRNA affects^cotreatment|increases^expression 19167446
2010 96-48-0 ZWINT Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ZWINT mRNA affects^cotreatment|increases^expression 19167446
2011 96-48-0 ZXDB Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZXDB mRNA affects^cotreatment|decreases^expression 19167446
2012 96-48-0 ZXDB Homo sapiens [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZXDB mRNA affects^cotreatment|decreases^expression 19167446
2013 96-48-0 FGF2 3-benzyl-5-((2-nitrophenoxy)methyl)dihydrofuran-2(3H)-one affects the susceptibility to FGF2 protein affects^response to substance 19199859
2014 96-48-0 FGF2 3-benzyl-5-((2-nitrophenoxy)methyl)dihydrofuran-2(3H)-one affects the susceptibility to FGF2 protein affects^response to substance 19199859
2015 96-48-0 ATG5 Homo sapiens 4-acetylantroquinonol B results in decreased expression of ATG5 protein decreases^expression 28408137
2016 96-48-0 ATG5 Homo sapiens 4-acetylantroquinonol B results in decreased expression of ATG5 protein decreases^expression 28408137
2017 96-48-0 ATG7 Homo sapiens 4-acetylantroquinonol B results in decreased expression of ATG7 protein decreases^expression 28408137
2018 96-48-0 ATG7 Homo sapiens 4-acetylantroquinonol B results in decreased expression of ATG7 protein decreases^expression 28408137
2019 96-48-0 CTNNB1 Homo sapiens 4-acetylantroquinonol B results in decreased expression of CTNNB1 mRNA decreases^expression 26235807
2020 96-48-0 CTNNB1 Homo sapiens 4-acetylantroquinonol B results in decreased expression of CTNNB1 mRNA decreases^expression 26235807
2021 96-48-0 EZH2 Homo sapiens 4-acetylantroquinonol B results in decreased expression of EZH2 protein decreases^expression 26235807
2022 96-48-0 EZH2 Homo sapiens 4-acetylantroquinonol B results in decreased expression of EZH2 protein decreases^expression 26235807
2023 96-48-0 JAK2 Homo sapiens 4-acetylantroquinonol B results in decreased expression of JAK2 protein decreases^expression 26235807
2024 96-48-0 JAK2 Homo sapiens 4-acetylantroquinonol B results in decreased expression of JAK2 protein decreases^expression 26235807
2025 96-48-0 JAK2 Homo sapiens 4-acetylantroquinonol B results in decreased expression of JAK2 protein modified form decreases^expression 26235807
2026 96-48-0 JAK2 Homo sapiens 4-acetylantroquinonol B results in decreased expression of JAK2 protein modified form decreases^expression 26235807
2027 96-48-0 LGR5 Homo sapiens 4-acetylantroquinonol B results in decreased expression of LGR5 mRNA decreases^expression 26235807
2028 96-48-0 LGR5 Homo sapiens 4-acetylantroquinonol B results in decreased expression of LGR5 mRNA decreases^expression 26235807
2029 96-48-0 LGR5 Homo sapiens 4-acetylantroquinonol B results in decreased expression of LGR5 protein decreases^expression 26235807
2030 96-48-0 LGR5 Homo sapiens 4-acetylantroquinonol B results in decreased expression of LGR5 protein decreases^expression 26235807
2031 96-48-0 NANOG Homo sapiens 4-acetylantroquinonol B results in decreased expression of NANOG protein decreases^expression 26235807
2032 96-48-0 NANOG Homo sapiens 4-acetylantroquinonol B results in decreased expression of NANOG protein decreases^expression 26235807
2033 96-48-0 SMO Homo sapiens 4-acetylantroquinonol B results in decreased expression of SMO mRNA decreases^expression 26235807
2034 96-48-0 SMO Homo sapiens 4-acetylantroquinonol B results in decreased expression of SMO mRNA decreases^expression 26235807
2035 96-48-0 SOX2 Homo sapiens 4-acetylantroquinonol B results in decreased expression of SOX2 mRNA decreases^expression 26235807
2036 96-48-0 SOX2 Homo sapiens 4-acetylantroquinonol B results in decreased expression of SOX2 mRNA decreases^expression 26235807
2037 96-48-0 SUZ12 Homo sapiens 4-acetylantroquinonol B results in decreased expression of SUZ12 protein decreases^expression 26235807
2038 96-48-0 SUZ12 Homo sapiens 4-acetylantroquinonol B results in decreased expression of SUZ12 protein decreases^expression 26235807
2039 96-48-0 TYK2 Homo sapiens 4-acetylantroquinonol B results in decreased expression of TYK2 protein decreases^expression 26235807
2040 96-48-0 TYK2 Homo sapiens 4-acetylantroquinonol B results in decreased expression of TYK2 protein decreases^expression 26235807
2041 96-48-0 HPGDS Mus musculus [Selenium deficiency co-treated with 4-(benzo(b)thiophen-2-yl)-3-bromo-5-hydroxydihydrofuran-2(3H)-one co-treated with Lipopolysaccharides] results in increased expression of HPGDS mRNA affects^cotreatment|increases^expression 21669866
2042 96-48-0 HPGDS Mus musculus [Selenium deficiency co-treated with 4-(benzo(b)thiophen-2-yl)-3-bromo-5-hydroxydihydrofuran-2(3H)-one co-treated with Lipopolysaccharides] results in increased expression of HPGDS mRNA affects^cotreatment|increases^expression 21669866
2043 96-48-0 HPGDS Mus musculus [Selenium deficiency co-treated with 4-(benzo(b)thiophen-2-yl)-3-bromo-5-hydroxydihydrofuran-2(3H)-one co-treated with Lipopolysaccharides] results in increased expression of HPGDS protein affects^cotreatment|increases^expression 21669866
2044 96-48-0 HPGDS Mus musculus [Selenium deficiency co-treated with 4-(benzo(b)thiophen-2-yl)-3-bromo-5-hydroxydihydrofuran-2(3H)-one co-treated with Lipopolysaccharides] results in increased expression of HPGDS protein affects^cotreatment|increases^expression 21669866
2045 96-48-0 BIRC2 Homo sapiens 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased expression of BIRC2 protein decreases^expression 21442130
2046 96-48-0 BIRC2 Homo sapiens 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased expression of BIRC2 protein decreases^expression 21442130
2047 96-48-0 BIRC3 Homo sapiens 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased expression of BIRC3 protein decreases^expression 21442130
2048 96-48-0 BIRC3 Homo sapiens 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased expression of BIRC3 protein decreases^expression 21442130
2049 96-48-0 CASP3 Homo sapiens [4-methylene-2-octyl-5-oxofuran-3-carboxylic acid co-treated with Cisplatin] results in increased cleavage of and results in decreased expression of CASP3 protein affects^cotreatment|decreases^expression|increases^cleavage 21442130
2050 96-48-0 CASP3 Homo sapiens [4-methylene-2-octyl-5-oxofuran-3-carboxylic acid co-treated with Cisplatin] results in increased cleavage of and results in decreased expression of CASP3 protein affects^cotreatment|decreases^expression|increases^cleavage 21442130
2051 96-48-0 CASP3 Homo sapiens [4-methylene-2-octyl-5-oxofuran-3-carboxylic acid co-treated with Cisplatin] results in increased cleavage of and results in increased activity of CASP3 protein affects^cotreatment|increases^activity|increases^cleavage 21442130
2052 96-48-0 CASP3 Homo sapiens [4-methylene-2-octyl-5-oxofuran-3-carboxylic acid co-treated with Cisplatin] results in increased cleavage of and results in increased activity of CASP3 protein affects^cotreatment|increases^activity|increases^cleavage 21442130
2053 96-48-0 CASP3 Homo sapiens 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in increased cleavage of and results in increased activity of CASP3 protein increases^activity|increases^cleavage 21442130
2054 96-48-0 CASP3 Homo sapiens 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in increased cleavage of and results in increased activity of CASP3 protein increases^activity|increases^cleavage 21442130
2055 96-48-0 CASP9 Homo sapiens [4-methylene-2-octyl-5-oxofuran-3-carboxylic acid co-treated with Cisplatin] results in increased activity of CASP9 protein affects^cotreatment|increases^activity 21442130
2056 96-48-0 CASP9 Homo sapiens [4-methylene-2-octyl-5-oxofuran-3-carboxylic acid co-treated with Cisplatin] results in increased activity of CASP9 protein affects^cotreatment|increases^activity 21442130
2057 96-48-0 CASP9 Homo sapiens 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in increased activity of CASP9 protein increases^activity 21442130
2058 96-48-0 CASP9 Homo sapiens 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in increased activity of CASP9 protein increases^activity 21442130
2059 96-48-0 CEBPA Mus musculus 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased expression of CEBPA mRNA decreases^expression 15707987
2060 96-48-0 CEBPA Mus musculus 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased expression of CEBPA mRNA decreases^expression 15707987
2061 96-48-0 DDIT3 Homo sapiens 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in increased expression of DDIT3 mRNA increases^expression 17283163
2062 96-48-0 DDIT3 Homo sapiens 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in increased expression of DDIT3 mRNA increases^expression 17283163
2063 96-48-0 FASN Homo sapiens 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid binds to and results in decreased activity of FASN protein affects^binding|decreases^activity 17847090
2064 96-48-0 FASN Homo sapiens 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid binds to and results in decreased activity of FASN protein affects^binding|decreases^activity 17847090
2065 96-48-0 FASN Homo sapiens [4-methylene-2-octyl-5-oxofuran-3-carboxylic acid co-treated with Cisplatin] results in decreased expression of FASN protein affects^cotreatment|decreases^expression 21442130
2066 96-48-0 FASN Homo sapiens [4-methylene-2-octyl-5-oxofuran-3-carboxylic acid co-treated with Cisplatin] results in decreased expression of FASN protein affects^cotreatment|decreases^expression 21442130
2067 96-48-0 FASN Homo sapiens 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased activity of FASN protein decreases^activity 21442130
2068 96-48-0 FASN Homo sapiens 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased activity of FASN protein decreases^activity 21442130
2069 96-48-0 FASN Homo sapiens [4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased activity of FASN protein] which results in increased susceptibility to Cisplatin decreases^activity|increases^response to substance 21442130
2070 96-48-0 FASN Homo sapiens [4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased activity of FASN protein] which results in increased susceptibility to Cisplatin decreases^activity|increases^response to substance 21442130
2071 96-48-0 FASN Mus musculus 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased expression of FASN mRNA decreases^expression 15707987
2072 96-48-0 FASN Mus musculus 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased expression of FASN mRNA decreases^expression 15707987
2073 96-48-0 FOS Mus musculus 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid affects the expression of FOS protein affects^expression 12724522
2074 96-48-0 FOS Mus musculus 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid affects the expression of FOS protein affects^expression 12724522
2075 96-48-0 MET Homo sapiens 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased expression of MET protein decreases^expression 25971889
2076 96-48-0 MET Homo sapiens 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased expression of MET protein decreases^expression 25971889
2077 96-48-0 PPARG Mus musculus 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased expression of PPARG mRNA decreases^expression 15707987
2078 96-48-0 PPARG Mus musculus 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased expression of PPARG mRNA decreases^expression 15707987
2079 96-48-0 PPP1R15A Homo sapiens [4-methylene-2-octyl-5-oxofuran-3-carboxylic acid co-treated with Thapsigargin] results in increased expression of PPP1R15A mRNA affects^cotreatment|increases^expression 17283163
2080 96-48-0 PPP1R15A Homo sapiens [4-methylene-2-octyl-5-oxofuran-3-carboxylic acid co-treated with Thapsigargin] results in increased expression of PPP1R15A mRNA affects^cotreatment|increases^expression 17283163
2081 96-48-0 TOP2A Homo sapiens 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased expression of TOP2A protein decreases^expression 17089011
2082 96-48-0 TOP2A Homo sapiens 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased expression of TOP2A protein decreases^expression 17089011
2083 96-48-0 XIAP Homo sapiens 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased expression of XIAP protein decreases^expression 21442130
2084 96-48-0 XIAP Homo sapiens 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased expression of XIAP protein decreases^expression 21442130
2085 96-48-0 GSTA1 Mus musculus angelica lactone results in increased expression of GSTA1 protein increases^expression 11309284
2086 96-48-0 GSTA1 Mus musculus angelica lactone results in increased expression of GSTA1 protein increases^expression 11309284
2087 96-48-0 GSTA2 Mus musculus angelica lactone results in increased expression of GSTA2 protein increases^expression 11309284
2088 96-48-0 GSTA2 Mus musculus angelica lactone results in increased expression of GSTA2 protein increases^expression 11309284
2089 96-48-0 GSTA3 Mus musculus angelica lactone results in increased expression of GSTA3 protein increases^expression 11309284
2090 96-48-0 GSTA3 Mus musculus angelica lactone results in increased expression of GSTA3 protein increases^expression 11309284
2091 96-48-0 GSTA4 Mus musculus angelica lactone results in increased expression of GSTA4 protein increases^expression 11309284
2092 96-48-0 GSTA4 Mus musculus angelica lactone results in increased expression of GSTA4 protein increases^expression 11309284
2093 96-48-0 GSTM1 Mus musculus angelica lactone results in increased expression of GSTM1 protein increases^expression 11309284
2094 96-48-0 GSTM1 Mus musculus angelica lactone results in increased expression of GSTM1 protein increases^expression 11309284
2095 96-48-0 GSTM5 Mus musculus angelica lactone results in increased expression of GSTM5 protein increases^expression 11309284
2096 96-48-0 GSTM5 Mus musculus angelica lactone results in increased expression of GSTM5 protein increases^expression 11309284
2097 96-48-0 GSTP1 Mus musculus angelica lactone results in increased expression of GSTP1 protein increases^expression 11309284
2098 96-48-0 GSTP1 Mus musculus angelica lactone results in increased expression of GSTP1 protein increases^expression 11309284
2099 96-48-0 GSTP2 Mus musculus angelica lactone results in increased expression of GSTP2 protein increases^expression 11309284
2100 96-48-0 GSTP2 Mus musculus angelica lactone results in increased expression of GSTP2 protein increases^expression 11309284
2101 96-48-0 GSTT1 Rattus norvegicus angelica lactone results in increased expression of GSTT1 protein increases^expression 9855024
2102 96-48-0 GSTT1 Rattus norvegicus angelica lactone results in increased expression of GSTT1 protein increases^expression 9855024
2103 96-48-0 NFE2L2 Mus musculus angelica lactone affects the activity of NFE2L2 protein affects^activity 11309284
2104 96-48-0 NFE2L2 Mus musculus angelica lactone affects the activity of NFE2L2 protein affects^activity 11309284
2105 96-48-0 NQO1 Mus musculus angelica lactone results in increased expression of NQO1 protein increases^expression 11309284
2106 96-48-0 NQO1 Mus musculus angelica lactone results in increased expression of NQO1 protein increases^expression 11309284
2107 96-48-0 NOS2 Mus musculus cacospongionolide B inhibits the reaction [Zymosan results in increased expression of NOS2 protein] decreases^reaction|increases^expression 12721113
2108 96-48-0 NOS2 Mus musculus cacospongionolide B inhibits the reaction [Zymosan results in increased expression of NOS2 protein] decreases^reaction|increases^expression 12721113
2109 96-48-0 PTGS2 Mus musculus cacospongionolide B inhibits the reaction [Zymosan results in increased expression of PTGS2 protein] decreases^reaction|increases^expression 12721113
2110 96-48-0 PTGS2 Mus musculus cacospongionolide B inhibits the reaction [Zymosan results in increased expression of PTGS2 protein] decreases^reaction|increases^expression 12721113
2111 96-48-0 TNF Homo sapiens cacospongionolide B inhibits the reaction [Zymosan results in increased expression of TNF protein] decreases^reaction|increases^expression 12721113
2112 96-48-0 TNF Homo sapiens cacospongionolide B inhibits the reaction [Zymosan results in increased expression of TNF protein] decreases^reaction|increases^expression 12721113
2113 96-48-0 TNF Mus musculus cacospongionolide B inhibits the reaction [Zymosan results in increased expression of TNF mRNA] decreases^reaction|increases^expression 12721113
2114 96-48-0 TNF Mus musculus cacospongionolide B inhibits the reaction [Zymosan results in increased expression of TNF mRNA] decreases^reaction|increases^expression 12721113
2115 96-48-0 PTGS2 Rattus norvegicus L 748706 results in decreased activity of PTGS2 protein decreases^activity 15878914
2116 96-48-0 PTGS2 Rattus norvegicus L 748706 results in decreased activity of PTGS2 protein decreases^activity 15878914
2117 96-48-0 PTGS2 Rattus norvegicus Piroxicam promotes the reaction [L 748706 results in decreased activity of PTGS2 protein] decreases^activity|increases^reaction 15878914
2118 96-48-0 PTGS2 Rattus norvegicus Piroxicam promotes the reaction [L 748706 results in decreased activity of PTGS2 protein] decreases^activity|increases^reaction 15878914
2119 96-48-0 APP Mus musculus ligustilide results in decreased expression of APP protein decreases^expression 23973442
2120 96-48-0 APP Mus musculus ligustilide results in decreased expression of APP protein decreases^expression 23973442
2121 96-48-0 CAT Mus musculus ligustilide results in increased expression of and results in increased activity of CAT protein increases^activity|increases^expression 23973442
2122 96-48-0 CAT Mus musculus ligustilide results in increased expression of and results in increased activity of CAT protein increases^activity|increases^expression 23973442
2123 96-48-0 CYP3A4 Homo sapiens [ligustilide results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA increases^activity|increases^expression 21524698
2124 96-48-0 CYP3A4 Homo sapiens [ligustilide results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA increases^activity|increases^expression 21524698
2125 96-48-0 HMOX1 Mus musculus ligustilide results in increased expression of HMOX1 mRNA increases^expression 23441843
2126 96-48-0 HMOX1 Mus musculus ligustilide results in increased expression of HMOX1 mRNA increases^expression 23441843
2127 96-48-0 HMOX1 Mus musculus ligustilide results in increased expression of HMOX1 protein increases^expression 23441843
2128 96-48-0 HMOX1 Mus musculus ligustilide results in increased expression of HMOX1 protein increases^expression 23441843
2129 96-48-0 KL Homo sapiens ligustilide results in increased expression of KL mRNA increases^expression 23973442
2130 96-48-0 KL Homo sapiens ligustilide results in increased expression of KL mRNA increases^expression 23973442
2131 96-48-0 KL Homo sapiens ligustilide results in increased expression of KL protein increases^expression 23973442
2132 96-48-0 KL Homo sapiens ligustilide results in increased expression of KL protein increases^expression 23973442
2133 96-48-0 NQO1 Mus musculus ligustilide results in increased expression of NQO1 mRNA increases^expression 23441843
2134 96-48-0 NQO1 Mus musculus ligustilide results in increased expression of NQO1 mRNA increases^expression 23441843
2135 96-48-0 NQO1 Mus musculus ligustilide results in increased expression of NQO1 protein increases^expression 23441843
2136 96-48-0 NQO1 Mus musculus ligustilide results in increased expression of NQO1 protein increases^expression 23441843
2137 96-48-0 NR1I2 Homo sapiens ligustilide results in increased activity of NR1I2 protein increases^activity 21524698
2138 96-48-0 NR1I2 Homo sapiens ligustilide results in increased activity of NR1I2 protein increases^activity 21524698
2139 96-48-0 SOD2 Mus musculus ligustilide results in increased expression of and results in increased activity of SOD2 protein increases^activity|increases^expression 23973442
2140 96-48-0 SOD2 Mus musculus ligustilide results in increased expression of and results in increased activity of SOD2 protein increases^activity|increases^expression 23973442
2141 96-48-0 UGT1A1 Mus musculus ligustilide results in increased expression of UGT1A1 protein increases^expression 23441843
2142 96-48-0 UGT1A1 Mus musculus ligustilide results in increased expression of UGT1A1 protein increases^expression 23441843
2143 96-48-0 ALB Bos taurus methyl 2-(7-hydroxy-2-oxonaphtho(1,2-b)furan-3(2H)-yliden)acetate binds to and affects the folding of ALB protein affects^binding|affects^folding 22074127
2144 96-48-0 ALB Bos taurus methyl 2-(7-hydroxy-2-oxonaphtho(1,2-b)furan-3(2H)-yliden)acetate binds to and affects the folding of ALB protein affects^binding|affects^folding 22074127
2145 96-48-0 CASP3 Mus musculus N-(3-oxododecanoyl)homoserine lactone results in increased activity of CASP3 protein increases^activity 25627690
2146 96-48-0 CASP3 Mus musculus N-(3-oxododecanoyl)homoserine lactone results in increased activity of CASP3 protein increases^activity 25627690
2147 96-48-0 CASP7 Mus musculus N-(3-oxododecanoyl)homoserine lactone results in increased activity of CASP7 protein increases^activity 25627690
2148 96-48-0 CASP7 Mus musculus N-(3-oxododecanoyl)homoserine lactone results in increased activity of CASP7 protein increases^activity 25627690
2149 96-48-0 P2RY2 Homo sapiens Ibuprofen inhibits the reaction [N-(3-oxododecanoyl)homoserine lactone results in decreased expression of P2RY2 mRNA] decreases^expression|decreases^reaction 10496880
2150 96-48-0 P2RY2 Homo sapiens Ibuprofen inhibits the reaction [N-(3-oxododecanoyl)homoserine lactone results in decreased expression of P2RY2 mRNA] decreases^expression|decreases^reaction 10496880
2151 96-48-0 P2RY2 Homo sapiens N-(3-oxododecanoyl)homoserine lactone results in decreased expression of P2RY2 mRNA decreases^expression 10496880
2152 96-48-0 P2RY2 Homo sapiens N-(3-oxododecanoyl)homoserine lactone results in decreased expression of P2RY2 mRNA decreases^expression 10496880
2153 96-48-0 P2RY4 Homo sapiens N-(3-oxododecanoyl)homoserine lactone results in decreased expression of P2RY4 mRNA decreases^expression 10496880
2154 96-48-0 P2RY4 Homo sapiens N-(3-oxododecanoyl)homoserine lactone results in decreased expression of P2RY4 mRNA decreases^expression 10496880
2155 96-48-0 PON2 Homo sapiens PON2 protein results in increased susceptibility to N-(3-oxododecanoyl)homoserine lactone increases^response to substance 25627690
2156 96-48-0 PON2 Homo sapiens PON2 protein results in increased susceptibility to N-(3-oxododecanoyl)homoserine lactone increases^response to substance 25627690
2157 96-48-0 P2RY2 Homo sapiens N-butyrylhomoserine lactone results in decreased expression of P2RY2 mRNA decreases^expression 10496880
2158 96-48-0 P2RY2 Homo sapiens N-butyrylhomoserine lactone results in decreased expression of P2RY2 mRNA decreases^expression 10496880
2159 96-48-0 P2RY4 Homo sapiens N-butyrylhomoserine lactone results in decreased expression of P2RY4 mRNA decreases^expression 10496880
2160 96-48-0 P2RY4 Homo sapiens N-butyrylhomoserine lactone results in decreased expression of P2RY4 mRNA decreases^expression 10496880
2161 96-48-0 BAX Homo sapiens protolichesterinic acid results in increased expression of BAX protein increases^expression 22063921
2162 96-48-0 BAX Homo sapiens protolichesterinic acid results in increased expression of BAX protein increases^expression 22063921
2163 96-48-0 BCL2 Homo sapiens protolichesterinic acid results in decreased expression of BCL2 protein decreases^expression 22063921
2164 96-48-0 BCL2 Homo sapiens protolichesterinic acid results in decreased expression of BCL2 protein decreases^expression 22063921
2165 96-48-0 CASP3 Homo sapiens protolichesterinic acid results in increased activity of CASP3 protein increases^activity 22063921
2166 96-48-0 CASP3 Homo sapiens protolichesterinic acid results in increased activity of CASP3 protein increases^activity 22063921
2167 96-48-0 HSPA1A Homo sapiens protolichesterinic acid results in decreased expression of HSPA1A protein decreases^expression 22063921
2168 96-48-0 HSPA1A Homo sapiens protolichesterinic acid results in decreased expression of HSPA1A protein decreases^expression 22063921
2169 96-48-0 NOS2 Homo sapiens protolichesterinic acid results in decreased expression of NOS2 protein decreases^expression 22063921
2170 96-48-0 NOS2 Homo sapiens protolichesterinic acid results in decreased expression of NOS2 protein decreases^expression 22063921
2171 96-48-0 TNFSF10 Homo sapiens protolichesterinic acid results in increased expression of TNFSF10 protein increases^expression 22063921
2172 96-48-0 TNFSF10 Homo sapiens protolichesterinic acid results in increased expression of TNFSF10 protein increases^expression 22063921
2173 96-48-0 CCL2 spirodiclofen results in decreased expression of CCL2 decreases^expression 21788198
2174 96-48-0 CCL2 spirodiclofen results in decreased expression of CCL2 decreases^expression 21788198
2175 96-48-0 CXCL10 spirodiclofen results in increased expression of CXCL10 increases^expression 21788198
2176 96-48-0 CXCL10 spirodiclofen results in increased expression of CXCL10 increases^expression 21788198
2177 96-48-0 SERPINE1 spirodiclofen affects the expression of SERPINE1 affects^expression 21788198
2178 96-48-0 SERPINE1 spirodiclofen affects the expression of SERPINE1 affects^expression 21788198
Serial No.Activity Name DetailsReferences (PubMed)Other details EPA (U.S)Clinical Trials (U.S. NIH)
1 96-48-0 Butyro-1,4-lactone
Print Back

Compound Image

2D Structure

Download



Download Sdf File Download PDB File Download MOL File
View Similar Structures
Disclaimer | © Copyright 2020
CSIR-CIMAP